Sentence,class,file
Semin Immunol 2014; 26:246–52; PMID:24856110; http://dx.doi.org/10.1016/j.smim.2014.03.005 e975093-12 Volume 2 Issue 4 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Cell 2009; 137:1100–11; PMID:19524512; http://dx.doi.org/10.1016/j.cell.2009.05.021 80 Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T, Mak TW, Wallach D, Green DR. Sur- vival function of the FADD-CASPASE-8-cFLIP(L) complex.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Cell Rep 2012; 1:401–7; PMID:22675671;http://dx.doi.org/10.1016/j.celrep.2012.03.010 81 Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, MocarskiES.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Nature 2011; 471:368–72; PMID:21368762; http://dx.doi.org/10.1038/ nature09857 82 Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Nature 2011;471:363–7; PMID:21368763; http://dx.doi.org/ 10.1038/nature09852 83 Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
Nature 2011; 471:373–6; PMID:21368761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Nat Rev Mol Cell Biol 2011; 12:757–63; PMID:22016059; http://dx.doi.org/10.1038/nrm3214 85 Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, H €acker G, Leverkus M. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell deathcomplex differentially regulated by cFLIP isoforms.",Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
Mol Cell 2011; 43:432–48;PMID:21737329; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Nature 2014;513:90–4; PMID:25132550; http://dx.doi.org/ 10.1038/nature13608 88 Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, Gon ¸calves A, Sze M, Gilbert B, Kourula S, et al.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Nature 2014; 513:95–9; PMID:25186904; http://dx.doi.org/ 10.1038/nature13706 89 Upton JW, Chan FK.",Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
Mol Cell 2014; 54:273–80; PMID:24766891; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Curr Opin Virol 2013;3:296–306; PMID:23773332; http://dx.doi.org/ 10.1016/j.coviro.2013.05.019 91 Khan N, Lawlor KE, Murphy JM, Vince JE.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Science 2014; 343:1357–60; PMID:24557836; http://dx.doi.org/10.1126/science.1249361 94 Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van TM, Lee TH, Chan FK, Pasparakis M, Kel-liher MA.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"J Immunol 2014; 193:1539–43; PMID:25015821; http://dx.doi.org/10.4049/ jimmunol.1400590 95 Boisson B, Laplantine E, Prando C, Giliani S, Israel- sson E, Xu Z, Abhyankar A, Isra €el L, Trevejo-Nunez G, Bogunovic D, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Science 2014; 343:1322–3; PMID:24653026; http://dx.doi.org/10.1126/ science.1252526 97 Moujalled DM, Cook WD, Okamoto T, Murphy J, Lawlor KE, Vince JE, Vaux DL.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Cell Death Dis 2013; 4:e465; PMID:23328672; http://dx.doi.org/10.1038/cddis.2012.201 98 Remijsen Q, Goossens V, Grootjans S, Van den Haute C, Vanlangenakker N, Dondelinger Y, Roelandt R,Bruggeman I, Goncalves A, Bertrand MJ, et al.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Cell Death Dis 2014; 5:e1004; PMID:24434512; http://dx.doi.org/10.1038/ cddis.2013.531 99 Mocarski ES, Kaiser WJ, Livingston-Rosanoff D, Upton JW, Daley-Bauer LP.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"J Immunol 2014; 192:2019–26; PMID:24563506; http://dx.doi.org/10.4049/jimmunol.1302426 100 Upton JW, Kaiser WJ, Mocarski ES.",Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Cell Host Microbe 2010; 7:302–13; PMID:20413098; http://dx.doi.org/ 10.1016/j.chom.2010.03.006 101 Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O’Reilly L, Mason K, Gross O, Ma S, Guarda G, et al.Inhibitor of apoptosis proteins limit RIP3 kinase- dependent interleukin-1 activation.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Immunity 2012; 36:215–27; PMID:22365665; http://dx.doi.org/ 10.1016/j.immuni.2012.01.012 102 Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inﬂammasome.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
Immunity 2013; 38:27– 40; PMID:23260196; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Proc Natl Acad Sci U S A 2014; 111:7391– 6; PMID:24799678; http://dx.doi.org/10.1073/ pnas.1403477111 104 Man SM, Tourlomousis P, Hopkins L, Monie TP, Fitzgerald KA, Bryant CE.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"J immunol 2013; 191:5239–46; PMID:24123685; http://dx.doi.org/ 10.4049/jimmunol.1301581 105 Gurung P, Anand PK, Malireddi RK, Vande Walle L, Van Opdenbosch N, Dillon CP, Weinlich R, Green DR, Lamkanﬁ M, Kanneganti TD.",Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"J Immunol 2014; 192:1835–46;PMID:24453255; http://dx.doi.org/10.4049/ jimmunol.1302839 106 Philip NH, Dillon CP, Snyder AG, Fitzgerald P, Wynosky-Dolﬁ MA, Zwack EE, Hu B, Fitzgerald L, Mauldin EA, Copenhaver AM, et al.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Proc Natl Acad Sci U S A 2014;111:7385–90; PMID:24799700; http://dx.doi.org/ 10.1073/pnas.1403252111 107 Sanjo H, Takeda K, Tsujimura T, Ninomiya-Tsuji J, Matsumoto K, Akira S. TAB2 Is Essential for Preven- tion of Apoptosis in Fetal Liver but Not for Interleu- kin-1 Signaling.",Non-OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"Mol Cell Biol 2003; 23:1231–8; PMID:12556483; http://dx.doi.org/10.1128/ MCB.23.4.1231-1238.2003 108 Ali M, Fritsch J, Zigdon H, Pewzner-Jung Y, Sch €utze S, Futerman AH.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"J Clin Invest 2006;116:2901–13; PMID:17024246; http://dx.doi.org/ 10.1172/JCI23771 110 Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, et al.",OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
Immunity 2004; 21:415–28;PMID:15357952; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/30/kmco-02-04-975093.PMC4905361.pdf
"pende@inserm.fr Submitted: 11/30/2014Revised: 12/09/2014Accepted: 12/10/2014 http://dx.doi.org/10.1080/23723556.2014.998100 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Dev Cell 2011; 21:193–215; PMID:21839917; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Cell 2012; 150:780–91; PMID:22863277; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Ann Intern Med 2002; 136:604–15; PMID:11955029; http://dx.doi.org/10.7326/0003- 4819-136-8-200204160-00010 5.,Non-OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
New Engl J Med 2008; 358:2649–51; PMID:18550886; http://dx.doi.org/ 10.1056/NEJMc0708819 6.,Non-OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Mol Cancer Ther 2009; 8:1799–807;PMID:19584242; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0055 7.,Non-OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Am J Res Cell Mol Biol 2013; 49:704–9; PMID:23947572; http://dx.doi.org/10.1165/rcmb.2013-0203RC 8.,OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Cancer Cell 2014; 25:166–80; PMID:24525233; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
Genes Dev 2010; 24:72–85; PMID:20048001; http://dx.doi.org/10.1101/gad.1843810 10.,OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
New Engl J Med 2013; 368:1845– 6; PMID:23656658; http://dx.doi.org/10.1056/ NEJMra1205406 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/53/84/kmco-02-04-998100.PMC4905364.pdf
"Although a preponderance of data sup- port the idea that Hedgehog signaling cor-relates with the potential for cancer © Zhen Xing, Chunru Lin, and Liuqing Yang *Correspondence to: Chunru Lin; Email: clin2@mdanderson.org; Liuqing Yang; Email: lyang7@mdanderson.orgSubmitted: 12/09/2014; Revised: 12/12/2014; Accepted: 12/12/2014 http://dx.doi.org/10.1080/23723556.2014.998900 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
Nat Rev Mol Cell Biol 2013; 14:699-712; PMID:24105322; http://dx.doi.org/10.1038/ nrm3679.,OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
Cell 2014; 158:593-606; PMID:25083870; http://dx.doi.org/10.1016/j.cell.2014.05.049.3.,OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
Trends Mol Med 2014; 20:428-436; PMID:24836411; http://dx.doi.org/10.1016/j.molmed.2014.03.005.,OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
Cell 2014; 159:1110-1125; PMID:25416949;http://dx.doi.org/10.1016/j.cell.2014.10.013.,OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
N Engl J Med 2009; 361:1164-1172; PMID:19726763; http://dx.doi.org/ 10.1056/NEJMoa0905360.,Non-OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
J Clin Oncol 2010; 28:5321- 5326; PMID:21041712; http://dx.doi.org/10.1200/ JCO.2010.27.9943.,Non-OADS,/arxiv_data1/oa_pdf/08/05/kmco-02-04-998900.PMC4905365.pdf
"This © Cyril H Benes *Correspondence to: Cyril Benes; Email: cbenes@partners.orgSubmitted: 12/11/2014; Revised: 12/12/2014; Accepted: 12/13/2014 http://dx.doi.org/10.1080/23723556.2014.999504 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
J Clin Oncol 2006; 24:3340-6; PMID:16785471; http://dx.doi.org/10.1200/ JCO.2005.05.4692 2.,Non-OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Lancet Oncol 2011; 12:1004-12; PMID:21933749; http://dx.doi.org/10.1016/S1470- 2045(11)70232-7 3.,Non-OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Sci Transl Med 2011; 3:75ra26;PMID:21430269; http://dx.doi.org/10.1126/ scitranslmed.3002003 4.,Non-OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Drug Resist Updat 2012; 15:268-75; PMID:23142522; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Nature 2013; 504:138-42; PMID:24185007; http://dx.doi.org/10.1038/ nature12688 6.,Non-OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Curr Opin Genet Dev 2008; 18:73-9; PMID:18325754; http://dx.doi.org/10.1016/j.gde.2008.01.004 7.,OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Am J Pathol 2012; 180:599-607; PMID:22189618; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Sci Signal 2013; 6:re6; PMID:24065147; http://dx.doi.org/10.1126/scisignal.2004652 10.,OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
Cell 2010; 141:69-80; PMID:20371346; http://dx.doi.org/ 10.1016/j.cell.2010.02.027 www.tandfonline.com e999504-3 Molecular & Cellular Oncology,OADS,/arxiv_data1/oa_pdf/95/88/kmco-02-04-999504.PMC4905366.pdf
"© Thierry Lebret, Yann Neuzillet, Nadine Hou /C19ed/C19e, Sandra Rebouissou, Isabelle Bernard-Pierrot, Aur /C19elien De Reyni /C18es, Simone Benhamou, Yves Allory, and Francois Radvanyi*Correspondence to: Thierry Lebret; Email: t.lebret@hopital-foch.orgSubmitted: 12/08/2014; Revised: 12/12/2014; Accepted: 12/13/2014 http://dx.doi.org/10.1080/23723556.2014.999507 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
65:778-92; PMID:24373477; http://dx.doi.org/ 10.1016/j.eururo.2013.11.046 2.,OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
2013; 63:58-66; PMID:22917984; http://dx.doi.org/ 10.1016/j.eururo.2012.08.010 3.,OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
Ann Oncol 2012; 23:2663-70; PMID:22473592; http://dx.doi.org/ 10.1093/annonc/mds057 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
Sci Transl Med 2014; 6:244ra91; PMID:25009231;http://dx.doi.org/10.1126/scitranslmed.3008970 7.,Non-OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
BJU Int 2010;106:349-54; PMID:20089114; http://dx.doi.org/10.1111/j.1464-410X.2009.09101.x 8.,OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
Clin Cancer Res 2012;18: 3377-86; PMID:22553347; http://dx.doi.org/ 10.1158/1078-0432.CCR-12-0077-T 9.,Non-OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
Nature 2014; 507:315-22; PMID:24476821; http://dx.doi.org/10.1038/nature12965 10.,Non-OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
Cancer Cell 2014; 25:152-65; PMID:24525232; http://dx.doi.org/ 10.1016/j.ccr.2014.01.009 www.tandfonline.com e999507-3 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/7a/58/kmco-02-04-999507.PMC4905367.pdf
"8T h eu n i q u er e v e r s i b i l i t yo fp r o t e i n acyl modiﬁcation a llows peripheral membrane proteins to rapidly pass backand forth between distinct intracellularKeywords: RARRES3, Wnt/ b-catenin pathway, protein acylation © Tzu-Hui Hsu and Tsu-Chung Chang *Correspondence to: Tsu-Chung Chang; Email: tcchang@ndmctsgh.edu.tw Submitted: 12/06/2014Revised: 12/13/2014Accepted: 12/15/2014 http://dx.doi.org/10.1080/23723556.2014.999512 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
Genome Biol 2003; 4:R11; http://dx.doi.org/10.1186/gb-2003-4-2-r11 3.,OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
FEBS Lett 2012; 586:1287-1293; http://dx.doi.org/10.1016/j.febslet.2012.03.020 4.,OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
"Cell Death Differ, 2015; 22:801-814; http://dx.doi.org/10.1038/ cdd.2014.175.",Non-OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
EMBO Mol Med 2014; 6:865-881; http://dx.doi.org/10.15252/ emmm.201303675 6.,Non-OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
Cell Signal 2011; 23:837-848; PMID:21244856;http://dx.doi.org/10.1016/j.cellsig.2011.01.007 8.,OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
"Oncogene, 2003; 22:4627-4635; http://dx.doi.org/10.1038/sj.onc.1206235 10.",OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
Cell Signal 2007; 19:989-999; PMID:17196792; http://dx.doi.org/10.1016/j.cellsig.2006.11.005 Figure 1.,OADS,/arxiv_data1/oa_pdf/f7/58/kmco-02-04-999512.PMC4905368.pdf
"2, e1062073 (2 pages)http://dx.doi.org/10.1080/23723556.2015.1062073",Non-OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
J Clin Oncol 2008; 26:374-9; http://dx.doi.org/10.1200/ JCO.2007.12.5906 2.,Non-OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
Nat Genet 2015:47; 250-6;PMID:25665005; http://dx.doi.org/10.1038/ng.3218 5 .,OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
Cancer Cell2015; 27:240-56; PMID:25600339; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
Cell Rep 2012; 2:840-54; PMID:23041317; http://dx.doi.org/10.1016/j.celrep.2012.08.028 7.,OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
Sci Signal 2015; 8:ra38; PMID:25900832; http://dx.doi.org/ 10.1126/scisignal.2005886 8.,OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
Deve lopment 2010; 137:1825-32; PMID:20460366; http://dx.doi.org/10.1242/dev.045484 9.,Non-OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
Cell 2010; 143:1136-48; PMID:21183076; http://dx.doi.org/10.1016/j.cell.2010.11.034e1062073-2 L. ESPINOSA,OADS,/arxiv_data1/oa_pdf/cc/38/kmco-03-02-1062073.PMC4905373.pdf
"2, e1088503 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1088503",Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Nat Rev Mol Cell Biol 2007; 8:379-93; PMID:17426725; http://dx.doi.org/10.1038/nrm2163 Figure 1.,OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Nat Rev Cancer 2007;7:107-17; PMID:17251917; http://dx.doi.org/10.1038/nrc2049 3.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Nat Rev Cancer 2004; 4:253-65; PMID:15057285; http://dx.doi.org/ 10.1038/nrc1317 4.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Cancer Cell 2009; 16:347-58; PMID:19800579; http://dx.doi.org/10.1016/j.ccr.2009.08.020 5.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Cancer Cell 2008; 14:111-22; PMID:18656424; http://dx.doi.org/ 10.1016/j.ccr.2008.07.002 6.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Cancer Cell 2003; 3:51-62; PMID:12559175; http://dx.doi.org/10.1016/S1535-6108(02)00235-07.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Cancer research2004; 64:2502-8; PMID:15059905; http://dx.doi.org/10.1158/0008-5472.CAN-03-2013 8.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Curr Opin Cell Biol 2006; 18:658-67; PMID:17046232; http://dx.doi.org/10.1016/j.ceb.2006.10.002 9.,OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
"Nat Commun 2015; 6:7668; PMID:26144554; http://dx.doi.org/10.1038/ ncomms8668 1 0 .M i k iH ,O k a d aY ,H i r o k a w aN .A n a l y s i so ft h ek i n e s i ns u p e r - family: insights into structure and function.",OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
Trends Cell Biol 2005; 15:467-76; PMID:16084724; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/7a/kmco-03-02-1088503.PMC4905391.pdf
"2, e1075643 (7 pages)http://dx.doi.org/10.1080/23723556.2015.1075643",Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nature 2006; 442:947-51; PMID:16862117; http://dx.doi.org/10.1038/nature04985 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2008; 10:322-8; PMID:18297061; http://dx.doi.org/10.1038/ncb1694 3.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2011; 13:966-72; PMID:21743463; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Biol Open 2012; 1:1153-60; PMID:23213396; http://dx.doi.org/10.1242/bio.20122626 7.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Dev Cell 2008; 14:331-41; PMID:18331714; http://dx.doi.org/10.1016/j.devcel.2007.12.007 8.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2007; 178:345-54; PMID:17664331; http://dx.doi.org/10.1083/jcb.200701163 9.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2009; 187:607-14; PMID:19948489; http://dx.doi.org/10.1083/jcb.200906019 10.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2013; 23:R601-3;PMID:23885871; http://dx.doi.org/10.1016/j.cub.2013.04.003 11.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2012; 22:915-21; PMID:22542101; http://dx.doi.org/10.1016/j.cub.2012.03.048 12.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Cell Cycle 2012; 11:2476-85; PMID:22722493; http://dx.doi.org/10.4161/cc.20878 13.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2013; 23:1380-7; PMID:23885867; http://dx.doi.org/10.1016/j.cub.2013.06.043 14.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2010; 20:1277-82; PMID:20656208; http://dx.doi.org/10.1016/j.cub.2010.05.050 15.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
JCell Biol 2011; 193:727-39; PMID:21576395; http://dx.doi.org/10.1083/jcb.201101109 16.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2014; 206:855-65;PMID:25246616; http://dx.doi.org/10.1083/jcb.201407087 17.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2012; 197:11-8; PMID:22472437;http://dx.doi.org/10.1083/jcb.201108006 18.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2007; 120:4321-31;PMID:18042621; http://dx.doi.org/10.1242/jcs.020248 19.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2011; 13:1154- 60; PMID:21968988; http://dx.doi.org/10.1038/ncb2345 20.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
DevCell 2007; 13:190-202; PMID:17681131; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2005; 7:1140-6; PMID:16244668; http://dx.doi.org/10.1038/ncb1320 22.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2005; 15:2199-207; PMID:16326102; http://dx.doi.org/10.1016/j.cub.2005.11.042 23.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2013; 126:3223-33; PMID:23641073;http://dx.doi.org/10.1242/jcs.129502 24.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2012; 14:1126-8; PMID:23131920; http://dx.doi.org/10.1038/ncb2617 26.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Struct MolBiol 2014; 21:696-703; PMID:24997597; http://dx.doi.org/10.1038/nsmb.2846 27.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Genet 2011; 43:1147-53; PMID:21983783; http://dx.doi.org/10.1038/ng.971 28.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
PLoS One2013; 8:e69986; PMID:23936128; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2013; 23:265-70; PMID:23333316; http://dx.doi.org/10.1016/j.cub.2012.12.030 3 0 .,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBO J 2011; 30:4790-804; PMID:22020124; http://dx.doi.org/10.1038/emboj.2011.378 31.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2012; 125:1342-52; PMID:22349698; http://dx.doi.org/10.1242/ jcs.099887 32.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Com- mun 2014; 5:5267; PMID:25342035; http://dx.doi.org/10.1038/ncomms6267 33.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Biol Open 2015; 4:370-7; PMID:25701666; http://dx.doi.org/10.1242/bio.201411023 34.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Opin Cell Biol 2014; 26:96-106; PMID:24529251; http://dx.doi.org/10.1016/j.ceb.2013.12.001 35.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Opin Cell Biol 2012; 24:4- 13; PMID:22321829; http://dx.doi.org/10.1016/j.ceb.2012.01.003 36.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
"Cell 2011; 144:364-75; PMID:21277013; http://dx.doi.org/10.1016/j.cell.2011.01.008 37. van Breugel M, Hirono M, Andreeva A, Yanagisawa HA, Yamaguchi S, Nakazawa Y, Morgner N, Petrovich M, Ebong IO, Robinson CV, et al.",OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Sci- ence 2011; 331:1196-9; PMID:21273447; http://dx.doi.org/10.1126/science.1199325MOLECULAR & CELLULAR ONCOLOGY e1075643-5,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Dev Cell 2014; 30:238-45; PMID:25017693; http://dx.doi.org/10.1016/j.devcel.2014.05.008 39.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2014; 24:351-60; PMID:24485834; http://dx.doi.org/ 10.1016/j.cub.2013.12.016 40.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBO J 2010; 29:1565-72;PMID:20339347; http://dx.doi.org/10.1038/emboj.2010.45 42.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Rev Mol Cell Biol 2012; 13:425-35; PMID:22691849; http://dx.doi.org/10.1038/nrm3373 43.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBO J 2013; 32:1141-54;PMID:23511974; http://dx.doi.org/10.1038/emboj.2013.56 44.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2009; 19:1005-11; PMID:19481458; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2009; 11:825-31; PMID:19503075; http://dx.doi.org/10.1038/ncb1889 47.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2012; 125:1353-62; PMID:22349705; http://dx.doi.org/10.1242/jcs.104109 48.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Structure 2013; 21:2069-77; PMID:24076405; http://dx.doi.org/ 10.1016/j.str.2013.08.019 49.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Elife 2013; 2:e01071;PMID:24052813; http://dx.doi.org/10.7554/eLife.01071 50.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J CellBiol 2010; 191:331-46; PMID:20956381; http://dx.doi.org/10.1083/jcb.201003009 51.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2013; 202:211-9; PMID:23857771; http://dx.doi.org/10.1083/jcb.201212060 52.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2013; 23:1360-6; PMID:23810536; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBO J 2010; 29:2395-406; PMID:20531387; http://dx.doi.org/10.1038/emboj.2010.118 54.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2011; 193:711-25; PMID:21576394; http://dx.doi.org/10.1083/jcb.201006135 55.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Biol Chem 2014; 289:15166-78; PMID:24700465; http://dx.doi.org/10.1074/jbc.M113.531152 56.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Biol Chem2015; 290:6890-902; PMID:25616662; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2009; 185:101-14; PMID:19349582; http://dx.doi.org/10.1083/jcb.200808082 58.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Dev Cell 2010; 18:410-24; PMID:20230748; http://dx.doi.org/ 10.1016/j.devcel.2009.12.022 59.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Mol Biol Cell 2009; 20:1150-66; PMID:19109428; http://dx.doi.org/10.1091/mbc.E08-06-0619 60.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Cell 2007; 130:678-90; PMID:17719545; http://dx.doi.org/10.1016/j.cell.2007.06.027 61.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nature 2010; 466:138-42; PMID:20596027; http://dx.doi.org/10.1038/nature09140 63.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nature 2013;495:255-9; PMID:23486064; http://dx.doi.org/10.1038/nature11941 64.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Commun 2011; 2:359; PMID:21694707; http://dx.doi.org/10.1038/ncomms1367 65.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2012; 14:865-73; PMID:22729084; http://dx.doi.org/10.1038/ncb2527 67.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Mol Cell Proteomics 2011; 10:M110 004457; PMID:20860994; http://dx.doi.org/10.1074/mcp.M110.004457 68.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2011; 195:1093- 101; PMID:22184200; http://dx.doi.org/10.1083/jcb.201106093 69.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2006; 172:505-15; PMID:16461362; http://dx.doi.org/10.1083/jcb.200510028 70.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2008; 18:136-41; PMID:18207742; http://dx.doi.org/10.1016/j.cub.2007.12.055 71.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Mol Biol Cell 2008; 19:115-25; PMID:17959831; http://dx.doi.org/10.1091/mbc.E07-04-0371e1075643-6 H. FUJITA ET AL.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2010;191:1089-95; PMID:21135143; http://dx.doi.org/10.1083/jcb.201007030 73.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Dev Cell 2003; 5:113-25; PMID:12852856;http://dx.doi.org/10.1016/S1534-5807(03)00193-X 74.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2005; 118:5101-8; PMID:16254247; http://dx.doi.org/10.1242/jcs.02622 75.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Rev Cancer 2010;10:825-41; PMID:21102634; http://dx.doi.org/10.1038/nrc2964 76.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Science 2008; 320:1655-8; PMID:18566290; http://dx.doi.org/10.1126/science.1157425 77.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery.Nature 2008; 455:119-23; PMID:18615013; http://dx.doi.org/ 10.1038/nature07185 78.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Proc Natl Acad Sci U S A 2011; 108:9310-5; PMID:21576470; http://dx.doi.org/10.1073/ pnas.1101112108 79.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2008; 181:65-78; PMID:18378770; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2014; 127:801-11; PMID:24338364; http://dx.doi.org/10.1242/jcs.137216 81.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Cell Cycle 2006; 5:296-303; PMID:16418575; http://dx.doi.org/10.4161/cc.5.3.2392 82.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 1998; 141:1563-74; PMID:9647649; http://dx.doi.org/10.1083/jcb.141.7.1563 83.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Biol 2005; 171:27-33; PMID:16203858; http://dx.doi.org/10.1083/jcb.200504107 84.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Exp Cell Res2008; 314:3692-700; PMID:18851962; http://dx.doi.org/10.1016/j.yexcr.2008.09.016 85.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
JCell Sci 2014; 127:2493-506; PMID:24695856; http://dx.doi.org/ 10.1242/jcs.142331 86.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
J Cell Sci 2014; 127:1631-9; PMID:24554434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Eur J Cell Biol 2015; 94:162-72; PMID:25704143; http://dx.doi.org/10.1016/j.ejcb.2015.01.004 88.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Cell Rep 2013;4:1100-7; PMID:24035387; http://dx.do i.org/10.1016/j.celrep.2013.08.00589.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
NatCommun 2013; 4:1531; PMID:23443559; http://dx.doi.org/10.1038/ ncomms2517 90.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Curr Biol 2011; 21:1145-51; PMID:21723128; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Nat Cell Biol 2010; 12:1166-76; PMID:21076410; http://dx.doi.org/10.1038/ncb2120 92.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Biochem Biophys Res Commun 2010; 398:217-23; PMID:20599736; http://dx.doi.org/10.1016/j.bbrc.2010.06.063 94.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Cancer Res 2007;67:1082-9; PMID:17283141; http://dx.doi.org/10.1158/0008-5472.CAN-06-3071 95.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBOJ 2011; 30:2233-45; PMID:21522128; http://dx.doi.org/10.1038/ emboj.2011.120 96.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBO J 2011; 30:2634-47; PMID:21642957; http://dx.doi.org/10.1038/emboj.2011.179 97.,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
EMBO J2012; 31:4179-90; PMID:23034402; http://dx.doi.org/10.1038/emboj.2012.272 98.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
CellCycle 2014; 13:1162-70; PMID:24553118; http://dx.doi.org/10.4161/cc.28031 100.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Dev Cell 2013; 25:229-40;PMID:23643362; http://dx.doi.org/10.1016/j.devcel.2013.03.012 101.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Cell Mol Life Sci 2013; 70:1021-34; PMID:22892665; http://dx.doi.org/10.1007/s00018-012-1102-6 103.,OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
"Pihan GA. Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer.Front Oncol 2013; 3:277; PMID:24282781; http://dx.doi.org/10.3389/fonc.2013.00277 104.",OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
Philos Trans R Soc Lond B Biol Sci 2014;369:20130467; PMID:25047621; http://dx.doi.org/10.1098/rstb.2013.0467MOLECULAR & CELLULAR ONCOLOGY e1075643-7,Non-OADS,/arxiv_data1/oa_pdf/d7/f6/kmco-03-02-1075643.PMC4905396.pdf
"2, e1103398 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1103398",Non-OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Microbiol Mol Biol Rev 2006; 70:1061- 95; PMID:17158707; http://dx.doi.org/10.1128/MMBR.00025-06 2.,Non-OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Br J Pharmacol 2014; 171:24-37; PMID:24117156; http://dx.doi.org/10.1111/bph.12432 3.,Non-OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Nat Commun 2015; 6:7882; PMID:26258887; http://dx.doi.org/10.1038/ncomms8882 4.,OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Onco- gene 2013; 32:4231-42; PMID:23045269; http://dx.doi.org/10.1038/onc.2012.448 5.,OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Trends Biochem Sci 2012; 37:309-16; PMID:22626471; http://dx.doi.org/10.1016/j.tibs.2012.04.003 6.,OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Nat Rev Cancer 2011; 11:85-95; PMID:21258394; http://dx.doi.org/10.1038/nrc2981 7.,Non-OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Oncogene 2014; 33:4279-85; PMID:24096483; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Sci Signal 2009; 2:ra73; PMID:19920251; http://dx.doi.org/10.1126/scisignal.2000431 9.,OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
Nat Cell Biol2012; 14:1295-304; PMID:23178880; http://dx.doi.org/10.1038/ ncb2629 10.,OADS,/arxiv_data1/oa_pdf/31/17/kmco-03-02-1103398.PMC4905410.pdf
"2, e1117700 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1117700",Non-OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Genes Dev 2015 Jul; 29(14):1447-62; PMID:26220992; http://dx.doi.org/10.1101/gad.263145.115 2.,OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Expert Opin Pharmacother 2013Oct; 14(15):2019-31; PMID:23901936; http://dx.doi.org/10.1517/14656566.2013.823401 3.,Non-OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Nature 2013 Oct; 502(7472):480-8; PMID:24153301; http://dx.doi.org/10.1038/nature12751 5.,OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Cancer Cell 2015 Jul; 28(1):57-69;PMID:26175415; http://dx.doi.org/10.1016/j.ccell.2015.06.002 6.,OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Med Res Rev 2015 Sep; 35(5):1032-71;PMID:25990136; http://dx.doi.org/10.1002/med.21350 7.,Non-OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Expert Opin Ther Targets 2012 Dec; 16(12):1239-49; PMID:22957941; http://dx.doi.org/10.1517/14728222.2012.722206 8.,Non-OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Nat Cell Biol 2011Jun; 13(6):652-9; PMID:21602794; http://dx.doi.org/10.1038/ncb2246 9.,OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
Leukemia 2012 Sep; 26(9):2039-51; PMID:22699452; http://dx.doi.org/10.1038/leu.2012.157 10.,Non-OADS,/arxiv_data1/oa_pdf/bd/0f/kmco-03-02-1117700.PMC4905412.pdf
"*Correspondence to: Konrad Krzewsk; Email: krzewskikj@niaid.nih.govSubmitted: 07/31/2014; Revised: 08/07/2014; Accepted: 08/12/2014 http://dx.doi.org/10.4161/23723548.2014.964625 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Annu Rev Pathol 2012; 7:61-98; PMID:21910624; http://dx.doi.org/10.1146/annurev- pathol-011811-132445 2.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Blood 2013; 121:1951-60; PMID:23293083; http://dx.doi.org/10.1182/blood-2012-09-435057 3.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Immunity 2012; 37:827-39; PMID:23123064; http://dx.doi.org/10.1016/j.immuni.2012.08.018 4.,OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Nat commun 2014; 5:3146;PMID:24477292; http://dx.doi.org/10.1038/ncomms 4146 5.,OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
J Exp Med 2010; 207:1501-11; PMID:20566714; http://dx.doi.org/ 10.1084/jem.20090581 6.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
J Immunol 2012; 189:1773-9; PMID:22772446; http://dx.doi.org/10.4049/jimmunol.1201139 7.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Blood 2012; 119:2799- 809; PMID:22302738; http://dx.doi.org/10.1182/blood-2011-08-3724258.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
J Immunol 2011; 187:3483-7; PMID:21865548; http://dx.doi.org/10.4049/jimmunol.1101549 9.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Blood 2008; 111:688-98; PMID:17928527; http://dx.doi.org/ 10.1182/blood-2007-04-085787 10.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
Cell Death Differ 2014; 21:1746-57; PMID:25034781; http://dx.doi.org/10.1038/cdd.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/kmco-02-04-964625.PMC4905414.pdf
"This PCR array-basedscreening led to the discovery of downre-gulation of several lipid catabolism genes,especially medium-chain acyl-CoA © Huafeng Zhang *Correspondence to: Huafeng Zhang; Email: hzhang22@ustc.edu.cnSubmitted: 10/20/2014; Revised: 10/21/2014; Accepted: 10/21/2014 http://dx.doi.org/10.4161/23723556.2014.980184 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
Cell metabolism 2006; 3:177-85; PMID:16517405; http://dx.doi.org/10.1016/j.cmet.2006.02.002 3.,OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.Cell metabolism 2006; 3:187-97; PMID:16517406; http://dx.doi.org/10.1016/j.cmet.2006.01.012 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
Cancer Cell 2007; 11:407-20; PMID: 17482131; http://dx.doi.org/10.1016/j.ccr.2007.04.001 5.,Non-OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
J Biol Chem 2008; 283: 10892- 903; PMID:18281291; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
Science 2009; 324:1029-33; PMID:19460998; http://dx.doi.org/ 10.1126/science.11608097.,Non-OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
Nature2009; 458:762-5; PMID:19219026; http://dx.doi.org/ 10.1038/nature07823 8.,Non-OADS,/arxiv_data1/oa_pdf/aa/4e/kmco-02-04-980184.PMC4905416.pdf
"Notably, © Deyong Jia and Lisheng Wang *Correspondence to: Lisheng Wang; Email: lwang@uottawa.caSubmitted: 10/21/2014; Revised: 10/22/2014; Accepted: 10/23/2014 http://dx.doi.org/10.4161/23723556.2014.981443 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
Oncogene 2014; 33(27):3485-95; PMID:23934186; http://dx.doi.org/ 10.1038/onc.2013.302 2.,Non-OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
BMC Cancer 2010; 10:665; PMID:21129170; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
Nat Rev Drug Discov 2012; 11(7):503-5;PMID:22743965; http://dx.doi.org/10.1038/nrd37755.,OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
Cell Stem Cell 2012; 10(6):717-28; PMID:22704512; http://dx.doi.org/10.1016/j.stem.2012.05.007 6.,OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
Cell Cycle 2013; 12(22):3471-7; PMID:24107627; http://dx.doi.org/10.4161/cc.26692 8.,Non-OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
J Clin Invest 2012; 122 (11):4077-93; PMID:23093782; http://dx.doi.org/10.1172/JCI64057 9.,Non-OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
Mol Cell 2014; 54(5):716-27; PMID:24905005; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
Cell 2012; 151(3):547- 558; PMID:23101625; http://dx.doi.org/10.1016/j.cell.2012.09.034 www.tandfonline.com e981443-3 Molecular & Cellular Oncology,OADS,/arxiv_data1/oa_pdf/27/df/kmco-02-04-981443.PMC4905417.pdf
"2, e1120845 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1120845",Non-OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Nat Rev Cancer 2004; 4:437-47; PMID:15170446; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Nat Rev Cancer 2010; 10:267-77; PMID:20300106; http://dx.doi.org/10.1038/nrc2817 3.,Non-OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Mol Cell 2008; 30:393-402;PMID:18498744; http://dx.doi.org/10.1016/j.molcel.2008.04.009 4.,OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Cancer Cell 2009; 16:413-24;PMID:19878873; http://dx.doi.org/10.1016/j.ccr.2009.09.029 5.,Non-OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Genes Dev 2014; 28:1429-44; PMID:24990963; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Cancer Cell 2007; 11:407-20; PMID:17482131; http://dx.doi.org/10.1016/j.ccr.2007.04.0018.,Non-OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Nature Med 2001; 7:1111-7; PMID:11590433; http://dx.doi.org/ 10.1038/nm1001-1111 9 .,OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
Mol Sys Biol 2013; 9:712; http://dx.doi.org/10.1038/msb.2013.65MOLECULAR & CELLULAR ONCOLOGY e1120845-3,Non-OADS,/arxiv_data1/oa_pdf/be/92/kmco-03-02-1120845.PMC4905419.pdf
"2, e1124174 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1124174",Non-OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
Cell Stem Cell 2012; 10:717-28; PMID:22704512; http://dx.doi.org/10.1016/j.stem.2012.05.007 2.,OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
Cell 2009; 138:822-9; PMID:19737509; http://dx.doi.org/10.1016/j.cell.2009.08.017 3.,OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
Nature 2006; 444:761-5; PMID:17151667; http://dx.doi.org/ 10.1038/nature05349 4.,Non-OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
Stem Cell Reports 2015; 5:829-42; http://dx.doi.org/10.1016/j.stemcr.2015.09.014 5 .,OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
Cell 2014; 157 (3):580-94; PMID:24726434; http://dx.doi.org/10.1016/j.cell.2014.02.030 7.,OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
Cancer Cell 2008; 13:69-80; PMID:18167341; http://dx.doi.org/10.1016/j.ccr.2007.12.005MOLECULAR & CELLULAR ONCOLOGY e1124174-3,Non-OADS,/arxiv_data1/oa_pdf/77/d3/kmco-03-02-1124174.PMC4905420.pdf
"2, e1128516 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1128516",Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Cancer 2011; 117:1687-96; PMID:20960525; http://dx.doi.org/10.1002/cncr.25634 2.,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Cell Reports 2015; 13:898-905; PMID:26565903; http://dx.doi.org/10.1016/j.celrep.2015.09.057 3.,OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Integrated Molecu- lar and Clinical Analysis of AKT Activation in Metastatic Melanoma.Clin Cancer Res 2009; 15:7538-46; PMID:19996208; http://dx.doi.org/10.1158/1078-0432.CCR-09-1985 4.,OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Cancer Med 2013; 2:76-85; PMID:24133630; http://dx.doi.org/10.1002/cam4.50 5.,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Clin Cancer Res 2014; 20(21):5537-46; PMID:24803579; http://dx.doi.org/10.1158/1078-0432.CCR-13-3003 6.,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Nat Genet 2009; 41:544-52; PMID:19282848; http://dx.doi.org/10.1038/ng.356 7.,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Cell 2012; 150:251-63; PMID:22817889;http://dx.doi.org/10.1016/j.cell.2012.06.024 8.,OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Cancer discovery 2014; 4:69-79; PMID:24265152; http://dx.doi.org/10.1158/2159-8290.CD-13-0279 9.,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
J Invest Derma- tol 2008; 128:980-7; PMID:17914450; http://dx.doi.org/10.1038/sj.jid.5701074 10.,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
Cancer Cell 2015; 27:41-56; PMID:25584893; http://dx.doi.org/10.1016/j.ccell.2014.11.014MOLECULAR & CELLULAR ONCOLOGY e1128516-3,Non-OADS,/arxiv_data1/oa_pdf/06/0b/kmco-03-02-1128516.PMC4905423.pdf
"The consequent increase inthe antiproliferative effect of TGF- b © Hadrien Demagny and Edward M De Robertis *Correspondence to: Edward M De Robertis; Email: ederobertis@mednet.ucla.eduSubmitted: 11/09/2014; Revised: 11/13/2014; Accepted: 11/14/2014 http://dx.doi.org/10.4161/23723556.2014.989133 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Nat Rev Mol Cell Biol 2001; 2: 769-76; PMID:11584304;http://dx.doi.org/10.1038/35096075 3.,OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Cell 2010; 143: 1136-48; PMID:21183076; http://dx.doi.org/ 10.1016/j.cell.2010.11.034 4.,OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Cytokine Growth Factor Rev 2006; 17: 41-58; PMID:16310402; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Cell 2011; 144: 646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013 7.,OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Nature 2011; 470: 269- 73; PMID:21289624; http://dx.doi.org/10.1038/nature096778.,OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Cell 1998; 92: 645-56; PMID:9506519; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
Hum Mutat 2006; 27: 897-905; PMID:16865698; http://dx.doi.org/10.1002/humu.20387 Figure 1.,OADS,/arxiv_data1/oa_pdf/4d/c2/kmco-03-02-989133.PMC4905428.pdf
"10Moreover, resection is essen- tial for all types of recombinational repair, © Pablo Huertas and Andr /C19es Cruz-García *Correspondence to: Pablo Huertas; Email: pablo.huertas@cabimer.esSubmitted: 10/29/2014; Revised: 10/29/2014; Accepted: 10/29/2014 http://dx.doi.org/10.4161/23723556.2014.982964 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
Nat Struct Mol Biol 2010; 17:11–6; PMID:0051983; http://dx.doi.org/10.1038/nsmb.1710 2.,OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
Annu Rev Genet 2010; 44:113-39; PMID:20690856; http://dx.doi.org/ 10.1146/annurev-genet-051710-150955 3.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
Nature 2012; 481:287-94; PMID:22258607; http://dx.doi.org/10.1038/nature10760 4.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
Cancer discovery 2012; 2:679-84;PMID:22843421; http://dx.doi.org/10.1158/2159- 8290.CD-12-0221 5.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
PLoS Genetics 2010; 6:e1000828; PMID:20107609; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
J Cell Biol 2013; 201:693-707; PMID:23712259; http://dx.doi.org/10.1083/jcb.201302145 8.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
Nature 2009; 459:460-3; PMID:19357644; http://dx.doi.org/10.1038/nature 07955 9.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
Biochem J2009; 423:157-68; PMID:19772495; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/6c/kmco-02-03-982964.PMC4905430.pdf
"© Rom Keshet, Nina Reuven, and Yosef Shaul *Correspondence to: Yosef Shaul; Email: yosef.shaul@weizmann.ac.ilSubmitted: 11/25/2014; Revised: 11/26/2014; Accepted: 11/26/2014 http://dx.doi.org/10.4161/23723556.2014.995006 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Physiol Rev 2014; 94:1287-1312; PMID:25287865; http://dx.doi.org/10.1152/physrev.00005.2014 2.,Non-OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Nature 1999; 399:809-813; PMID:10391250; http://dx.doi.org/10.1038/21697 3.,Non-OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Cell Death Differ 2007; 14:743-751; PMID:17110958; http://dx.doi.org/ 10.1038/sj.cdd.4402063 5.,Non-OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
PMID:25361080; http://dx.doi.org/10.1038/cdd.2014.,OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Cell 2014; 158:1022-32; PMID:25171404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Cell Death Differ 2013; 20:1330-1340;PMID:23852372; http://dx.doi.org/10.1038/ cdd.2013.838.,Non-OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Proc Natl Acad Sci USA 2014; 111:16365-16370;PMID:25368164; http://dx.doi.org/10.1073/ pnas.1411086111 www.tandfonline.com e995006-3 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/74/a8/kmco-02-03-995006.PMC4905508.pdf
Alterations in this equilibrium can result in  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/9f/emss-62191.PMC4905521.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/09/awv328.PMC4905522.pdf
"2, e1083648 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1083648",Non-OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
PLoS One 2010; 5:e15852; PMID:21209853; http://dx.doi.org/ 10.1371/journal.pone.0015852 2.,Non-OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Trends Cell Biol 2011; 2:81 –90; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Cancer Res 2007 ; 67:2657 –2665; PMID:17363586; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Proc Natl AcadSci USA 2012 ;109:19280 –19285; PMID:23129656; http://dx.doi.org/ 10.1073/pnas.1214394109 5.,OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Oncotarget 2014; 5(22):11054 –63; PMID:25373410; http://dx.doi.org/10.18632/oncotarget.2609 6.,OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Sem Cell Dev Biol 2010 ;21:944 –950; http://dx.doi.org/ 10.1016/j.semcdb.2010.08.007 9.,OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Cancer Cell 2011; 19:58 –71; PMID:21215704; http://dx.doi.org/10.1016/j.ccr.2010.10.031 10.,Non-OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
"Singh A, Ye M, Bucur O, Zhu S, Tanya Santos M, Rabinovitz I, Wei W, Gao D, Hahn WC, Khosravi-Far R. Protein phosphatase 2A reacti-vates FOXO3a through a dynamic interplay with 14-3-3 and AKT.Mol Biol Cell 2010; 21:1140 –1152; PMID:20110348; http://dx.doi.org/ 10.1091/mbc.E09-09-0795MOLECULAR & CELLULAR ONCOLOGY e1083648-3",Non-OADS,/arxiv_data1/oa_pdf/6c/8a/kmco-03-02-1083648.PMC4905527.pdf
Retrieved from http://www.cdc.gov/mmwr/ pdf/ss/ss60e0606.pdf.,OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
"Retrieved December 21, 2015, from http://www.cdc.-gov/lgbthealth/youth-programs.htm Cook, D. T., & Kaiser, S. B.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
"Retrieved December 21, 2015, from http://www.gsanetwork.org/about-us Gedicks, A.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
Retrieved from http://comm-org.wisc.edu/si/sihome.htm Gonzalez v. School Board of Okeechobee County .,Non-OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
"Retrieved fromhttp://grants.nih.gov/grants/guide/notice-ﬁles/NOT-OD-01-053.html Noguera, P. A.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
Retrieved from http://rhrealitycheck.org/article/2012/05/01/he-men-14 RUSSELL,Non-OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
"Retrieved from http://www.theatlantic.com/ business/archive/2015/05/stranded-how-americas- failing-public-transportation-increases-inequality/ 393419/ Wilkinson-Lee, A., Russell, S. T., & Lee, F. C. H., & Latina/o Teen Pregnancy Prevention Workgroup.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/JORA-26-4.PMC4905581.pdf
"Washington, DC;  September 2013. http://www.gao.gov/assets/660/657454.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/10.1177_0046958016652523.PMC4905592.pdf
Manski et al 11 2013. http://www.ada.org/~/media/ADA/Science%20and%20 Research/HPI/Files/HPIBrief_0813_1.ashx.,OADS,/arxiv_data1/oa_pdf/c7/a7/10.1177_0046958016652523.PMC4905592.pdf
"Baltimore, MD: Centers for Medicare &  Medicaid Services; 2010. https://www.medicare.gov/cover-age/dental-services.html.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/10.1177_0046958016652523.PMC4905592.pdf
"April 10, 2015. http://www.dentaleconom-ics.com/articles/print/volume-105/issue-4/macroeconomics/ the-future-of-dental-practice-demographics-patients-profes- sionals-and-procedures.html.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/10.1177_0046958016652523.PMC4905592.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/1e/main.PMC4905604.pdf
"However, programmatic physical activity interventions often require resourc es that are not available in certain settings and may produce relativel y modest, short-term effects, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.03.004 2352-8273/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/cf/1e/main.PMC4905604.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/1e/main.PMC4905604.pdf
Available at 〈http://www.who.int/ topics/physical_activity/en/ 〉Last accessed 10.02.16.,OADS,/arxiv_data1/oa_pdf/cf/1e/main.PMC4905604.pdf
Available from 〈http://apps.who.int/iris/bit stream/10665/112792/1/GPW_2014-2019_eng.pdf?ua ¼1〉Last accessed 10.02.16.,OADS,/arxiv_data1/oa_pdf/cf/1e/main.PMC4905604.pdf
The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/10/b3/hyp-67-0941.PMC4905620.pdf
"Richard Hobbs, Jonathan Mant, Brian McKinstry, Martin Myers,   David Nunan, Alison Ward, Bryan Williams, Richard J. McManus Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.115.07108Blood Pressure Measurement",Non-OADS,/arxiv_data1/oa_pdf/10/b3/hyp-67-0941.PMC4905620.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/b3/hyp-67-0941.PMC4905620.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/67/62/CTS-9-51.PMC4905720.pdf
"For permissions, please e-mail: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/68/dvv013.PMC4905724.pdf
All anal- ysis was conducted using R 3.0.2 (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/94/68/dvv013.PMC4905724.pdf
2009. http://had.co.nz/ggplot2/book.Organic pollutants disrupt placental epigenetic marks |7,Non-OADS,/arxiv_data1/oa_pdf/94/68/dvv013.PMC4905724.pdf
e-mail:	tsaihj@ntu.edu.tw ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b1/ae/jvms-78-727.PMC4905823.pdf
"The	single-nucleotide	 polymor - phisms	(SNPs)	are	located	in	exon	3	of	the	bovine	TNF-α gene SNP rs-numberChromosome  positiona) GenotypeGene model  functiona)mRNA   positiona)Allele changea) Protein   positiona) Residue changea) rs453652706 23:27535013 GA missense 587 CTT/T TTb)132 L	[Leu]/F	[Phe] rs383890418 23:27534972 CC, CT cds-synon 628 GGC /GGT 145 G	[Gly]/G	[Gly] rs432068289 23:27534962 AA, AT missense 638 ACC/T CC 149 T	[Thr]/S	[Ser] g.27534932A>C 23:27534932 CC, CA missense 668 CGC/A GC 159 R	[Arg]/S	[Ser] a)	Source:	National	Center	for	Biotechnology	 Information	 (NCBI),	the	Single	Nucleotide	 Polymorphism	 database	(http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/b1/ae/jvms-78-727.PMC4905823.pdf
e-mail: h-iwano@rakuno.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/aa/5b/jvms-78-733.PMC4905824.pdf
e-mail: mmatsui@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/15/a2/jvms-78-739.PMC4905825.pdf
e-mail:	z_takatu@morinagamilk.co.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/91/c5/jvms-78-747.PMC4905826.pdf
e-mail: ohtaki.tadatoshi@nihon-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/42/b4/jvms-78-755.PMC4905827.pdf
e-mail: shira-m@vet.kagoshima-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cf/b8/jvms-78-761.PMC4905828.pdf
e-mail: nakamuta@iwate-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/30/52/jvms-78-769.PMC4905829.pdf
e-mail: tohei@nvlu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a8/e2/jvms-78-775.PMC4905830.pdf
"Student’s t-test or paired t -test was performed using JSTAT  software, version 10.0 for Windows (http://toukeijstat.web.",OADS,/arxiv_data1/oa_pdf/a8/e2/jvms-78-775.PMC4905830.pdf
e-mail: machida@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8e/c2/jvms-78-781.PMC4905831.pdf
e-mail: nnonaka@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f1/c2/jvms-78-785.PMC4905832.pdf
e-mail: okazu@vetmed.hokudai.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c3/11/jvms-78-791.PMC4905833.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/27/2d/jvms-78-797.PMC4905834.pdf
e-mail: mikivet@me.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4b/a3/jvms-78-803.PMC4905835.pdf
e-mail: kozue-mt@nibiohn.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4d/62/jvms-78-811.PMC4905836.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/15/d9/jvms-78-819.PMC4905837.pdf
e-mail: goryo@iwate-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/af/58/jvms-78-825.PMC4905838.pdf
e-mail: takehara@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5a/b3/jvms-78-831.PMC4905839.pdf
"http://jlia.lin.gr.jp/haccp/ (accessed Dec 13, 2015).",OADS,/arxiv_data1/oa_pdf/5a/b3/jvms-78-831.PMC4905839.pdf
"Kewpie Corporation “Egg Products Business”, http://www.kewpie.co.jp/english/our_business/index03.html (accessed Dec  13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/5a/b3/jvms-78-831.PMC4905839.pdf
"“The improve-ment of the breeding hygiene management standard in the stage of production of the domestic animal”, http://www.maff.go.jp/j/ syouan/douei/katiku_yobo/k_haccp/index.html (accessed Jan 4,  2016).",Non-OADS,/arxiv_data1/oa_pdf/5a/b3/jvms-78-831.PMC4905839.pdf
"“Handling of the lime to use for the lines of the athletic ground”,  http://www.gankaikai.or.jp/info/pdf/20080101_monbu.pdf (ac-cessed Jan 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/5a/b3/jvms-78-831.PMC4905839.pdf
e-mail: kimie@brain.riken.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/jvms-78-837.PMC4905840.pdf
"In a phase I clinical trial of Oncept ™, 9 vaccinated dogs  experienced an overall MST of 389 days, and prolonged survival times have been reported in 2 patients with Stage II/*Corresponden Ce to: Treggiari , E., VRCC Veterinary Referrals,  Bramston Way, Southfield, Laindon, SS156TP, U.K.   e-mail: e.treggiari@gmail.com #present  address : Treggiari , E., Willows Veterinary Centre and  Referral Service, Highlands Road, Solihull, West Midlands, B90  4NH, U.K., G rant , J. P., Rutland House Veterinary Hospital, St.  Helens, Merseyside, WA9 4HU, U.K. ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/01/0b/jvms-78-845.PMC4905841.pdf
e-mail: amori@nvlu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/73/c3/jvms-78-851.PMC4905842.pdf
e-mail: huhk2015@126.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/11/88/jvms-78-855.PMC4905843.pdf
e-mail: yoshida7@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/06/96/jvms-78-859.PMC4905844.pdf
e-mail: gen@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/af/55/jvms-78-863.PMC4905845.pdf
"ITS1 REGION OF BABESIA GIBSONI  FROM JAPAN 865 by BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi), and  percentage identity was determined.",OADS,/arxiv_data1/oa_pdf/af/55/jvms-78-863.PMC4905845.pdf
e-mail:	chingho@ntu.edu.tw ©2016	The	Japanese	Society	of	 Veterinary	Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8c/5b/jvms-78-867.PMC4905846.pdf
e-mail: atsushi.sugiyama@med.toho-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/69/47/jvms-78-873.PMC4905847.pdf
e-mail: atsuji@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/jvms-78-877.PMC4905848.pdf
e-mail: atsuboi@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/da/f3/jvms-78-883.PMC4905849.pdf
e-mail: takehiro.ochi@astellas.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/99/bb/jvms-78-889.PMC4905850.pdf
e-mail: shirota@azabu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c2/01/jvms-78-895.PMC4905851.pdf
e-mail: michishita@nvlu.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/be/fe/jvms-78-901.PMC4905852.pdf
e-mail: nagahata@rakuno.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/82/2e/jvms-78-905.PMC4905853.pdf
e-mail: kwon@knu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/74/86/jvms-78-909.PMC4905854.pdf
e-mail: azakami@nvlu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/02/7c/jvms-78-913.PMC4905855.pdf
e-mail: kawai@azabu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/16/59/jvms-78-917.PMC4905856.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d9/22/jpts-28-1398.PMC4905877.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/cc/2f/jpts-28-1403.PMC4905878.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e4/c9/jpts-28-1407.PMC4905879.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/18/88/jpts-28-1412.PMC4905880.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ee/f3/jpts-28-1418.PMC4905881.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1f/a5/jpts-28-1422.PMC4905882.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/jpts-28-1427.PMC4905883.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f0/0f/jpts-28-1432.PMC4905884.pdf
http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/fruf.def.,OADS,/arxiv_data1/oa_pdf/f0/0f/jpts-28-1432.PMC4905884.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a8/16/jpts-28-1438.PMC4905885.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/cd/88/jpts-28-1443.PMC4905886.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1f/0a/jpts-28-1448.PMC4905887.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/5a/31/jpts-28-1450.PMC4905888.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/73/47/jpts-28-1454.PMC4905889.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/13/0c/jpts-28-1459.PMC4905890.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/21/00/jpts-28-1465.PMC4905891.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ce/b5/jpts-28-1472.PMC4905892.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/9e/c4/jpts-28-1478.PMC4905893.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/2a/89/jpts-28-1482.PMC4905894.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/97/19/jpts-28-1487.PMC4905895.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/af/4e/jpts-28-1493.PMC4905896.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/47/9f/jpts-28-1496.PMC4905897.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/60/af/jpts-28-1499.PMC4905898.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c3/b9/jpts-28-1505.PMC4905899.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f5/12/jpts-28-1508.PMC4905900.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/00/51/jpts-28-1511.PMC4905901.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/jpts-28-1518.PMC4905902.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f9/35/jpts-28-1524.PMC4905903.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/dc/34/jpts-28-1534.PMC4905904.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e3/a2/jpts-28-1538.PMC4905905.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/63/83/jpts-28-1544.PMC4905906.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/09/26/jpts-28-1547.PMC4905907.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a9/a6/jpts-28-1552.PMC4905908.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/59/10/jpts-28-1556.PMC4905909.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/jpts-28-1560.PMC4905910.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/51/72/jpts-28-1565.PMC4905911.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/52/3f/jpts-28-1569.PMC4905912.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/99/ce/jpts-28-1574.PMC4905913.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a0/ac/jpts-28-1577.PMC4905914.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/54/a4/jpts-28-1582.PMC4905915.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/42/4a/jpts-28-1584.PMC4905916.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/cb/3b/jpts-28-1588.PMC4905917.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e9/27/jpts-28-1595.PMC4905918.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/08/bf/jpts-28-1599.PMC4905919.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/95/07/jpts-28-1602.PMC4905920.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/59/0e/jpts-28-1607.PMC4905921.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/38/70/jpts-28-1611.PMC4905922.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/79/77/jpts-28-1614.PMC4905923.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/0b/fc/jpts-28-1621.PMC4905924.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/91/62/jpts-28-1629.PMC4905925.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/69/f5/jpts-28-1633.PMC4905926.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c1/33/jpts-28-1636.PMC4905927.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/dd/a7/jpts-28-1640.PMC4905928.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ec/95/jpts-28-1644.PMC4905929.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8c/62/jpts-28-1651.PMC4905930.pdf
"Smartphone users worldwide will total 1.75 billion in 2014. http://www.emarketer.com/Article/Smartphone-Users-Worldwide-Will-Total-175-Bil - lion-2014/1010536 (Accessed Dec. 28, 2015) 11) Shim JM: The effect of carpal tunnel changes on smartphone users.",Non-OADS,/arxiv_data1/oa_pdf/8c/62/jpts-28-1651.PMC4905930.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f9/44/jpts-28-1657.PMC4905931.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/jpts-28-1660.PMC4905932.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/17/bb/jpts-28-1665.PMC4905933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/82/main.PMC4906033.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/82/main.PMC4906033.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.003Urology Case Reports 8 (2016) 9 e11,Non-OADS,/arxiv_data1/oa_pdf/e2/82/main.PMC4906033.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/7c/main.PMC4906035.pdf
"The  ﬁrst patient to  be  discovered  with  focal  mastitis  was  a high-risk  patient  and  had  a  history  of  two  previous  operations, http://dx.doi.org/10.1016/j.ejro.2016.05.001 2352-0477/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ad/7c/main.PMC4906035.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/7c/main.PMC4906035.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/d8/main.PMC4906038.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/d8/main.PMC4906038.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.001Urology Case Reports 8 (2016) 12 e14,Non-OADS,/arxiv_data1/oa_pdf/23/d8/main.PMC4906038.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/02/main.PMC4906039.pdf
"Meniscus  extrusion  is  evaluated  with  magnetic  resonance  imag- ing  (MRI),  typically  with  the  patient’s  knee  in  supine,  neutral http://dx.doi.org/10.1016/j.ejro.2016.05.002 2352-0477/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/66/02/main.PMC4906039.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/66/02/main.PMC4906039.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/3b/main.PMC4906040.pdf
Our  study  was  aimed  to  assess  whether  contrast-enhanced MR  Cholangiography  may  provide  additional  information  in  the http://dx.doi.org/10.1016/j.ejro.2016.05.003 2352-0477/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/31/3b/main.PMC4906040.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/3b/main.PMC4906040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/3e/main.PMC4906080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/3e/main.PMC4906080.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.002Urology Case Reports 8 (2016) 15 e17,Non-OADS,/arxiv_data1/oa_pdf/dd/3e/main.PMC4906080.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.38 Cardiol Ther (2016) 5:19–41",Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
NLM Identiﬁer: 01684423. https://clinicaltrials.gov/ct2/show/NCT01684423 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT02234843 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ct2/show/ NCT02497716 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT01853800 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT02564718 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ct2/show/ NCT01707394 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ct2/show/ NCT02369653 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
NLM Identiﬁer: NCT02464969.https://clinicaltrials.gov/ct2/show/NCT02464969 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT02303431 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT00844415 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT02223260 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ct2/show/ NCT01773174 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/record/NCT01895777 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
https://clinicaltrials.gov/ ct2/show/NCT02197416 .,Non-OADS,/arxiv_data1/oa_pdf/36/9b/40119_2015_Article_54.PMC4906081.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b6/0b/40119_2015_Article_55.PMC4906082.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/12/9f/40119_2016_Article_56.PMC4906083.pdf
http://www.roche.,Non-OADS,/arxiv_data1/oa_pdf/12/9f/40119_2016_Article_56.PMC4906083.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.Cardiol Ther (2016) 5:63–73 71",Non-OADS,/arxiv_data1/oa_pdf/85/4a/40119_2016_Article_57.PMC4906084.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/30/34/40119_2016_Article_58.PMC4906085.pdf
NLM Identiﬁer: NCT02220725.https://clinicaltrials.gov/ct2/show/NCT02220725 .,Non-OADS,/arxiv_data1/oa_pdf/30/34/40119_2016_Article_58.PMC4906085.pdf
NLM Identiﬁer: NCT02207257.https://clinicaltrials.gov/ct2/show/NCT02207257 .,Non-OADS,/arxiv_data1/oa_pdf/30/34/40119_2016_Article_58.PMC4906085.pdf
"NDA 206316.Meeting date October 30, 2014. http://www.fda.",Non-OADS,/arxiv_data1/oa_pdf/30/34/40119_2016_Article_58.PMC4906085.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/e5/40119_2016_Article_59.PMC4906086.pdf
http://www.drugs.com/pro/ diltiazem.html .,Non-OADS,/arxiv_data1/oa_pdf/e2/e5/40119_2016_Article_59.PMC4906086.pdf
http://www.heart.org .,Non-OADS,/arxiv_data1/oa_pdf/e2/e5/40119_2016_Article_59.PMC4906086.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/44/e1/40119_2016_Article_60.PMC4906087.pdf
Sensitivity analysis after excluding silent cerebral lesions on MRI showed there was no increased risk ofEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/47B 4F06014C4DF95 .,Non-OADS,/arxiv_data1/oa_pdf/7d/24/40119_2016_Article_61.PMC4906088.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercialuse, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.84 Cardiol Ther (2016) 5:83–84",Non-OADS,/arxiv_data1/oa_pdf/9e/84/40119_2016_Article_62.PMC4906089.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a9/4e/13555_2016_Article_105.PMC4906099.pdf
"http://www.fda.gov/downloads/BiologicsBlood Vaccines/Vaccines/ApprovedProducts/UCM20 1669.pdf .A c c e s s e dJ a n1 ,2 0 1 6 .",Non-OADS,/arxiv_data1/oa_pdf/a9/4e/13555_2016_Article_105.PMC4906099.pdf
"Work life and social life were affected, especially in subjects with severe PSA (62% with social life at least somewhat affected).Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2884F06075A3983E .",Non-OADS,/arxiv_data1/oa_pdf/29/75/13555_2016_Article_106.PMC4906100.pdf
This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/4d/69/13555_2016_Article_107.PMC4906101.pdf
This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License(http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/ab/b9/13555_2016_Article_112.PMC4906106.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 94B4F0601CAA2319 .,Non-OADS,/arxiv_data1/oa_pdf/97/66/13555_2016_Article_113.PMC4906107.pdf
Keywords: Moderate-to-severe; Psoriasis; SecukinumabEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 34B4F0606AAA28E7 .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm 430969.htm .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/ DermatologicandOphthal micDrugsAdvisoryCom mittee/UCM419023.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
Oral OTEZLA /C210(apremilast) approved by the U.S. Food and Drug Administration for the treatment of patients withmoderate to severe plaque psoriasis [media release].http://ir.celgene.com/releasedetail.cfm?ReleaseID= 872240 .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
http://ir.celgene.,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
http://www.nice.org.uk/ guidance/ta134/resources/guidance-inﬂiximab-for-the-treatment-of-adults-with-psoriasis-pdf .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
http://www.nice.org.uk/ guidance/ta146/resources /guidance-adalimumab- for-the-treatment-of-adu lts-with-psoriasis-pdf .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
http://www.ema.europa.eu/ ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/13555_2016_Article_114.PMC4906108.pdf
We foundEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D4B4F0601BB50AFB .,Non-OADS,/arxiv_data1/oa_pdf/d0/39/13555_2016_Article_115.PMC4906109.pdf
"Worldwide it is now a well-established and approved treatment option for actinic keratosis (AK) grade I, basal cell carcinoma (BCC), and also Bowen’s disease (BD), with an acceptable tolerability proﬁle and few reported complications [ 4–6].Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ F4B4F06021CD60B4 .",Non-OADS,/arxiv_data1/oa_pdf/88/6e/13555_2016_Article_116.PMC4906110.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/f3/19/13555_2016_Article_117.PMC4906111.pdf
113. http://www.ema.europa.e u/docs/en_GB/document_ library/EPAR__Product_Information/human/000481/ WC500050870.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f3/19/13555_2016_Article_117.PMC4906111.pdf
118. http://www.ema.europa.e u/docs/en_GB/document_ library/EPAR__Summary_for_the_public/human/ 003729/WC500183132.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f3/19/13555_2016_Article_117.PMC4906111.pdf
119. http://www.ema.europa.e u/docs/en_GB/document_ library/Summary_of_opinion_-_Initial_authorisation/human/003746/WC500177621.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f3/19/13555_2016_Article_117.PMC4906111.pdf
"Lesions exhibit no gender preference, but principally emerge in younger individuals and ethnicities with darker complexions, such as African Americans,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D7B4F06021217B16 .",Non-OADS,/arxiv_data1/oa_pdf/74/f5/13555_2016_Article_118.PMC4906112.pdf
Individual patient choice should be considered to increase the acceptability and a range of topicalEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ A2C4F060169BA8D3 .,Non-OADS,/arxiv_data1/oa_pdf/99/b2/13555_2016_Article_119.PMC4906113.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/99/b2/13555_2016_Article_119.PMC4906113.pdf
Keywords: Acute; Chronic; Radiation dermatitis; Radiation burns; Radiation recall; Radiation skin toxicityEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 21D4F0606B97A130 .,Non-OADS,/arxiv_data1/oa_pdf/b5/3e/13555_2016_Article_120.PMC4906114.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b5/3e/13555_2016_Article_120.PMC4906114.pdf
Keywords: AMAGINE; Anti-interleukin-17; Biologics; Brodalumab; Interleukin 17; Phase III; PsoriasisEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D0D4F0601FA6776C .,Non-OADS,/arxiv_data1/oa_pdf/5f/8b/13555_2016_Article_121.PMC4906115.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5f/8b/13555_2016_Article_121.PMC4906115.pdf
http://www.jimmunol.org/cgi/pmidlookup?,Non-OADS,/arxiv_data1/oa_pdf/5f/8b/13555_2016_Article_121.PMC4906115.pdf
2009. https://www.google.com/ webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=Guidance ?for?Industry ?Patient-Repor- ted?Outcome ?Measures%3A ?Use?in?Medical ?,Non-OADS,/arxiv_data1/oa_pdf/aa/1c/13555_2016_Article_98.PMC4906116.pdf
The RNA-Seq data generated by these experiments is deposited in Gene Expression Omnibus (Gene accession GSE62055) and may be found at NCBI ( http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE62055 ).,OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Staphylococcus aureusPhototherapy Reactive oxygen intermediates RNA-seqMRSA Speci ﬁcations Organism/cell line/tissue S. aureus BUSA2288 (Nasal isolate ) Sex NA Sequencer or array type MiSeq Data format Raw Experimental factors Blue light illumination vs no light Experimental features RNA-Seq was used to analyze the differential gene expression of S. aureus in culture in response to blue light exposure.,Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
Direct link to deposited data [provide URL below] http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62055 2.,OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.011 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
http://www.mouser.,Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
"B 92 (2008) 180–184, http://dx.doi.org/10.1016/j.jphotobiol.2008.06.006 .",OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
http://www.geospiza.,Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
"42 (2004) 4947 –4955, http://dx.doi.org/10.1128/JCM.42.11.4947-4955.2004 .6 T.L.",Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC4906118.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: NCLDVGiant virus Mimivirus bombay AmoebaCRISPR Speciﬁcations Organism/cell line/tissue Mimivirus bombay Sex NA Sequencer or array type Illumina MiSeq v2 150 x 2 PE Data format analyzed, complete genome FASTA sequenceExperimental factors virus grown in Acanthamoeba castellanii Experimental features de novo genome assembly and annotationConsent not applicableSample source location Mumbai, India, City, 19.180158 N, 72.848614 E Direct link to deposited data http://www.ebi.ac.uk/ena/data/view/KU761889 http://www.ncbi.nlm.nih.gov/nuccore/KU761889 NCBI Sequence graphics https://www.ncbi.nlm.nih.gov/nuccore/1020265955?report= graphExperimental design, materials and methods Environmental sample processing and virus isolation Water (50 ml) from sewage was ﬁltered through a 20 μmW h a t m a n ﬁlter paper, incubated overnight incubation at 4 °C in 8% w/vPEG and 0.4% w/vNaCl (pH 7.2) and centrifuged at 500 × gfor 15 min at 4 °C.",Non-OADS,/arxiv_data1/oa_pdf/7d/8a/main.PMC4906119.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.013 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/8a/main.PMC4906119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/8a/main.PMC4906119.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/main.PMC4906120.pdf
As  a  consequence  of http://dx.doi.org/10.1016/j.ijscr.2016.04.033 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/e6/e5/main.PMC4906120.pdf
"122  (August (3))  (2010)  619–626,  http://dx.doi.org/10.1007/s10549-010-0915-y .",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/main.PMC4906120.pdf
"198  (April  (4))  (2012) W386–393, http://dx.doi.org/10.2214/AJR.11.7341 .",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/main.PMC4906120.pdf
"52  (July  (6)) (2011) 597–601,  http://dx.doi.org/10.1258/ar.2011.100468 .",Non-OADS,/arxiv_data1/oa_pdf/e6/e5/main.PMC4906120.pdf
"37  (August  (8))  (2011)  703–708, http://dx.doi.org/10.1016/j.ejso.2011.04.006 .",OADS,/arxiv_data1/oa_pdf/e6/e5/main.PMC4906120.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/20/main.PMC4906122.pdf
Carcinoembryonic  antigen  and  carbohydrate http://dx.doi.org/10.1016/j.ijscr.2016.04.049 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/20/main.PMC4906122.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/89/main.PMC4906123.pdf
"On  admission, he  presented  decreased  breath  sounds  bilaterally,  thoracic  subcu- taneous  emphysema,  chest  pain,  breathing  rate  of  22,  peripheral saturation  of  87%,  which  increased  to  93%  with  supplementary  oxy- http://dx.doi.org/10.1016/j.ijscr.2016.04.052 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/e7/89/main.PMC4906123.pdf
"Case  Rep.  7  (2013)  1–6,  http://dx.doi.org/10.1186/1752-1947-7-223 .",Non-OADS,/arxiv_data1/oa_pdf/e7/89/main.PMC4906123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/fd/main.PMC4906124.pdf
Questions such as “how does the activation of mitogen-activated protein kinase (MAPK) modules in response to differentContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.05.006 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/53/fd/main.PMC4906124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/fd/main.PMC4906124.pdf
"Rep. 6 (2016) 20172 –20183, http://dx.doi.org/ 10.1038/srep20172 .A.",Non-OADS,/arxiv_data1/oa_pdf/53/fd/main.PMC4906124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/dc/main.PMC4906126.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/dc/main.PMC4906126.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.005Urology Case Reports 8 (2016) 7 e8,Non-OADS,/arxiv_data1/oa_pdf/49/dc/main.PMC4906126.pdf
Most  external http://dx.doi.org/10.1016/j.bdq.2016.05.001 2214-7535/© 2016  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
"UKNEQAS,  Edinburgh,  UK and European Society of Pathology EQA  scheme)  require  reports to  be  submitted  to  their  molecular  pathology  schemes,  based  on drug licence information (see  http://www.ukneqas-molgen.org.uk/ molecular-pathology and  http://kras.eqascheme.org )  [11,12] .",Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
"LoD,  Limit  of  Detection  http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm .",Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
"DNA  can  also  be  released  from  FFPE  by  focussed  ultra- sound  (Covaris,  http://covarisinc.com/products/ffpe-extraction/ ),  a method  that  has  found  application  in  the  extraction  of  DNA  for sequencing  [33] .",Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
"Mutations should  be  reported  using  Human  Genome  Variation  Society  (HGVS) nomenclature  (http://www.hgvs.org/mutnomen/ )  and  an  interpre-tation  given  which  is  understandable  to  the  clinician  who  must  act on  it,  while  allowing  a  pathologist  to  understand  what  test  has  been done  and  its  limitations.",Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
The  effect  of  all  of  these  choices  on  service  provision  can  be modelled  using  the  Cancer  Molecular  Diagnostic  Implementation Planning  and  Commissioning  Toolkit (CMD-ImPACT)  tool  which  is  freely  available  from  the  UK  Royal College  of  Pathologists  (RCPath)  website  (https://www.rcpath.org/ cmd-impact.html ).,Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
"Guidance  on  how  to  set  up  and  run  a  molecular pathology  laboratory  is  available  from  several  sources,  particularly College  of  American  Pathologists  (http://www.cap.org/ ),  the  Asso- ciation  for  Molecular  Pathology  (http://www.amp.org ),  and  the European  Society  of  Pathology  [11] .",Non-OADS,/arxiv_data1/oa_pdf/1c/1b/main.PMC4906127.pdf
http://dx.doi.org/10.1016/j.bdq.2016.05.003 2214-7535/© 2016  Published  by  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/61/7c/main.PMC4906133.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/7c/main.PMC4906133.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/7c/main.PMC4906133.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online version, at http://dx.doi.org/10.1016/j.bdq.2016.05.003 .",OADS,/arxiv_data1/oa_pdf/61/7c/main.PMC4906133.pdf
"[47] NICE,  NICE  guidance  recommends  new  test  to  guide  breast  cancer  treatment decisions,  2013  http://www.nice.org.uk/newsroom/pressreleases/ NICERecommendsTestBreastCancerTreatmentDecisions.jsp .",Non-OADS,/arxiv_data1/oa_pdf/61/7c/main.PMC4906133.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
The  effects  of  treating  RNA  with  heparinase  for  PCR-based studies  have  been  estimated  by  several  approaches  that  include http://dx.doi.org/10.1016/j.bdq.2016.03.001 2214-7535/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"Supplementary data Supplementary data associated with this article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.03.001 .",OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"59  (2013) 1125–1127,  http://dx.doi.org/10.1373/clinchem.2012.199505 .",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"110  (2013)  609–615,  http://dx.doi.org/10.1160/ TH13-05-0368 .",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"2  (2014)  13,  http://dx.doi.org/10.1186/ 2050-7771-2-13 .",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"13  (2012)  358–369,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"31  (2010)  659–666,  http://dx.doi.org/10.1093/eurheartj/ehq013 .",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"62  (2013)  992–998,  http://dx.doi.org/ 10.1016/j.jacc.2013.05.025 .",OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"[15]  X.  Zhou,  A.  Mao,  X.  Wang,  et  al.,  Urine  and  serum  microRNA-1  as  novel biomarkers  for  myocardial  injury  in  open-heart  surgeries  with cardiopulmonary  bypass,  PLoS  One  8  (2013)  e62245,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"13  (2013)  12,  http://dx.doi.org/10.1186/1471-2261-13-12 .",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"Du,  X.  Cao,  et  al.,  Plasma  levels  of  microRNA-499  provide  an  early indication  of  perioperative  myocardial  infarction  in  coronary  artery  bypass graft patients, PLoS  One  9  (2014)  e104618,  http://dx.doi.org/10.1371/journal.",OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"63  (2014)  940–941,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
"[20] A. Copley, The  excretion  of  injected  heparin  in  the  urine  of  mice  and  dogs, Science  93 (1941)  478–479,  http://dx.doi.org/10.1016/j.jmoldx.2011.09.002 .",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/main.PMC4906134.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/17/main.PMC4906136.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.04.057 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/86/17/main.PMC4906136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/86/main.PMC4906137.pdf
"Oxidative stress to RNA can be measured non-invasively based on the excretion of the ribonucleoside 8-oxoGuo (8-oxo-7,8-dihy- droguanosine) in urine, and its clinical relevance has beenContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.05.007 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/57/86/main.PMC4906137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/86/main.PMC4906137.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/df/main.PMC4906138.pdf
The  surgical  procedure  was  performed  without http://dx.doi.org/10.1016/j.ijscr.2016.05.048 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/56/df/main.PMC4906138.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/d2/main.PMC4906139.pdf
"Computed  tomography  (CT)  revealed  a  dilated  small  intestine, http://dx.doi.org/10.1016/j.ijscr.2016.05.051 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/69/d2/main.PMC4906139.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2016.05.051 .",OADS,/arxiv_data1/oa_pdf/69/d2/main.PMC4906139.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
"Many  cancer  cells,  including  these  breast  cancer  cell  lines,  have highly  abnormal  karyotypes,  with  multiple  chromosome  copies http://dx.doi.org/10.1016/j.bdq.2016.02.001 2214-7535/© 2016  Published  by  Elsevier  GmbH.",Non-OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
Spectral  karyotyping  (SKY)  using ﬂuorescent  staining  for  each  chromosome  showed  a  large  number of  complex  alterations  in  the  chromosome  complement  of  breast cancer  cell  lines  [18]  (http://old-www.path.cam.ac.uk/ ∼paweﬁsh/ index.html ).,OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
"All  oligonucleotide sequences  were  designed  with  Primer3  (http://frodo.wi.mit.edu/ )  or  Primer  Express  (Version  3.0.1,  Life  Technologies)  and  checked for  speciﬁcity  using  BLAST  searches  of  NCBI  Nucleotide  database.",OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
"These  cancer  cell  lines  and  many others,  because  of  their  importance  to  basic  research  and  thera- peutic  screening,  are  now  the  subject  of  sequencing  projects,  such as  the  Cancer  Cell  line  Encyclopedia  (http://www.broadinstitute.",Non-OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
"org/ccle/home )  and  the  Catalogue  of  Somatic  Mutations  in  Cancer (COSMIC,  http://cancer.sanger.ac.uk/cell  lines ).",Non-OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
BLAST  searches  (http://blast.ncbi.nlm.nih.gov/Blast.cgi ) were  done  to  ensure  that  the  primers  and  probes  for  the  dPCR assays  only  bind  to  the  target  sequences  in  the  human  genome.,OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
"Supplementary data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.02.001 .",OADS,/arxiv_data1/oa_pdf/e1/48/main.PMC4906140.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/52/main.PMC4906141.pdf
"Computed  tomography  scan  of  chest,  abdomen  and  pelvis  revealed a  20  cm  right  pelvic  mass  extending  to  right  ischiorectal  fossa  and inferior  aspect  of  right  perineum  with  no  deﬁnite  invasion  to  rec- http://dx.doi.org/10.1016/j.ijscr.2016.05.047 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/4b/52/main.PMC4906141.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/a7/main.PMC4906142.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.05.004 2213-2244/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/a7/main.PMC4906142.pdf
"[http://dx.doi.org/10.1111/j.1600-0757.1997.tb00190.x ] [PMID: 9567964 ] [2] Socransky SS, Haffajee AD.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/j.1600-0757.2005.00107.x ] [PMID: 15853940 ] [3] Preshaw PM, Taylor JJ.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.1111/j.1600-051X.2010.01671.x ] [PMID: 21323705 ] [4] Axelsson P. Diagnosis and Risk Prediction of Periodontal Diseases.,OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.1177/0022034512457373 ] [PMID: 22935673 ] [6] Axelsson P Minimally Invasive Treatment.,Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1016/S1532-3382(12)70019-2 ] [PMID: 23040340 ] [8] Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/j.1462-5822.2009.01323.x ] [PMID: 19374653 ] [9] Kuramitsu HK, He X, Lux R, Anderson MH, Shi W. Interspecies interactions within oral microbial communities.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1128/MMBR.00024-07 ] [PMID: 18063722 ] [10] Karlsson M, Lofgren C, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1902/jop.2008.080197 ] [PMID: 18980508 ] [11] Sgolastra F, Petrucci A, Gatto R, Monaco A. Efficacy of Er:YAG laser in the treatment of chronic periodontitis: systematic review and meta- analysis.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-011-0928-8 ] [PMID: 21553003 ] [12] Sgolastra F, Petrucci A, Severino M, Graziani F, Gatto R, Monaco A. Adjunctive photodynamic therapy to non-surgical treatment of chronic periodontitis: a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/jcpe.12094 ] [PMID: 23557433 ] [13] Sgolastra F, Severino M, Gatto R, Monaco A.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-012-1181-5 ] [PMID: 22895576 ] [14] Sgolastra F, Severino M, Petrucci A, Gatto R, Monaco A. Nd:YAG laser as an adjunctive treatment to nonsurgical periodontal therapy: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-013-1293-6 ] [PMID: 23474742 ] [15] Slot DE, Jorritsma KH, Cobb CM, Van der Weijden FA.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/jcpe.12233 ] [PMID: 24460795 ] [16] Aoki A, Sasaki KM, Watanabe H, Ishikawa I.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.1111/j.1600-0757.2004.03679.x ] [PMID: 15330944 ] [17] American Academy of Periodontology Statement.,Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.1902/jop.2011.114001 ] [PMID: 21453136 ] [18] Cobb CM.,OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1902/jop.2006.050417 ] [PMID: 16584335 ] [19] Cobb CM, Low SB, Coluzzi DJ.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1016/j.cden.2009.08.007 ] [PMID: 20103471 ] [20] Roncati M, Gariffo A.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1089/pho.2013.3695 ] [PMID: 24697584 ] [21] Ishikawa  I,  Aoki  A,  Takasaki  AA,  Mizutani  K,  Sasaki  KM,  Izumi  Y.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/j.1600-0757.2008.00283.x ] [PMID: 19388956 ] [22] Aoki A, Mizutani K, Schwarz F, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/prd.12080 ] [PMID: 25867988 ] [23] Smiley CJ, Tracy SL, Abt E, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1016/j.adaj.2015.01.028 ] [PMID: 26113099 ] [24] Mizutani K, Aoki A, Coluzzi D. Lasers in minimally invasive periodontal and peri-implant therapy.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-010-0799-4 ] [PMID: 20549280 ] [27] Dyer B, Sung EC.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.2174/1874210601206010074 ] [PMID: 22615717 ] [28] Aoki A.,Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.2174/1874210601307010016 ] [PMID: 23524914 ] [30] Gutknecht N, Van Betteray C, Ozturan S, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.5005/jp-journals-10022-1001 ] [32] Carroll JD, Milward MR, Cooper PR, Hadis M, Palin WM.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1016/j.dental.2014.02.006 ] [PMID: 24656472 ] [33] Tuner J, Hode L. The Laser Therapy Handbook.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1563/AAID-JOI-D-09-00120.1 ] [PMID: 20594059 ] [35] Pourzarandian A, Watanabe H, Ruwanpura SM, Aoki A, Ishikawa I.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1902/jop.2005.76.2.187 ] [PMID: 15974841 ] [36] Pourzarandian  A,  Watanabe  H,  Ruwanpura  SM,  Aoki  A,  Noguchi  K,  Ishikawa  I.  Er:YAG  laser  irradiation  increases  prostaglandin  E production via the induction of cyclooxygenase-2 mRNA in human gingival fibroblasts.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.1111/j.1600-0765.2005.00789.x ] [PMID: 15733154 ],Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-014-1691-4 ] [PMID: 25429773 ] [38] Hakki SS, Berk G, Dundar N, Saglam M, Berk N. Effects of root planing procedures with hand instrument or erbium, chromium:yttrium- scandium-gallium-garnet laser irradiation on the root surfaces: a comparative scanning electron microscopy study.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-009-0643-x ] [PMID: 19219484 ] [39] Ting CC, Fukuda M, Watanabe T, Aoki T, Sanaoka A, Noguchi T. Effects of Er,Cr:YSGG laser irradiation on the root surface: morphologic analysis and efficiency of calculus removal.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1902/jop.2007.070160 ] [PMID: 17970683 ] [40] Hakki SS, Korkusuz P, Berk G, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1902/jop.2010.090715 ] [PMID: 20476883 ] [41] Kimura Y, Yu DG, Kinoshita J, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1089/104454701750285386 ] [PMID: 11443792 ] [42] Noori ZT, Fekrazad R, Eslami B, Etemadi A, Khosravi S, Mir M. Comparing the effects of root surface scaling with ultrasound instruments and Er,Cr:YSGG laser.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1007/s10103-007-0480-8 ] [PMID: 17764026 ] [43] de Oliveira GJ, Pavone C, Sampaio JE, Marcantonio RA.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1002/lsm.20973 ] [PMID: 20976808 ] [44] Lavu V, Sundaram S, Sabarish R, Rao SR. Root surface bio-modification with erbium lasers- A myth or a reality??",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
[http://dx.doi.org/10.2174/1874210601509010079 ] [PMID: 25713635 ] [45] Cobb CM.,Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1902/annals.1996.1.1.443 ] [PMID: 9118268 ] [46] Loos B, Nylund K, Claffey N, Egelberg J.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1989.tb02326.x ] [PMID: 2778083 ] [47] Gupta M, Lamba AK, Verma M, et al.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/adj.12021 ] [PMID: 23441791 ] [48] Cortellini P, Tonetti MS. Clinical and radiographic outcomes of the modified minimally invasive surgical technique with and without regenerative materials: a randomized-controlled trial in intra-bony defects.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2011.01705.x ] [PMID: 21303402 ] [49] Kao RT, Nares S. Periodontal regeneration-Intrabony defects: A systematic review.",OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/TODENTJ-10-298.PMC4906144.pdf
"[http://dx.doi.org/10.1136/ard.2004.034447 ] [PMID: 15731286 ] [3] Spitzer WO, Skovron ML, Salmi LR, et al.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1097/BRS.0b013e3181643ece ] [PMID: 18204401 ] [5] Scholten-Peeters  GG,  Bekkering  GE,  Verhagen  AP,  et  al.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1097/00007632-200202150-00018 ] [PMID: 11840109 ] [6] Childs JD, Cleland JA, Elliott JM, et al.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.2519/jospt.2008.0303 ] [PMID: 18758050 ] [7] Finch E, Mayo NE, Stratford PW.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1097/00007632-199811150-00011 ] [PMID: 9836355 ] [9] Stratford PW, Kennedy D, Pagura SM, Gollish JD.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1002/art.11196 ] [PMID: 12910560 ] [10] Novy DM, Simmonds MJ, Lee CE.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1053/apmr.2002.27397 ] [PMID: 11782832 ] [11] MacDermid JC, Ghobrial M, Quirion KB, et al.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1186/1471-2474-8-42 ] [PMID: 17509150 ] [12] Kumta  P,  MacDermid  JC,  Mehta  SP,  Stratford  PW.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.2519/jospt.2012.3796 ] [PMID: 22281818 ] [13] Pool JJ, Ostelo RW, Hoving JL, Bouter LM, de Vet HC.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1097/BRS.0b013e31815cf75b ] [PMID: 18091500 ] [14] Cleland JA, Childs JD, Whitman JM.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1016/j.apmr.2007.08.126 ] [PMID: 18164333 ] [15] Stratford PW, Spadoni G. Feature articles: The reliability, consistency, and clinical application of a numeric pain rating scale.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.2519/jospt.2008.2680 ] [PMID: 18827326 ] [18] MacDermid JC, Walton DM, Avery S, et al.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.2519/jospt.2009.2930 ] [PMID: 19521015 ] [19] Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L ] [PMID: 8773720 ] [20] Roy JS, MacDermid JC, Woodhouse LJ.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1002/art.24396 ] [PMID: 19405008 ] [21] Mehta S, Macdermid JC, Carlesso LC, McPhee C. Concurrent validation of the DASH and the QuickDASH in comparison to neck-specific scales in patients with neck pain.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1097/BRS.0b013e3181c85151 ] [PMID: 20453724 ] [22] Prushansky T, Dvir Z. Cervical motion testing: methodology and clinical implications.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1016/j.jmpt.2008.08.004 ] [PMID: 18804000 ] [23] Youdas JW, Carey JR, Garrett TR.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.2310/6640.2004.15377 ] [26] Portney L, Watkins M. Foundations of clinical research: applications to clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1191/026921598672178340 ] [PMID: 9688034 ] [28] Bland JM, Altman DG.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
[http://dx.doi.org/10.1016/S0140-6736(86)90837-8 ] [PMID: 2868172 ] [29] Fleiss JL.,OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.2519/jospt.2009.2826 ] [PMID: 19411765 ] [32] Streiner D, Norman G. Health measurement scales.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1016/S0304-3959(01)00349-9 ] [PMID: 11690728 ] [34] Cleland JA, Childs JD, Whitman JM.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1016/j.apmr.2007.08.126 ] [PMID: 18164333 ] [35] Hawkes DH, Alizadehkhaiyat O, Fisher AC, Kemp GJ, Roebuck MM, Frostick SP.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"[http://dx.doi.org/10.1002/jor.21482 ] [36] Wittink H, Rogers W, Sukiennik A, Carr DB.",OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
[http://dx.doi.org/10.1097/01.BRS.0000085304.01483.17 ] [PMID: 14560092 ],Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/TOORTHJ-10-179.PMC4906145.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0b/14/ijp-26-02-3620.PMC4906148.pdf
"2528 Biophysical Journal 110, 2528–2539, June 7, 2016http://dx.doi.org/10.1016/j.bpj.2016.04.034 ArrayThis is an open access article under the CC BY-NC-ND license ( http:// creativecommons.org/licenses/by-nc-nd/4.0/ ).",OADS,/arxiv_data1/oa_pdf/d6/cf/main.PMC4906360.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (http://creativecommons.org/licenses/by-nc/ 4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/ec/1b/ipri-34-111.PMC4906363.pdf
"2, 111http://dx.doi.org/10.1080/02813432.2016.1191261",Non-OADS,/arxiv_data1/oa_pdf/ec/1b/ipri-34-111.PMC4906363.pdf
"Biophysical Journal 110, 2507–2516, June 7, 2016 2507http://dx.doi.org/10.1016/j.bpj.2016.04.037 /C2112016 Biophysical Society This is an open access article under the CC BY-NC-ND license ( http:// creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8d/7b/main.PMC4906377.pdf
"MATERIALS AND METHODS Experiments All peptides were purchased from Genscript ( http://www.genscript.com/ ) at>98% purity (HPLC puriﬁed), and all buffers were prepared in ultrapure de- ionized water (Millipore, Billerica, MA).",OADS,/arxiv_data1/oa_pdf/8d/7b/main.PMC4906377.pdf
"At  PATRIC (http://patricbrc.org/), we have been collecting bacterial genomes with AMR metadata for several years.",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
Bacterial species with over 100 distinct susceptible and resistant phenotypes on the P ATRIC FTP  site (http://ftp.patricbrc.org/).,Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"These genomes are also pushed to the PATRIC FTP site (ftp://ftp.patricbrc.org/patric2/patric3/genomes/) where  users can download the original source data and the PATRIC-specific analyses including the RASTtk annotation results 36, biochemical pathways44,45, and BLAST matches to the ARDB (antibiotic resistance genes database) and  CARD (the comprehensive antibiotic resistance database) compendia of hand-curated AMR-related genes41,46,47.",OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
We maintain a list of genomes with AMR data on the FTP site (ftp://ftp.patricbrc.org/BRC_Mirrors/AMR/)  and report both MIC and SIR data when they are available.,OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"For species with at least 100 susceptible and resist - ant genomes for a given antibiotic, we also maintain directories of the susceptible and resistant genomes (ftp://ftp.patricbrc.org/patric2/current_release/AMR_genome_sets/).",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"Antibiotic resistance phenotype prediction and genomic feature identification for the genomes  and antibiotics described in this study (excluding ethambutol and ethionamide in M. tuberculosis) has been made  available as an option in the RASTtk workflow36, from the RAST website (http://rast.nmpdr.org/), and in the  PATRIC annotation service32 (http://patricbrc.org/).",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
http://www.who.int/drugresistance/documents/surveillancereport/en/ (2014) (Date of access: 11/04/2016).,OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"Centers for Disease Control and Prevention, Atlanta, GA: http://www.cdc.gov/drugresistance/threat-report-2013/ (2013) (access:04/01/2016).",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
https://olive.broadinstitute.org/projects/tb_mrc_sa.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
http://www.inf.fu-berlin.de/inst/ag-ki/adaboost4.pdf (2009) (Date of access: 11/04/2016).,Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"National Institute of Allergy and Infectious Diseases, Genomic Centers for Infectious Diseases, https://www.niaid.nih.gov/ labsandresources/resources/dmid/gsc/pages/default.aspx (2016) (Date of access:01/04/2016) Acknowledgements This work was supported by the United States National Institute of Allergy and Infectious Diseases, National  Institutes of Health, Department of Health and Human Service [Contract No.",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"AMR data curation and deployment of AMR metadata Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Davis, J. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/30/5f/srep27930.PMC4906388.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bf/48/ncomms11892.PMC4906403.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Veal, B. W. et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/48/ncomms11892.PMC4906403.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11892 8 NATURE COMMUNICATIONS | 7:11892 | DOI: 10.1038/ncomms11892 | www.nature.com/naturecommunications",Non-OADS,/arxiv_data1/oa_pdf/bf/48/ncomms11892.PMC4906403.pdf
"B classiﬁcation has become the established standard for the classiﬁcation of1Institute of Radiology, Kantonsspital Baden AG, Baden, Switzerland 2Institute of Radiology, Kantonsspital Aarau AG, Aarau, Switzerland 3Centro di Radiologia Luganese, Lugano, Switzerland 4Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland 5Division of Biostatistics, Institute for Social and Preventive Medicine, University of Zurich, Zu ¨rich, Switzerland 6Adjumed Services AG, Zurich, Switzerland 7Brustzentrum, Zurich, Switzerland 8Institute of Pathology, Kantonsspital Baden AG, Baden, Switzerland Corresponding author: Camilla Saladin, Austrasse 19, CH-5430, Wettingen, Switzerland.Email: camilla.saladin@bluewin.ch*Institutes, which are members of the MIBB Group and which have entered the data forming the basis of the analysis, are listed underhttp://www.mibb.ch/.Acta Radiologica 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
Available at:http://www.sgpath.ch/docs/QR_SGPath_DE_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
Available at: http://www.mibb.ch/Documents/con-sensus_mri_deu-(1).aspx.,Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
Available at: http://www.mibb.ch/Documents/ consensus_ster_deu-(1).aspx.,Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
Available at: http://www.mibb.ch/Documents/consensus_us_deu-(1).aspx.,Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
Avaiable at: http://www.awmf.org/uploads/tx_szleitlinien/077-001_S3_Brustkrebs- Frueherkennung_lang_02-2008_02-2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
Available at: http://www.iarc.fr/ en/publications/pdfs-online/pat-gen/bb4/BB4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/24/10.1177_0284185115610931.PMC4906532.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/38/rjw074.PMC4906533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/80/rjw103.PMC4906534.pdf
1998 http://dermnetnz.org/reactions/pyoderma-gangrenosum.html (updated Sept 2015; cited 22 Septemeber 2015).,OADS,/arxiv_data1/oa_pdf/f1/80/rjw103.PMC4906534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/69/rjw101.PMC4906546.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d3/4c/ijp-26-02-4403.PMC4906561.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1c/60/ijp-26-02-3667.PMC4906562.pdf
Proteomics data were processed  using the Perseus software  suite (http://www.perseus- frame - work .org/) and R (20).,OADS,/arxiv_data1/oa_pdf/ca/52/br-05-01-0035.PMC4906564.pdf
YIN et al:  MOLECULAR MECHANISMS OF OV ARIAN CANCER 406 Omnibus ( http://www.ncbi.nlm.nih.gov /geo/) and was based  on the platform of the GPL6947 Illumina HumanHT -12 V3.0  expression beadchip.,OADS,/arxiv_data1/oa_pdf/26/03/ol-12-01-0405.PMC4906568.pdf
"In addition, a regula - tory network was constructed using the known regulatory data  between transcription factors (TFs) and target genes in the  University of California Santa Cruz (UCSC) Genome Browser  (http://genome.ucsc.edu)  and the regulatory impact factor of  each TF was calculated.",OADS,/arxiv_data1/oa_pdf/85/53/ol-12-01-0073.PMC4906613.pdf
"The gene expression profile  dataset GSE6344 (21), including 10 RCC samples and  10 patient -matched normal control samples, was obtained from  the Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/85/53/ol-12-01-0073.PMC4906613.pdf
The data of TF binding  sites of human genome hg18 and the coordinates of genes were  downloaded from UCSC (http://genome.ucsc.edu).,OADS,/arxiv_data1/oa_pdf/85/53/ol-12-01-0073.PMC4906613.pdf
"Microarray and outcome data were obtained from the glioblas - toma data set of the TGCA network available on December 11,  2014 ( http://cancergenome.nih.gov /) (36).",OADS,/arxiv_data1/oa_pdf/fc/d0/ol-12-01-0445.PMC4906635.pdf
"Subsequently,  the probe sets were mapped to the genes using the  ̔getSymbol ̓ function in Package ̔ annotate ̓ (version 1.49.1;  http://www.bioconductor.org/ ).",OADS,/arxiv_data1/oa_pdf/b9/cd/etm-12-01-0201.PMC4906647.pdf
"Initially, all human PPIs, involving 15,750 genes and  248,584 interactions were downloaded from the Biological  General Repository for Interaction Datasets (BioGrid;  http://thebiogrid.org /) database.",OADS,/arxiv_data1/oa_pdf/b9/cd/etm-12-01-0201.PMC4906647.pdf
"Actual norm, 2010, http://www.spps.gob.mx/images/stories/SPPS/Docs/nom/NOM-015-SSA2-2010.pdf  7.",Non-OADS,/arxiv_data1/oa_pdf/6a/68/10.1177_2050312115622957.PMC4906675.pdf
"Nuevo León, 2012, http://www3.inegi.org.mx/sistemas/bibliotecas/detalle.aspx?c=265&upc=70282 5045838&s=est&tg=2&pf=Prod&ef=19&cl=0 (accessed 23  January 2014).",Non-OADS,/arxiv_data1/oa_pdf/6a/68/10.1177_2050312115622957.PMC4906675.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/0f/hepatmon-16-05-37412.PMC4906707.pdf
"EXPERIMENTAL AND THERAPEUTIC MEDICINE  12:  87-94,  2016 93 (http://www.nlm.nih.gov/mesh/MBrowser.html ) the  82 diseases were classified into 26 groups, including skin  and connective tissue diseases, neoplasms, immune system  diseases, cardiovascular diseases and musculoskeletal  diseases.",OADS,/arxiv_data1/oa_pdf/cb/07/etm-12-01-0087.PMC4906768.pdf
"Using the key words ̔optic nerve ̓  and ̔IgG4 -related disease ̓, a literature search was performed  using PubMed (http://www.ncbi.nlm.nih.gov/pubmed) .",OADS,/arxiv_data1/oa_pdf/59/bd/etm-12-01-0111.PMC4906810.pdf
The  protein structure data of CYP11B2 was downloaded from the   Research Collaboratory for Structural Bioinformatics  Protein  Data Bank (RCSB PDB; http://www.rcsb.org /pdb/home /home.,OADS,/arxiv_data1/oa_pdf/f9/4d/ol-12-01-0035.PMC4906842.pdf
(A) Severity of CYP mutations were estimated in six cancer types using Polyphen‑2 (http://genetics.bwh.harvard.edu /pph2 /).,Non-OADS,/arxiv_data1/oa_pdf/f9/4d/ol-12-01-0035.PMC4906842.pdf
"(B) Overall protein secondary structure of CYP11B2, created using PyMOL (http://www.pymol.org/).",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/ol-12-01-0035.PMC4906842.pdf
Available from: http://www.hngn.com/articles/193628/20160330/ prehistoric-dental-calculus-trap-ancient-human-dna-genome- reconstruction.htm.,Non-OADS,/arxiv_data1/oa_pdf/e8/03/CCD-7-129.PMC4906851.pdf
Available from:  http://www.who.int/ageing/about/facts/en/.,Non-OADS,/arxiv_data1/oa_pdf/71/12/CCD-7-153.PMC4906855.pdf
Available from: http://www.aapd.org/assets/1/7/ POHRPCTechBrief2.pdf.,OADS,/arxiv_data1/oa_pdf/99/8a/CCD-7-198.PMC4906863.pdf
http://www.w3.org /2001 /sw/.,Non-OADS,/arxiv_data1/oa_pdf/13/e7/etm-12-01-0288.PMC4906911.pdf
McGuinness DL and Harmelen FV (eds): OWL Web Ontology  Language Overview: W3C Recommendation 10 February 2004.  http://www.w3.org/TR/owl‑features/.,OADS,/arxiv_data1/oa_pdf/13/e7/etm-12-01-0288.PMC4906911.pdf
The patients conformed to the diagnostic criteria of chronic  nephropathy proposed by the Kidney Disease Improving  Global Outcomes (http://kdigo.org).,Non-OADS,/arxiv_data1/oa_pdf/c0/08/etm-12-01-0157.PMC4906941.pdf
"RESTplus 1.1 software (RESTplus, Hangzhou,  China; http://restfmri.net/forum/index.php?q=rest) was used  to manually test ROI was used to manually test ROI signal  strength, and the image method was used to place ROI at the  other side to measure signal strength of the corresponding side  and perform semiquantitative analysis.",OADS,/arxiv_data1/oa_pdf/3b/8d/etm-12-01-0297.PMC4907036.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/67/main.PMC4907037.pdf
"Then, because of a suspicion of cutaneous tuberculosis,treatment with intravenous injection of levo ﬂoxacin at 0.4 g perContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.05.001 2211-7539/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2a/67/main.PMC4907037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/67/main.PMC4907037.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AlachlorEndosulfanBiodegradationWhole Genome Sequencing (WGS)Pseudomonas Speci ﬁcations Organism Pseudomonas sp.,Non-OADS,/arxiv_data1/oa_pdf/0e/17/main.PMC4907040.pdf
http://dx.doi.org/10.1016/j.gdata.2016.05.008 2213-5960/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/0e/17/main.PMC4907040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/17/main.PMC4907040.pdf
"43 (W1) (2015) W104 –W108, http://dx.doi.org/10.1093/nar/gkv401 .138 A. Chauhan et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/17/main.PMC4907040.pdf
"Familial Amy- loidotic Polyneuropathy World Transplant Registry and DominoLiver Transplant Registry; [Accessed November 1, 2015]: Avail- able from: http://www.fapwtr.org/.",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/CJP2-2-072.PMC4907057.pdf
GSE55940 was downloaded from the  Gene Expression Omnibus database (GEO; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/fe/61/ol-12-01-0473.PMC4907103.pdf
Gene expression profile dataset GSE42148 was down - loaded from the Gene Expression Omnibus (GEO;  http://www.ncbi.nlm.nih.gov/geo/)  database.,OADS,/arxiv_data1/oa_pdf/7a/6c/etm-12-01-0257.PMC4907106.pdf
Three- node  network motifs that occurred at a significantly greater frequency  compared with random networks in the constructed integrated  network (P<0.05) were detected using Fast Network Motif  Detection  (version  2.2; http://theinf1.informatik.uni -jena.de/ motifs/)  (16).,OADS,/arxiv_data1/oa_pdf/7a/6c/etm-12-01-0257.PMC4907106.pdf
"Genes involved in the resulting differential  network motifs were subject to pathway enrichment analysis  based on Kyoto Encyclopedia of Genes and Genomes ( KEGG;  www.genome.jp /kegg) (18) and functional annotation analysis  based on the gene ontology (GO) database (19) using Database  for Annotation, Visualization and Integrated Discovery  (version 6.7; https://david.ncifcrf.gov/)  (20).",OADS,/arxiv_data1/oa_pdf/7a/6c/etm-12-01-0257.PMC4907106.pdf
2010 [cité 2014 juill 25];Available from: http://www.sfar.,Non-OADS,/arxiv_data1/oa_pdf/1a/e2/0392-100X-36-127.PMC4907159.pdf
"This will improve understanding of contemporary African population  This open-access work is published under the terms of the Creative Commons Attribution NonCommercial License 2.0 Germany,  which permits use, reproduction & distribution in any medium for non-commercial purposes, provided the original author(s) and  source are given credit.See http://creativecommons.org/licenses/by-nc/2.0/de/Europe PMC Funders Group Author Manuscript Demogr Res .",Non-OADS,/arxiv_data1/oa_pdf/51/1e/emss-68778.PMC4907354.pdf
"Some previous studies have  used parish registers for demographic and epidemiological reconstruction, particularly in South Africa and Namibia, but there has  been no comprehensive attempt to survey the available data ( Nhonoli 1954 , Thornton 1977 , Feltz 1990 , Katzenellenbogen, Yach, and  Dorrington 1993 , Colwell 2000 , Notkola and Siiskonen 2000 , Notkola, Timæus, and Siiskonen 2000 , Shemeikka, Notkola, and  Siiskonen 2005 , Doyle 2012 ).3A Fujifilm X10 camera and tripod were used to photograph the registers as raw files, following digitisation guidelines from the  Endangered Archives Programme at the British Library to enable future archiving and storage: http://eap.bl.uk/downloads/ guidelines_copying.pdf  (last accessed 14 March 2014).Walters Page 2 Demogr Res .",Non-OADS,/arxiv_data1/oa_pdf/51/1e/emss-68778.PMC4907354.pdf
Rome: Site international des  Missionnaires d’Afrique; http://www.mafrome.org/livre_shorter.htm  (n.d.) [electronic resource] Johnson-Hanks J.,Non-OADS,/arxiv_data1/oa_pdf/51/1e/emss-68778.PMC4907354.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/d3/jew027.PMC4907382.pdf
A vailable from: http://www.ncbi.nlm.nih.gov/pubmed/10352594.,Non-OADS,/arxiv_data1/oa_pdf/34/d3/jew027.PMC4907382.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 10796935.,Non-OADS,/arxiv_data1/oa_pdf/34/d3/jew027.PMC4907382.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/jew090.PMC4907384.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/25/jiw073.PMC4907407.pdf
"Washington, DC: American Society for Microbiology, 2014 .http://www.icaaconline.com/php/icaac2014abstracts/data/index.htm .",Non-OADS,/arxiv_data1/oa_pdf/be/25/jiw073.PMC4907407.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/e5/jiw100.PMC4907417.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
Reporting period: January 2010 –December 2011. http://www.unaids.org/en/dataanalysis /knowyourresponse/countryprogress reports/2012countries/ce_ZW_Narrative_Report.pdf .,OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
http://www.unaids.org/sites/default/ ﬁles/country/ documents/ZWE_narrative_report_2015.pdf .,Non-OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
"The world factbook, 2015 .https://www.cia.gov/ library/publications/the-world-factbook/geos/zi.html .",Non-OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
"17. WHO HIV drug resistance report, 2012 .http://www.who.int/hiv/pub/ drugresistance/report2012/en/ .",Non-OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
https://www.york.ac.uk/media/che/ documents/papers/researchpapers/CHERP109_cost-effectiveness_threshold_LMICs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
http://data.worldbank.org/indicator/ NY.GDP.PCAP.CD .,OADS,/arxiv_data1/oa_pdf/39/56/jiw120.PMC4907418.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction an d distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/02/jiw128.PMC4907420.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/ff/copd-11-1261.PMC4907478.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1261–1268International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1261OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9411 9Impact of combined pulmonary fibrosis and  emphysema on surgical complications and long- term survival in patients undergoing surgery for  non-small-cell lung cancer atsushi hata1,2 Yasuo sekine1 Ohashi Kota1 eitetsu Koh1 Ichiro Y oshino2 1Department of Thoracic surgery,   Tokyo Women’s Medical University  Yachiyo Medical Centre, Yachiyo,   2Department of general Thoracic  surgery, graduate school of Medicine,   Chiba University, Chiba City, Chiba,   JapanPurpose:  The outcome of radical surgery for lung cancer was investigated in patients with  combined pulmonary fibrosis and emphysema (CPFE).",Non-OADS,/arxiv_data1/oa_pdf/93/ff/copd-11-1261.PMC4907478.pdf
"Keywords:  combined pulmonary fibrosis and emphysema, lung cancer, surgical treatment,  long-term outcomes Introduction Combined pulmonary fibrosis and emphysema (CPFE) is a clinical syndrome  defined by upper lobe emphysema and lower lobe pulmonary fibrosis on computed  tomography (CT).1,2 A previous report found that 8.9% of lung cancer patients had CPFE, and these patients  had a poorer prognosis than those with emphysema alone.3 However, the impact of CPFE  on the outcomes of lung cancer surgery has not been extensively investigated.4Correspondence: Yasuo sekine Department of Thoracic surgery, Tokyo  Women’s Medical University Yachiyo  Medical Center, 477-96 Owadashinden,  Yachiyo, Chiba 276-8524, Japan Tel +81 47 450 6000 Fax +81 47 458 7047 email sekine.yasuo@twmu.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hata et al Running head recto: Impact of CPFE on surgical outcomes DOI: http://dx.doi.org/10.2147/COPD.S94119",Non-OADS,/arxiv_data1/oa_pdf/93/ff/copd-11-1261.PMC4907478.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/93/ff/copd-11-1261.PMC4907478.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/ff/copd-11-1261.PMC4907478.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/da/43/copd-11-1207.PMC4907479.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1207–1216International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1207OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10368 0 smokers with emphysema and small airway  disease on computed tomography have lower  bone density esther Pompe1 Pim a de Jong2 eva M van rikxoort3  leticia gallardo estrella3 Werner U de Jong2 rozemarijn Vliegenthart4,5 Matthijs Oudkerk5 Carlijn M van der aalst6 Bram van ginneken3 Jan-Willem J lammers1 Firdaus aa Mohamed  hoesein2 1Department of Pulmonology,   2Department of radiology, University  Medical Center Utrecht, Utrecht,   3Department of radiology, radboud  University Medical Center, nijmegen,   4Center for Medical Imaging- north  east netherlands, University of  groningen, University Medical  Center groningen, groningen,   the netherlands; 5Department of  radiology, University of groningen,   University Medical Center groningen,   groningen, 6Department of Public  health, erasmus Medical Center,   rotterdam, the netherlandsAbstract:  Osteoporosis is more common in patients with COPD and in smokers.",Non-OADS,/arxiv_data1/oa_pdf/da/43/copd-11-1207.PMC4907479.pdf
"Computed tomography (CT) is increasingly used to identify bio - markers to classify COPD patients, and it could be helpful in studying the association  between morphologic abnormalities underlying COPD and osteoporosis.9 Next to  smoking-related lung changes on CT, bone density measurements based on Hounsfield Correspondence: esther Pompe Department of Pulmonology, University  Medical Center Utrecht, Postbus 85500,  3508 ga Utrecht, Postbox: e.03.511,  the netherlands Tel +31 30 887 550 846 email e.pompe@umcutrecht.n lJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Pompe et al Running head recto: Smokers and lower bone density DOI: http://dx.doi.org/10.2147/COPD.S103680",Non-OADS,/arxiv_data1/oa_pdf/da/43/copd-11-1207.PMC4907479.pdf
Available from:  http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis- management.htm l  2.,Non-OADS,/arxiv_data1/oa_pdf/da/43/copd-11-1207.PMC4907479.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/da/43/copd-11-1207.PMC4907479.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/43/copd-11-1207.PMC4907479.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1223–1231International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1223OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10257 0 Prompt initiation of maintenance treatment  following a COPD exacerbation: outcomes  in a large insured population anna D Coutinho1 Tasneem lokhandwala1 robert l Boggs2 anand a Dalal2 Pamela B landsman- Blumberg1 Julie Priest2 David a stempel3 1real World evidence, Xcenda  llC, Palm harbor, Fl, 2Us health  Outcomes, glaxosmithKline, research  Triangle Park, nC, 3Us Medical affairs,   glaxosmithKline, research Triangle  Park, nC, UsaBackground:  The aim of this study was to extend previous findings and determine the value  of prompt initiation of maintenance treatment (MT) following COPD exacerbations requiring  hospitalization or an emergency department (ED) visit.",Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
"Keywords:  COPD, maintenance treatment, costs, exacerbations Introduction COPD is characterized by persistent airflow obstruction and is a major cause of ill  health worldwide.1 Within USA, COPD has been estimated to have annual costs of  US$75 billion for a nationally representative population (4.6 million individuals)2 and  US$15.7 billion for commercially insured patients (2.9 million individuals).3 Direct  health care costs account for 39%–73% of these total costs,4 and the major component  of these direct costs is hospitalization.2,3 Exacerbations are also a significant contributor  to COPD-related costs, as patients with COPD exacerbations have ten times the annual  health care costs of patients without exacerbations.5 However, economic costs are Correspondence: anna D Coutinho Xcenda llC, 4114 Woodlands Parkway,  suite 500, Palm harbor, Fl 34685, Usa Tel +1 513 474 1528 Fax +1 727 771 4145 email anna.coutinho@xcenda.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Coutinho et al Running head recto: Prompt maintenance treatment initiation following a COPD exacerbation DOI: http://dx.doi.org/10.2147/COPD.S102570",Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
Available from: http://www.goldcopd.com /.,Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
"Available from: http://www.chestnet.org/Guidelines-and-Resources/ Health-Policy/Position-Paper s. Accessed July 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
Available from: https://www.gpo.gov/fdsys/pkg/ FR-2014-08-22/pdf/2014-18545.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
Available from: http://www.goldcopd.com /.,Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
Available from: http://www.cdc.gov/nchs/icd/icd9cm.,OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
Available from: http://www.bls.gov/cpi /.,Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/05/copd-11-1223.PMC4907480.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/75/amep-7-347.PMC4907481.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p)Advances in Medical Education and Practice 2016:7 347–355Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  347OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S8880 6“Maternal health and Family Planning Distance  Education” experience among physicians: a three- phase study to determine the educational needs,  develop education program, and evaluate efficacy  of the education administered Bestami ciftci1 nesibe Uzel1 M Onur Ozel2 sema Zergeroglu1 cetin Deger2 s sare T urasan1 Ayse gul Karakoc1 semra Ozbalci1 1general Directorate of health  research (sA gEM), T urkish Ministry  of health, Ankara, T urkey; 2Bayer Türk  Kimya San Ltd, Şti, Ankara, T urkey correspondence: cetin Deger   Bayer Türk Kimya San Ltd Şti,   Ehlibeyt Mahallesi Ceyhun Atıf Kansu  caddesi, Ata Plaza B Blok no 100/53,  Balgat 06520, Ankara, Turkey   Tel +90 312 472 2646   Fax +90 312 473 2999   Email cetin.deger@bayer.co mAim:  This study aims to assess the educational needs of family practitioners and evaluate the  efficacy of the ongoing “Maternal Health and Family Planning Distance Education” program  conducted by the General Directorate of Health Research (SAGEM) of the Turkish Ministry  of Health.",Non-OADS,/arxiv_data1/oa_pdf/0d/75/amep-7-347.PMC4907481.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/0d/75/amep-7-347.PMC4907481.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/75/amep-7-347.PMC4907481.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/53/copd-11-1217.PMC4907482.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1217–1222International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1217OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10085 3agreement between a simple dyspnea-guided  treatment algorithm for stable COPD and the  gOlD guidelines: a pilot study Carlos Cabrera,1 Ciro  Casanova,2 Y olanda Martín,3  Virginia Mirabal,3 María del  Carmen sánchez,4 Felisa  Álvarez,5 gabriel Juliá,1  Pedro Cabrera-n avarro,1  Miguel Ángel garcía-Bello,6  José María Marín,7 Juan  Pablo de-T orres,8 Miguel  Divo,9 Bartolomé Celli9 1University hospital of gran Canaria  Dr n egrín, respiratory service,  las Palmas de gran Canaria, spain;  2University hospital nuestra señora  de la Candelaria, respiratory service,  santa Cruz de T enerife, spain; 3arucas  health Center, Primary Care las  Palmas de gran Canaria, spain; 4Cueva  Torres health Center, Primary Care  las Palmas de gran Canaria, spain;  5la Feria health Center, Primary  Care las Palmas de gran Canaria,  spain; 6University hospital of gran  Canaria Dr negrín, Investigation Unit,  las Palmas de gran Canaria, spain;  7University hospital Miguel servet,  respiratory service, Zaragoza, spain;  8navarra University Clinic, respiratory  service, Pamplona, spain; 9Brigham and  Women’s hospital, Pulmonary and  Critical Care service, Boston, M a, Usa  Introduction:  Guidelines recommendations for the treatment of COPD are poorly followed.",Non-OADS,/arxiv_data1/oa_pdf/95/53/copd-11-1217.PMC4907482.pdf
"However, several international studies have shown that the actual implementa - tion of guidelines is very limited including the one published by the Global Initiative  for Obstructive Lung Disease (GOLD).6 Pérez et al found that in the US just 12% of  primary care physicians used the forced expiratory volume in the 1st second (FEV1)  to guide their prescriptions, while Chávez et al showed how only 40% of patients had  a treatment in agreement with the international recommendations.7,8 These data are  similar to those shown in Denmark, Canada, Switzerland, or the People’s Republic  of China.9–12 Moreover, only 18% of patients in Spain were being treated following  the international standards.13 The reasons for the guidelines being poorly followed are not known, but the lack of  real-time spirometry, incorporation of several symptoms scales of different dimension Correspondence: Carlos Cabrera University hospital of gran Canaria Dr  negrín, respiratory service, la Ballena s/n,  35010 las Palmas de gran Canaria, spain email ccablopn@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Cabrera et al Running head recto: A new treatment algorithm for COPD DOI: http://dx.doi.org/10.2147/COPD.S100853",Non-OADS,/arxiv_data1/oa_pdf/95/53/copd-11-1217.PMC4907482.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/95/53/copd-11-1217.PMC4907482.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/53/copd-11-1217.PMC4907482.pdf
Available from:  http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/95/53/copd-11-1217.PMC4907482.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/82/copd-11-1199.PMC4907483.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1199–1206International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1199OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10437 6 Development of a Barthel Index based on dyspnea  for patients with respiratory diseases Michele Vitacca1 Mara Paneroni1 Paola Baiardi2 Vito De Carolis3 elisabetta Zampogna4 stefano Belli5 Mauro Carone3 antonio spanevello4,6 Bruno Balbi5 giorgio Bertolotti7 1respiratory rehabilitation Division,   salvatore Maugeri Foundation, IrCCs,   Institute of lumezzane, Brescia,   2scientific Direction, salvatore  Maugeri Foundation, I rCCs, Institute  of Pavia, Pavia, 3respiratory Division,   salvatore Maugeri Foundation,   IrCCs, Institute of Cassano delle  Murge, Bari, 4respiratory Division,   salvatore Maugeri Foundation,   IrCCs, Institute of Tradate, Varese,   5respiratory Division, salvatore  Maugeri Foundation, I rCCs, Institute  of Veruno, novara, 6respiratory  Diseases Unit, University of Insubria,   Varese, 7Psychology Unit, salvatore  Maugeri Foundation, I rCCs, Institute  of Tradate, Varese, ItalyBackground:  As Barthel Index (BI) quantifies motor impairment but not breathlessness, the use  of only this index could underestimate disability in chronic respiratory disease (CRD).",Non-OADS,/arxiv_data1/oa_pdf/72/82/copd-11-1199.PMC4907483.pdf
"Keywords:  activities of daily living, psychometric tests, chronic obstructive pulmonary disease,  pulmonary rehabilitation Introduction Dyspnea affects quality of life, exercise tolerance, and mortality in various disease  conditions.1 Relief from dyspnea during activities of daily living (ADLs) represents  the major goal of respiratory rehabilitation2 and its quantification through specific  instruments (scales) is essential to define disability level and postrehabilitation  improvement.3–17 Approximately 40% of patients with chronic obstructive pulmonary disease  (COPD) report a degree of disability and 68% lose at least one relevant function in  daily life.18 In routine clinical practice, various scales measuring ADLs are used to evalu - ate patients’ motor and functional autonomy/disability, the most widely used being  the Barthel Index (BI).19 This index was developed for chronic patients and long- term hospital patients with neurological diseases examining their performance Correspondence: Michele Vitacca respiratory rehabilitation Division,  salvatore Maugeri Foundation, IrCCs,  Institute of lumezzane, Via g Mazzini  129, 25065 lumezzane, Brescia, Italy Tel +39 30 825 3182 Fax +39 30 825 3189 email michele.vitacca@fsm.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Vitacca et al Running head recto: Barthel Index dyspnea for respiratory patients DOI: http://dx.doi.org/10.2147/COPD.S104376",Non-OADS,/arxiv_data1/oa_pdf/72/82/copd-11-1199.PMC4907483.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/72/82/copd-11-1199.PMC4907483.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/82/copd-11-1199.PMC4907483.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1139–1150International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1139OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10387 3asthma-chronic obstructive pulmonary disease  overlap syndrome in the urban Chinese population:  prevalence and disease burden using the 2010,  2012, and 2013 China national health and  Wellness surveys Bo Ding1 Marco DiBonaventura2 niklas Karlsson1 Xia ling3 1Department of global Medical  affairs, astraZeneca, gothenburg,   sweden; 2Department of health  Outcomes Practice, Kantar health,   new Y ork, nY, Usa; 3Department of  Medical affairs China, astraZeneca,   shanghai, People’s republic of ChinaBackground:  Research has suggested a significant burden for patients with asthma-chronic  obstructive pulmonary disease (COPD) overlap syndrome (ACOS).",Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
"Keywords:  ACOS, quality of life, work productivity, healthcare resource use Background Asthma is a chronic inflammatory condition that causes the airways to swell and narrow,  leading to dyspnea, coughing, and tightening of the chest.1,2 Asthma has been found to  be quite common, though its prevalence varies significantly by region, ranging from Correspondence: Marco DiBonaventura Kantar health, 11 Madison avenue,  12th Floor, new York, nY 10010, Usa Tel +1 212 706 3988 Fax +1 212 647 7659 email marco.dibonaventura@ kantarhealth.co mJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ding et al Running head recto: Burden of ACOS in the People’s Republic of China DOI: http://dx.doi.org/10.2147/COPD.S103873",Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
"All respondents were compensated  Table 1  Distribution of age and sex between the nhWs sample  and the urban China population Age  (years)NHWS sample Urban China populationa Male (%) Female (%) Male (%) Female (%) 18–29 13 13 13 12 30–39 13 10 10 9 40–49 12 8 12 11 50–59 8 8 8 7 60–69 5 5 5 5 70+ 2 2 4 4 Note:  aBased on the China statistical Yearbook from the national Bureau of  statistics of the People’s republic of China (accessed at: http://www.stats.gov.cn /).24 Abbreviation:  nhWs, national health and Wellness survey.",Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
Available  from: http://www.globalasthmareport.org/resources/Global_Asthma_ Report_2014.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/b6/copd-11-1139.PMC4907484.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/4d/copd-11-1245.PMC4907487.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1245–1259International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1245OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10100 3 lung perfusion and emphysema distribution affect  the outcome of endobronchial valve therapy Christian Thomsen1 Dorothea Theilig2 Dominik herzog1 alexander Poellinger2 Felix Doellinger2 nils schreiter3 Vera schreiter2 Dirk schürmann1 Bettina T emmesfeld- Wollbrueck1 stefan hippenstiel1 norbert suttorp1 ralf-harto hubner1 1Department of Internal Medicine/ Infectious Diseases and respiratory  Medicine, 2Institute of radiology,   3Institute of nuclear Medicine,   Charité – Universitätsmedizin Berlin,   Berlin, germanyAbstract:  The exclusion of collateral ventilation (CV) and other factors affect the clinical  success of endoscopic lung volume reduction (ELVR).",Non-OADS,/arxiv_data1/oa_pdf/0a/4d/copd-11-1245.PMC4907487.pdf
"The development of target lobe (TL) atelectasis is an important surrogate marker for  clinical response.6,7 A TL volume reduction of 350 mL has been defined in several stud - ies as indicative of significant lobe volume reduction associated with clinical benefits.8  Recent post hoc analyses of large studies have identified complete lobular occlusion by  valves and the exclusion of interlobar collateral ventilation (CV) as important predic - tive factors.9–12 CV is defined as the ventilation between lobes that bypasses the normal  airways.13 The importance of CV to the outcome of ELVR was recently demonstrated by  a prospective sham-controlled randomized trial.2 It has become clinical routine to assess Correspondence: ralf-harto hubner Department of Internal Medicine/ Infectious Diseases and respiratory  Medicine, Charité – Universitätsmedizin  Berlin, augustenburger Platz 1, 13353  Berlin, germany Tel +49 30 450 553122 email ralf-harto.huebner@charite.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Thomsen et al Running head recto: Lung perfusion and emphysema distribution DOI: http://dx.doi.org/10.2147/COPD.S101003",Non-OADS,/arxiv_data1/oa_pdf/0a/4d/copd-11-1245.PMC4907487.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0a/4d/copd-11-1245.PMC4907487.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/4d/copd-11-1245.PMC4907487.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1233–1243International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1233OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10044 5Efficacy and safety of twice-daily glycopyrrolate  in patients with stable, symptomatic COPD  with moderate-to-severe airflow limitation:  the GEM1 study Craig LaForce1 Gregory Feldman2 Selwyn Spangenthal3 Joerg H Eckert4 Michelle Henley5 Francesco Patalano4 Peter D’andrea5 1north Carolina Clinical research,   Raleigh, NC, USA; 2south Carolina  Pharmaceutical Research, Spartanburg,   SC, USA; 3american health research,   Charlotte, NC, USA; 4novartis  Pharma AG, Basel, Switzerland;   5novartis Pharmaceuticals  Corporation, East Hanover, NJ, USABackground:  The purpose of this study was to confirm the efficacy and safety of twice-daily  glycopyrrolate 15.6 µg, a long-acting muscarinic antagonist, in patients with stable, symptomatic,  chronic obstructive pulmonary disease (COPD) with moderate-to-severe airflow limitation.",Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
"The prevalence of COPD is lower among those  aged 18–44 years (3.2%) than those aged 45–64 years (6.4%) and $65 years (9.8%).2  COPD is characterized by partially reversible airflow limitation, which is usually Correspondence: Craig LaForce north Carolina Clinical research, 2615  Lake Dr, Raleigh, NC 27607, USA email claforce@nccr.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: LaForce et al Running head recto: Efficacy and safety of glycopyrrolate DOI: http://dx.doi.org/10.2147/COPD.S100445",Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
"Avail - able from: http://www.nhlbi.nih.gov/research/reports/2012-mortality- chart-boo k. Accessed 22 July, 2015.",Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
"Available  from: http://www.goldcopd.or g. Accessed February 2, 2016.",OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/002430/WC500133769.,Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
Available from: http://www.pharma.us.novartis.,Non-OADS,/arxiv_data1/oa_pdf/48/7c/copd-11-1233.PMC4907493.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/copd-11-1269.PMC4907494.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1269–1278International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1269OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10545 4 Impact of mild exacerbation on COPD symptoms  in a Japanese cohort Minako sato1 shotaro Chubachi1 Mamoru sasaki1 Mizuha haraguchi1 naofumi Kameyama1 akihiro Tsutsumi1 saeko Takahashi1 hidetoshi nakamura1,2 Koichiro asano3 T omoko Betsuyaku1 1Division of Pulmonary Medicine,   Department of Medicine, Keio  University school of Medicine,   T okyo, 2Department of respiratory  Medicine, saitama Medical University,   saitama, 3Division of Pulmonary  Medicine, Department of Medicine,   T okai University school of Medicine,   Kanagawa, JapanBackground:  Patients with COPD might not report mild exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/copd-11-1269.PMC4907494.pdf
"Keywords:  COPD, chronic emphysema, COPD exacerbation, quality of life, comorbidity Introduction COPD is characterized by progressive and partially reversible airflow limitation, and  it is among the leading causes of death worldwide.1 The disease is complicated by  exacerbation, which is associated with a poor prognosis,2,3 and places a considerable  economic burden on health services and society.4,5 It has also been recognized that  some patients with COPD are particularly prone to exacerbations, and these patients  have been termed “frequent exacerbators”.6,7 Exacerbations are categorized into  mild, moderate, and severe ones in terms of either clinical presentation (number of  symptoms) or utilization of health care resources.8–10 Most of the published studies  have surveyed moderate-to-severe exacerbation that required a change in regular  medication or hospital admission.2,3,11 However, one observational study found that  about half of all exacerbations remain unreported, yet the recovery periods are similar  to those of moderate or severe exacerbations.12 Other studies have also shown that  unreported exacerbations might negatively affect the health-related quality of life Correspondence: shotaro Chubachi Division of Pulmonary Medicine,  Department of Medicine, Keio University  school of Medicine, 35 shinanomachi,  shinjuku-ku, Tokyo 160-8582, Japan Tel +81 3 5363 3406 Fax +81 3 3353 2502 email bachibachi472000@live.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Sato et al Running head recto: Mild exacerbation in COPD DOI: http://dx.doi.org/10.2147/COPD.S105454",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/copd-11-1269.PMC4907494.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/copd-11-1269.PMC4907494.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/5a/copd-11-1269.PMC4907494.pdf
The authors would like to apologise for any inconvenience caused.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.04.003 2211-7539/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/ed/main.PMC4907524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.mmcr.2015.08.001 E-mail address: sophie.brun@avc.aphp.fr (S. Brun).Medical Mycology Case Reports 11 (2016) 27,Non-OADS,/arxiv_data1/oa_pdf/78/ed/main.PMC4907524.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/5e/dddt-10-1927.PMC4907636.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1927–1933Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1927Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10314 7 The efficacy of nebulized magnesium sulfate  alone and in combination with salbutamol in  acute asthma hatem a sarhan1 Omar h el-garhy1 Mohamed a ali2 nouran a Y oussef1 1Department of Pharmaceutics,   Faculty of Pharmacy, 2Department of  chest Diseases, Faculty of Medicine,   Minia University, Minia, egyptObjective:  Evaluation of the efficacy of nebulized magnesium sulfate (MgSO4) alone and in  combination with salbutamol in acute asthma.",Non-OADS,/arxiv_data1/oa_pdf/77/5e/dddt-10-1927.PMC4907636.pdf
"Exacerbations  are associated with airway obstruction that should be documented and quantified correspondence: hatem a sarhan Department of Pharmaceutics,   Faculty of Pharmacy, Minia University,  61519 Minia, egypt email hatem.sarhan@mu.edu.e gJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Sarhan et al Running head recto: Efficacy of nebulized MgSO4 in acute asthma DOI: http://dx.doi.org/10.2147/DDDT.S103147",Non-OADS,/arxiv_data1/oa_pdf/77/5e/dddt-10-1927.PMC4907636.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/77/5e/dddt-10-1927.PMC4907636.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/5e/dddt-10-1927.PMC4907636.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/5b/dddt-10-1917.PMC4907637.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1917–1925Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1917Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10291 8 in vivo gastric residence and gastroprotective  effect of floating gastroretentive tablet of DA-9601,  an extract of Artemisia asiatica , in beagle dogs Jeong soo Kim1 Kwang ho cha1 Seung Yeob Kang1 Donghan Won1 sun Woo Jang1 Miwon son1 Moon ho son1 ho Jung choi2 Y oung Won lee2 Myung Joo Kang3 1Dong-A Pharmaceutical Co. Ltd.,   Giheung-gu, Y ongin, Gyeonggi, 2college  of Veterinary Medicine and research  institute of Veterinary Medicine,   chungnam national University,   Daejeon, 3College of Pharmacy,   Dankook University, Dongnam-gu,   cheonan, chungnam, south KoreaObjective:  DA-9601, an extract of Artemisia asiatica  containing eupatilin and jaceosidin as  active compounds, has been prescribed to treat gastritis in Asia.",Non-OADS,/arxiv_data1/oa_pdf/3e/5b/dddt-10-1917.PMC4907637.pdf
"Thus, the necessity for frequent daily dosing with an IR formulation  has led to the need for a prolonged release dosage form of DA-9601.correspondence: Myung Joo Kang College of Pharmacy, Dankook  University, 119 Dandae-ro, Dongnam-gu,  Cheonan, Chungnam 330-714, South  Korea Tel +82 41 550 1446 Fax +82 41 550 7899 email kangmj@dankook.ac.k rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kim et al Running head recto: Gastroprotective effect of prolonged release GR tablet of DA-9601 DOI: http://dx.doi.org/10.2147/DDDT.S102918",Non-OADS,/arxiv_data1/oa_pdf/3e/5b/dddt-10-1917.PMC4907637.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3e/5b/dddt-10-1917.PMC4907637.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/5b/dddt-10-1917.PMC4907637.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/cd/dddt-10-1885.PMC4907638.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1885–1895Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1885Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10641 2Molecular mechanisms of cisplatin resistance in   cervical cancer Haiyan Zhu Hui Luo wenwen Zhang Zhaojun Shen Xiaoli Hu Xueqiong Zhu Department of Obstetrics and  Gynecology, The Second Affiliated  Hospital of wenzhou Medical  University, wenzhou, People’s  Republic of ChinaAbstract:  Patients with advanced or recurrent cervical cancer have poor prognosis, and their  1-year survival is only 10%–20%.",Non-OADS,/arxiv_data1/oa_pdf/93/cd/dddt-10-1885.PMC4907638.pdf
"In this article, we summarize recent advances in  our understanding of the mechanisms underlying cisplatin resistance (CPR) in cervical  cancer and propose strategies to overcome CPR in cervical cancer.Correspondence: Xueqiong Zhu Department of Obstetrics and Gynecology,  The Second Affiliated Hospital of  wenzhou Medical University, No 109,  Xueyuan Xi Road, wenzhou 325027,  Zhejiang, People’s Republic of China Tel +86 577 8800 2796 Fax +86 577 8800 2560 email zjwzzxq@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Zhu et al Running head recto: Cisplatin resistance in cervical cancer DOI: http://dx.doi.org/10.2147/DDDT.S106412",Non-OADS,/arxiv_data1/oa_pdf/93/cd/dddt-10-1885.PMC4907638.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/93/cd/dddt-10-1885.PMC4907638.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/cd/dddt-10-1885.PMC4907638.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/f5/dddt-10-1935.PMC4907639.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1935–1945Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1935Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10565 1inhibitory effects of compounds from Phyllanthus   amarus  on nitric oxide production, lymphocyte  proliferation, and cytokine release from phagocytes Yuandani1,2 ibrahim Jantan1 Menaga ilangkovan1 Khairana husain1 Kok Meng chan3 1Drug and herbal research center,   Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan raja Muda  abdul aziz, Kuala lumpur, Malaysia;   2Falkultas Farmasi, Universitas  sumatera Utara, UsU-Kampus,   Medan, indonesia; 3Biomedical  science Programme, Faculty of health  sciences, Universiti Kebangsaan  Malaysia, Jalan raja Muda abdul aziz,   Kuala lumpur, MalaysiaAbstract:  Standardized extract of Phyllanthus amarus has previously been shown to have a  strong inhibitory effect on phagocytic activity of human neutrophils.",Non-OADS,/arxiv_data1/oa_pdf/fc/f5/dddt-10-1935.PMC4907639.pdf
"Th2 cells are characterized by  the production of IL-4, IL-5, and IL-10, thereby stimulating humoral immunity.2  Besides the defensive roles during infections, the phagocyte–microbe interactions correspondence: ibrahim Jantan Drug and herbal research center,  Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan raja Muda  abdul aziz, 50300 Kuala lumpur,  Malaysia Tel +60 1 6288 6445 Fax +60 3 2698 3271 email profibj@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Yuandani et al Running head recto: Immunosuppressive effects of compounds from Phyllanthus amarus DOI: http://dx.doi.org/10.2147/DDDT.S105651",Non-OADS,/arxiv_data1/oa_pdf/fc/f5/dddt-10-1935.PMC4907639.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fc/f5/dddt-10-1935.PMC4907639.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/f5/dddt-10-1935.PMC4907639.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/e3/dddt-10-1909.PMC4907640.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1909–1916Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1909Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10617 5 role of cytochrome P450 2D6 genetic  polymorphism in carvedilol hydroxylation in vitro Zhe Wang1,* li Wang2,3,* ren-ai Xu4 Yun-yun Zhan2 cheng-ke huang1 Da-peng Dai5 Jian-ping cai5 guo-xin hu2 1Department of Pharmacy, The  second affiliated hospital & Yuying  children’s hospital of Wenzhou  Medical University, 2Department of  Pharmacology, school of Pharmacy,   Wenzhou Medical University,   Wenzhou, 3Department of Pharmacy,   Women’s hospital, school of  Medicine, Zhejiang University,   hangzhou, 4Department of Pharmacy,   The First affiliated hospital of  Wenzhou Medical University,   Wenzhou, 5The Key laboratory of  geriatrics, Beijing hospital & Beijing  institute of geriatrics, Ministry of  health, Beijing, People’s republic  of china *These authors contributed equally  to this workAbstract:  Cytochrome P450 2D6 (CYP2D6) is a highly polymorphic enzyme that catalyzes  the metabolism of a great number of therapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/26/e3/dddt-10-1909.PMC4907640.pdf
"Meanwhile, according correspondence: guo-xin hu Department of Pharmacology, school of  Pharmacy, Wenzhou Medical University,  University-Town, Wenzhou 325000,  People’s republic of china email hgx@wmu.edu.c n  Jian-ping cai The Key laboratory of geriatrics, Beijing  hospital & Beijing institute of geriatrics,  Ministry of health, no 1, Dahua road,  Dongdan, Beijing 100730, People’s  republic of china email caijp61@vip.sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: Cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation DOI: http://dx.doi.org/10.2147/DDDT.S106175",Non-OADS,/arxiv_data1/oa_pdf/26/e3/dddt-10-1909.PMC4907640.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/26/e3/dddt-10-1909.PMC4907640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/e3/dddt-10-1909.PMC4907640.pdf
Medicine (2016) 95:23(e3588)Received: 10 December 2015 / Received in ﬁnal form: 20 March 2016 / Accepted: 12 April 2016Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003588Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/cd/medi-95-e3588.PMC4907645.pdf
Medicine (2016) 95:23(e3711)Received: 17 November 2015 / Received in ﬁnal form: 24 April 2016 / Accepted: 25 April 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003711Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cb/1b/medi-95-e3711.PMC4907648.pdf
Appendix 1 (http://links.lww.-com/MD/B8) shows the demographic and health-related characteristics of our respondents.,Non-OADS,/arxiv_data1/oa_pdf/10/23/medi-95-e3761.PMC4907652.pdf
"21There is no limitation on the use of Appendix 1 (http://links.lww.com/MD/B8), because the previous publication ‘‘permits unrestricted use, distribution, and reproduction in any medium, provided the original workis properly cited.’’21It should be highlighted that, although the data were collected in the same survey as described in a previous publication,21focus on the current study is on self- care strategies, and there is no overlapping of data presented inall remaining tables and figure.",Non-OADS,/arxiv_data1/oa_pdf/10/23/medi-95-e3761.PMC4907652.pdf
Available at: http://china-trade-research.hktdc.com/business-news/article/China-Consumer-Market/China-s-health-food-market/ccm/en/1/1X000000/1X002L54.htm.,Non-OADS,/arxiv_data1/oa_pdf/10/23/medi-95-e3761.PMC4907652.pdf
Available at: http://apps.who.int/medicinedocs/en/m/abstract/Js18676en/.,Non-OADS,/arxiv_data1/oa_pdf/10/23/medi-95-e3761.PMC4907652.pdf
"No statistical significance was observed regarding the association of the ESR with endoscopic diseaseactivity in any disease group (see Supplementary STARD Flow Diagram, http://links.lww.com/MD/B56).",OADS,/arxiv_data1/oa_pdf/29/99/medi-95-e3772.PMC4907655.pdf
Medicine (2016) 95:23(e3777)Received: 1 February 2016 / Received in ﬁnal form: 22 April 2016 / Accepted: 3 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003777Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fe/7d/medi-95-e3777.PMC4907657.pdf
Medicine (2016) 95:23(e3784)Received: 1 March 2016 / Received in ﬁnal form: 26 April 2016 / Accepted: 30 April 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003784Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/73/medi-95-e3784.PMC4907659.pdf
Available at: http://www.cdc.gov/nchs/ahcd.htm.,OADS,/arxiv_data1/oa_pdf/98/73/medi-95-e3784.PMC4907659.pdf
Medicine (2016) 95:23(e3803)Received: 28 December 2015 / Received in ﬁnal form: 11 April 2016 / Accepted: 4 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003803Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/de/15/medi-95-e3803.PMC4907660.pdf
Available at: http://www.moh.gov.cn/wsb/pzcjd/200804/21154.shtml.,Non-OADS,/arxiv_data1/oa_pdf/de/15/medi-95-e3803.PMC4907660.pdf
Available at: http://www.stats-hb.gov.cn/wzlm/tjgb/rkpcgb/fz/11023.htm.,OADS,/arxiv_data1/oa_pdf/de/15/medi-95-e3803.PMC4907660.pdf
Available at: http://xn.stats-hb.9hb.cn/html/tjsj/tjnj/4962.html.,Non-OADS,/arxiv_data1/oa_pdf/de/15/medi-95-e3803.PMC4907660.pdf
Medicine (2016) 95:23(e3832)Received: 12 October 2015 / Received in ﬁnal form: 4 May 2016 / Accepted: 10 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003832Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/06/b7/medi-95-e3832.PMC4907663.pdf
Medicine (2016) 95:23(e3833)Received: 27 March 2016 / Received in ﬁnal form: 26 April 2016 / Accepted: 10 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003833Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7c/60/medi-95-e3833.PMC4907664.pdf
"We quanti ﬁed the following variables: (1) MG acinar area (MAA) (manually drawn a linearound the inner lumen of the acinar unit and calculated the area automatically by Image J, an open source software program from http://rsb.info.nih.gov/ij/), (2) MG acinar density (MAD) (manu-ally marked inside each 400 /C2400mm frame and calculated the density automatically using Image J), (3) MG ori ﬁce diameter (MOD) (manually marked along the longest axis of ori ﬁce and calculated the diameter automatically by Image J), (4) meibum secretion re ﬂectivity (MSR), (5) MG acinar irregularity (MAI), (6) inhomogeneous appearance of periglandular interstices, and(7) walls of acinar units.",OADS,/arxiv_data1/oa_pdf/7c/60/medi-95-e3833.PMC4907664.pdf
Medicine (2016) 95:23(e3834)Received: 7 December 2015 / Received in ﬁnal form: 3 May 2016 / Accepted: 10 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003834Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/64/02/medi-95-e3834.PMC4907665.pdf
Medicine (2016) 95:23(e3835)Received: 11 March 2016 / Received in ﬁnal form: 3 May 2016 / Accepted: 8 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003835Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/64/0c/medi-95-e3835.PMC4907666.pdf
"All search information was summarized in electronic supplementary material (ESM)-search strategy ﬁle, http://links.lww.com/MD/B11.",OADS,/arxiv_data1/oa_pdf/64/0c/medi-95-e3835.PMC4907666.pdf
"Information abstraction The essential information for this study were abstracted independently by 2 investigators from each eligible meta-analysisusing prespeci ﬁed standard information extraction forms (ESM- Table 1, http://links.lww.com/MD/B12) based on Microsoft Excel, including ﬁrst author name, publication year, retrieval database, study design of the original trial, number of included RCTs, level of evidence, additional statistical analysis method, heterogeneity level, and all outcomes of interest.",OADS,/arxiv_data1/oa_pdf/64/0c/medi-95-e3835.PMC4907666.pdf
"We also summarized the heterogeneitylevel, subgroup analysis, and sensitive analysis of each meta- analysis in ESM-Table 2, http://links.lww.com/MD/B13.",OADS,/arxiv_data1/oa_pdf/64/0c/medi-95-e3835.PMC4907666.pdf
Medicine (2016) 95:23(e3836)Received: 25 March 2016 / Received in ﬁnal form: 4 May 2016 / Accepted: 8 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003836Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/89/97/medi-95-e3836.PMC4907667.pdf
Medicine (2016) 95:23(e3853)Received: 1 December 2015 / Received in ﬁnal form: 28 April 2016 / Accepted: 2 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003853Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/be/d8/medi-95-e3853.PMC4907672.pdf
Medicine (2016) 95:23(e3858)Received: 28 January 2016 / Received in ﬁnal form: 26 April 2016 / Accepted: 26 April 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003858Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/a7/medi-95-e3858.PMC4907675.pdf
Medicine (2016) 95:23(e3868)Received: 15 March 2016 / Received in ﬁnal form: 6 May 2016 / Accepted: 16 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003868 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/2c/medi-95-e3868.PMC4907677.pdf
Medicine (2016) 95:23(e3870)Received: 5 February 2016 / Received in ﬁnal form: 12 April 2016 / Accepted: 3 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003870Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/55/a3/medi-95-e3870.PMC4907678.pdf
Medicine (2016) 95:23(e3874)Received: 17 February 2016 / Received in ﬁnal form: 7 May 2016 / Accepted: 16 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003874Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f5/b6/medi-95-e3874.PMC4907679.pdf
"Available at: http://www.invs.sante.fr/ publications/2006/guide_raisin/index.html (accessed March 10, 2016).",Non-OADS,/arxiv_data1/oa_pdf/f5/b6/medi-95-e3874.PMC4907679.pdf
Available at: http://www.cnil.fr.,Non-OADS,/arxiv_data1/oa_pdf/f5/b6/medi-95-e3874.PMC4907679.pdf
Medicine (2016) 95:23(e3883)Received: 17 March 2016 / Received in ﬁnal form: 12 May 2016 / Accepted: 16 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003883Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9e/06/medi-95-e3883.PMC4907681.pdf
Medicine (2016) 95:23(e3886)Received: 3 January 2016 / Received in ﬁnal form: 14 April 2016 / Accepted: 16 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003886Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d8/17/medi-95-e3886.PMC4907682.pdf
Medicine (2016) 95:23(e3887)Received: 11 February 2016 / Received in ﬁnal form: 13 May 2016 / Accepted: 17 May 2016 Published online 1 May 2016http://dx.doi.org/10.1097/MD.0000000000003887Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"Three (7.5%) patients had F2 ﬁbrosis and 4 (10%) patients F3 ﬁbrosis, details are found in Supplementary Table 1, http://links.lww.com/MD/B26.",Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"1A, Supple- mentary Table 2, http://links.lww.com/MD/B26).",Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"1, Supplementary Table 2, http://links.lww.com/MD/B26).",Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"Further details can be found in Supplementary Table 3, http://links.lww.com/MD/B26.",Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"The total consumption of fructose was higher in our NAFLD patients compared with thehealthy controls (Supplementary Table 2, http://links.lww.com/ MD/B26).",Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"Dietary guidelines for Americans 2015 –2 0 2 0 ,8 t he d .A v a i l a b l ea t : http://health.gov/dietaryguidelines/2015/guidelines/.",Non-OADS,/arxiv_data1/oa_pdf/fe/65/medi-95-e3887.PMC4907683.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/53/tcrm-12-941.PMC4907704.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 941–955Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  941Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8479 2 Pazopanib in the management of advanced soft  tissue sarcomas Lee D Cranmer1  elizabeth T Loggers2  Seth M Pollack2 1Division of Medical Oncology,   University of washington, Seattle, wA,   USA; 2Clinical Research Division, Fred  Hutchinson Cancer Research Center,   Seattle, wA, USAAbstract:  Therapy of soft tissue sarcomas represents an area of significant unmet need in  oncology.",Non-OADS,/arxiv_data1/oa_pdf/ee/53/tcrm-12-941.PMC4907704.pdf
"Correspondence: Lee D Cranmer Division of Medical Oncology, University  of washington, 825 eastlake Avenue e,  G3-630, Seattle, wA 98109, USA Tel +1 206 288 7439 email lcranmer@seattlecca.or g Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Cranmer et al Running head recto: Pazopanib for advanced soft tissue sarcomas DOI: http://dx.doi.org/10.2147/TCRM.S84792",Non-OADS,/arxiv_data1/oa_pdf/ee/53/tcrm-12-941.PMC4907704.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ee/53/tcrm-12-941.PMC4907704.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/53/tcrm-12-941.PMC4907704.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1059–1077Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1059Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S11162 0 Meta-analysis and review: effectiveness, safety, and  central port design of the intraocular collamer lens Mark Packer Mark Packer MD Consulting, inc.,   Boulder, CO, USAAbstract:  The purpose of this review is to summarize relevant data from publications  appearing in the peer-reviewed scientific literature over the past decade since US Food and  Drug Administration approval of the implantable collamer lens (ICL), and, in particular, to  review studies relating to sizing methodology, safety, and effectiveness, as well as more recent  studies reporting clinical outcomes of the V4c Visian ICL with KS Aquaport, VICMO.",Non-OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
"Keywords:  refractive surgery, Phakic lens, posterior chamber, myopia Introduction One decade has passed since the United States Food and Drug Administration (US  FDA) determined that implantation of the STAAR Visian Implantable Collamer Lens  (ICL, STAAR Surgical, Monrovia, CA, USA) is a safe and effective refractive proce - dure for the correction of myopia.1 Worldwide, the Visian ICL has been marketed for  approximately two decades, and over 550,000 lenses have been implanted.2 The benefits  of the ICL for the correction of moderate-to-high myopia and myopic astigmatism3  include predictable, stable refractive correction4 and a high efficacy index,5 as well as  improvement in quality of vision6 and quality of life.7 Long-term studies have inves - tigated the safety profile of the ICL and demonstrated generally low rates of adverse  events.8 In a prospective, randomized, study comparing ICL implantation and pho - torefractive keratectomy, the ICL performed better than photorefractive keratectomy  in all measures of safety, efficacy, predictability, and stability, supporting the ICL as  a viable alternative to this popular refractive surgical procedure.6Correspondence: Mark Packer Mark Packer MD Consulting, inc.,  1400 Bluebell Avenue, Boulder,  CO 80302, USA Tel +1 541 915 0291 email mark@markpackerconsulting.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Packer Running head recto: ICL meta-analysis and review DOI: http://dx.doi.org/10.2147/OPTH.S111620",Non-OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
"Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf3/ P030016b.pd f. Accessed March 31, 2016.",OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
"Available from: http://finance.yahoo.com/news/staar-surgical-reports- fourth-quarter-210100370.htm l. Accessed April 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/d1/opth-10-1059.PMC4907705.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 917–925Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  917Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8921 5Management of chemotherapy-induced nausea  and vomiting by risk profile: role of netupitant/ palonosetron vito Lorusso National Cancer Research Centre,   istituto T umori Giovanni Paolo ii, Bari,   italyAbstract:  As recommended by most recent antiemetic guidelines, the optimal prophylaxis of  chemotherapy-induced nausea and vomiting (CINV) requires the combination of 5-HT3 receptor  antagonist (RA) with an NK1-RA.",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Keywords:  NEPA, netupitant, NK1, CINV, vomiting, risk factors Introduction Chemotherapy-induced nausea and vomiting (CINV) is the most unpleasant side  effect of treatment, and, in particular, nausea is still cited by patients as the one with  the highest impact on their quality of life.1 Patients undergoing chemotherapy show three different types of emesis (acute,  delayed, and overall), each having particular characteristics.1 In fact, acute emesis,  which develops within 24  hours after the administration of chemotherapy, and delayed  emesis, which develops 24 hours after chemotherapy and can persist for a number  of days, are controlled by different pathways and need different pharmacological  approaches.2,3 Modern prophylaxis of CINV includes the administration of a drug that inhibits  serotonin (5-HT3 receptor antagonist [RA]), the major neurotransmitter responsible  for acute nausea and vomiting in association with a drug that inhibits P-substance  (NK1-RA), and the major neurotransmitter responsible for delayed nausea and  vomiting.Correspondence: vito Lorusso National Cancer Research Centre,  istituto Tumori Giovanni Paolo ii, viale  Orazio Flacco 65, 70124 Bari, italy email vitolorusso@me.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Lorusso Running head recto: NEPA and CINV risk DOI: http://dx.doi.org/10.2147/TCRM.S89215",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ antiemesis.pd f. Accessed January 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/003728/ WC500188432.pd f. Accessed January 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000743/ WC500037153.pd f. Accessed January 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000527/ WC500026537.pd f. Access January 11, 2016.",OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Public_assessment_report/ human/003728/WC500188434.pd f. Accessed January 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/3b/tcrm-12-917.PMC4907706.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/58/ijn-11-2711.PMC4907707.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2711–2719International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2711OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10314 0evaluation of oxidative response and tissular  damage in rat lungs exposed to silica-coated gold  nanoparticles under static magnetic fields soumaya Ferchichi1 hamdi Trabelsi1 Inès azzouz1 amel hanini2 ahmed rejeb3 Olfa T ebourbi1 Mohsen sakly1 hafedh abdelmelek1 1laboratory of Integrative Physiology,   Faculty Of sciences of Bizerte,   2laboratory of Vascular Pathology,   carthage University, carthage  3laboratory of Pathological anatomy,   National school of Veterinary  Medicine of sidi Thabet, Manouba  Univeristy, Manouba, T unisiaAbstract:  The purpose of our study was the evaluation of toxicological effects of silica-coated  gold nanoparticles (GNPs) and static magnetic fields (SMFs; 128 mT) exposure in rat lungs.",Non-OADS,/arxiv_data1/oa_pdf/76/58/ijn-11-2711.PMC4907707.pdf
"This is of concern because during synthesis  and applications, GNPs of various sizes, shapes, and surface charges are generated  that may be of health risk.3 A previous study suggested that GNPs can be used safely.4 However, other data  found that gold was toxic to the body, where it becomes soluble by cyanidation and  can undergo oxidation.3 Investigations revealed that GNPs are heavily taken up by  kidneys and can also initiate eryptosis.5,6 Physicochemical properties related to size, correspondence: soumaya Ferchichi laboratory of Physiologie Intégrée,  Faculty of sciences of Bizerte, carthage  University, carthage, carthage – 7021,  Tunisia Fax +216 2 72 590 566 email ferchichi.soumeya@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ferchichi et al Running head recto: GNPs could induce tissular damage and oxidative stress in rat lungs DOI: http://dx.doi.org/10.2147/IJN.S103140",Non-OADS,/arxiv_data1/oa_pdf/76/58/ijn-11-2711.PMC4907707.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/76/58/ijn-11-2711.PMC4907707.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/58/ijn-11-2711.PMC4907707.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/96/ijn-11-2543.PMC4907708.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2543–2555International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2543OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10286 1 Fast and safe fabrication of a free-standing  chitosan/alginate nanomembrane to promote  stem cell delivery and wound healing Yi Kong1,2,* rui Xu1,* Mohammad ali Darabi2 Wen Zhong3 gaoxing luo1 Malcolm MQ Xing1,2 Jun Wu1 1Institute of Burn research,   southwest hospital, state Key  laboratory of Trauma, Burns, and  combined Injury, chongqing Key  laboratory for Diseases Proteomics,   Third Military Medical University,   chongqing, People’s republic of  china; 2Department of Mechanical  engineering, Biochemistry and  Medical genetics, children’s  hospital research Institute of  Manitoba, 3Department of Biosystem  engineering, University of Manitoba,   Winnipeg, MB, canada *These authors contributed equally  to this workAbstract:  Polymeric ultrathin membranes that are compatible with cells offer tremendous  advantages for tissue engineering.",Non-OADS,/arxiv_data1/oa_pdf/20/96/ijn-11-2543.PMC4907708.pdf
"The polysaccharide nanosheet was correspondence: Jun Wu Institute of Burn research, southwest  hospital, state Key laboratory of  Trauma, Burns, and combined Injury,  Third Military Medical University,  30 gaotanyan street, chongqing 400038,  People’s republic of china Tel +86 23 6875 2688 email editorinchief@burninchina.co m  Malcolm MQ Xing Department of Mechanical engineering,  Biochemistry and Medical genetics,  children’s hospital research Institute  of Manitoba, University of Manitoba,  Winnipeg, MB r3T 2N2, canada Tel +1 204 480 1396 email malcolm.xing@umanitoba.c a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kong et al Running head recto: Fast and safe fabrication of a free-standing CHI/ALG nanomembrane DOI: http://dx.doi.org/10.2147/IJN.S102861",Non-OADS,/arxiv_data1/oa_pdf/20/96/ijn-11-2543.PMC4907708.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/20/96/ijn-11-2543.PMC4907708.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/96/ijn-11-2543.PMC4907708.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/e8/ijn-11-2601.PMC4907709.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2601–2617International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2601OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10490 8Design and statistical modeling of mannose- decorated dapsone-containing nanoparticles as  a strategy of targeting intestinal M-cells alexandre cc Vieira1,* luíse l chaves1,* Marina Pinheiro1 Domingos Ferreira2 Bruno sarmento3–5 salette reis1 1UcIBIO, reQUIMT e, chemistry  Department, Faculty of Pharmacy,   2laboratory of Pharmaceutical  Technology, Department of Drug  sciences, Faculty of Pharmacy, 3I3s,   Institute for research and Innovation  in health, 4INeB – Institute of  Biomedical engineering, University  of Porto, Porto, 5cesPU, Institute of  research and advanced Formation  in health sciences and T echnology,   University Institute of health  sciences, gandra, Portugal *These authors contributed equally  to this workAbstract:  The aim of the present work was to develop and optimize surface-functionalized  solid lipid nanoparticles (SLNs) for improvement of the therapeutic index of dapsone (DAP),  with the application of a design of experiments.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/ijn-11-2601.PMC4907709.pdf
"Keywords:  Box–Behnken design, leprosy, drug delivery, targeting, oral route, solid lipid  nanoparticle Introduction The oral route is still considered the most convenient and safest route of drug  administration with higher patient compliance, lesser complications, and lower cost,  in comparison with parenteral drug delivery.1–5 Besides all the advantages of the  oral route, factors like low aqueous solubility of drugs, limited gastrointestinal (GI)  absorption, rapid metabolism of drug, and low mucosal permeability play a major role  in the disappointing in vivo results.5–8 The intestinal mucosa plays an effective role correspondence: salette reis chemistry Department, Faculty  of Pharmacy, University of Porto, Jorge  Viterbo Ferreira street, 228,   4050-313, Porto, Portugal Tel +351 2 2042 8672 Fax +351 2 2609 3483 email shreis@ff.up.p tJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Vieira et al Running head recto: Mannose-decorated dapsone-containing nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S104908",Non-OADS,/arxiv_data1/oa_pdf/86/e8/ijn-11-2601.PMC4907709.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/ijn-11-2601.PMC4907709.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/e8/ijn-11-2601.PMC4907709.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ijn-11-2557.PMC4907710.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2557–2567International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2557OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9784 6Delivery of dexamethasone from bioactive  nanofiber matrices stimulates odontogenesis of  human dental pulp cells through integrin/BMP/ mTOR signaling pathways Hyun-Chang Lim,1,* Ok  Hyung Nam,2,* Mi-joo Kim,3  Ahmed El-Fiqi,4,5 Hyung- Mun Yun,3 Y oo-Mi Lee,3  Guang-Zhen Jin,4,5 hae- Hyoung Lee,5,6 hae-Won  Kim,4–6 Eun-Cheol Kim3 1Department of Periodontology,  2Department of Pediatric Dentistry,  3Department of Oral and Maxillofacial  Pathology, Research Center for  Tooth and Periodontal Regeneration  (MRC), School of Dentistry, Kyung  Hee University, Seoul, 4Department  of Nanobiomedical Science, BK21  PLUS NBM Global Research Center  for Regenerative Medicine, 5Institute  of Tissue Regeneration Engineering,  6Department of Biomaterials Science,  College of Dentistry, Dankook University,  Cheonan, Republic of Korea *These authors contributed equally  to this work as first authorsAbstract:  Therapeutically relevant design of scaffolds is of special importance in the repair and  regeneration of tissues including dentin and pulp.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ijn-11-2557.PMC4907710.pdf
"Correspondence: Eun-Cheol Kim Department of Oral and Maxillofacial  Pathology, Research Center for Tooth and  Periodontal Regeneration (MRC), School  of Dentistry, Kyung Hee University, 24  Kyungheedae-ro, Dongdaemun-gu, Seoul  02453, Republic of Korea Tel +82 2 961 0746 Fax +82 2 960 1457 email eckim@khu.ac.k r  Hae-Won Kim Institute of Tissue Regeneration Engineering  (ITREN), Dankook University, 119,  Dandae-ro, Dongnam-gu, Cheonan-si,  Chungnam, 31116, Republic of Korea Tel +82 41 550 3081 Fax +82 41 550 3085 email kimhw@dku.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lim et al Running head recto: Odontogenic stimulation by dexamentasone-releasing nanofibers DOI: http://dx.doi.org/10.2147/IJN.S97846",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ijn-11-2557.PMC4907710.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ijn-11-2557.PMC4907710.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/cb/ijn-11-2557.PMC4907710.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/43/ijn-11-2721.PMC4907711.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2721–2736International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2721OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10245 0Biodegradable micelles enhance the antiglioma  activity of curcumin in vitro and in vivo songping Zheng1,* Xiang gao1,2,* Xiaoxiao liu1 Ting Yu1 Tianying Zheng1 Yi Wang1 chao Y ou1 1Department of Neurosurgery,   West china hospital, West china  Medical school, sichuan University,   chengdu, People’s republic of china;   2Department of Pharmacology, Yale  school of Medicine, Yale University,   New haven, cT, Usa *These authors contributed equally  to this workAbstract:  Curcumin (Cur), a natural polyphenol of Curcuma longa , has been recently reported  to possess antitumor activities.",Non-OADS,/arxiv_data1/oa_pdf/1f/43/ijn-11-2721.PMC4907711.pdf
"It has been reported to possess anticancer property through  various mechanisms, including cell cycle inhibition (suppressing cyclin D and inducing  p21), differentiation induction (promoting autophagy), apoptosis promotion (activating correspondence: chao You Department of Neurosurgery, West  china hospital, West china Medical  school, sichuan University, No 37,  guoxue alley, chengdu 610041,  People’s republic of china Tel +86 28 8542 2136 Fax +86 28 8550 2796 email chaoyouyouchao@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zheng et al Running head recto: Biodegradable micelles enhance the antiglioma activity DOI: http://dx.doi.org/10.2147/IJN.S102450",Non-OADS,/arxiv_data1/oa_pdf/1f/43/ijn-11-2721.PMC4907711.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/43/ijn-11-2721.PMC4907711.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/43/ijn-11-2721.PMC4907711.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/35/ijn-11-2675.PMC4907712.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2675–2683International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2675OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10437 4In vivo targeted gene delivery to peripheral  neurons mediated by neurotropic poly(ethylene  imine)-based nanoparticles  cátia DF lopes,1–3,* hugo  Oliveira,1,* Inês estevão,1  liliana raquel Pires,1 ana  Paula Pêgo1,2,4,5 1INeB – Instituto de engenharia  Biomédica, Universidade do Porto  (UPorto), Porto, Portugal; 2i3s – Instituto  de Investigação e Inovação em saúde,  NanoBiomaterials for Targeted Therapies  group, UPorto, Porto, Portugal; 3FMUP –  Faculdade de Medicina da Universidade  do Porto, Porto, Portugal; 4IcBas –  Instituto de ciências Biomédicas abel  salazar, UPorto, Porto, Portugal; 5FeUP –  Faculdade de engenharia da Universidade  do Porto, Porto, Portugal *These authors contributed equally  to this workAbstract:  A major challenge in neuronal gene therapy is to achieve safe, efficient, and minimally  invasive transgene delivery to neurons.",Non-OADS,/arxiv_data1/oa_pdf/8d/35/ijn-11-2675.PMC4907712.pdf
"Gene transfer to the peripheral nervous system has been previously explored,  mainly through the use of viral vectors, since some have natural neurotropism and are  associated with high transduction efficiencies.2 However, in spite of important advances  toward the increased safety of viral vehicles, they still present risks regarding toxicity  and immunogenicity.3 In turn, nonviral gene delivery vectors have become attractive correspondence: ana Paula Pêgo i3s – Instituto de Investigação e Inovação  em saúde, Universidade do Porto,  rua alfredo allen, 208, 4200-135 Porto,  Portugal Tel +351 22 408 800 email apego@ineb.up.p t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lopes et al Running head recto: Targeted gene delivery to peripheral neurons DOI: http://dx.doi.org/10.2147/IJN.S104374 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/8d/35/ijn-11-2675.PMC4907712.pdf
Or use: http://youtu.be/-93fEIO5hw oVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/8d/35/ijn-11-2675.PMC4907712.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8d/35/ijn-11-2675.PMC4907712.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/35/ijn-11-2675.PMC4907712.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2a/70/ott-9-3443.PMC4907713.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3443–3450OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3443Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10443 1 comparison of the effectiveness and toxicity  of neoadjuvant chemotherapy regimens,  capecitabine/epirubicin/cyclophosphamide vs  5-fluorouracil/epirubicin/cyclophosphamide,  followed by adjuvant, capecitabine/docetaxel vs  docetaxel, in patients with operable breast cancer Minmin Zhang* Wei Wei* Jianlun liu huawei Yang Yi Jiang Wei Tang Qiuyun li Xiaoming liao Department of Breast surgery,   affiliated Tumor hospital of guangxi  Medical University, nanning, guangxi,   People’s republic of china *These authors contributed equally  to this workAbstract:  The aim of this study was to compare the effectiveness and toxicity of neoadjuvant che - motherapy regimens, xeloda/epirubicin/cyclophosphamide (XEC) vs 5-fluorouracil/epirubicin/ cyclophosphamide (FEC), followed by adjuvant chemotherapy regimens, capecitabine/taxotere  (XT) vs taxotere (T), in axillary lymph node (LN)-positive early-stage breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/2a/70/ott-9-3443.PMC4907713.pdf
"Neoadjuvant chemotherapy can be used to evaluate the therapeutic effect of tumors,  and the evaluation of neoadjuvant chemotherapy has advantages in providing prognosis correspondence: Jianlun liu Department of Breast Surgery, Affiliated  Tumor hospital of guangxi Medical  University, 71 hedi road, nanning  530021, guangxi, People’s republic of  china email jianlunliu@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Comparison of neoadjuvant chemotherapy regimens DOI: http://dx.doi.org/10.2147/OTT.S104431",Non-OADS,/arxiv_data1/oa_pdf/2a/70/ott-9-3443.PMC4907713.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2a/70/ott-9-3443.PMC4907713.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/70/ott-9-3443.PMC4907713.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/99/78/ijn-11-2655.PMC4907714.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2655–2661International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2655OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10183 8XanoMatrix surfaces as scaffolds for mesenchymal  stem cell culture and growth garima Bhardwaj1 Thomas J Webster1,2 1Department of chemical engineering,   Northeastern University, Boston, M a,   Usa; 2center of excellence for  advanced Materials research, King  abdulaziz University, Jeddah, saudi  arabiaAbstract:  Stem cells are being widely investigated for a wide variety of applications in tissue  engineering due to their ability to differentiate into a number of cells such as neurons, osteoblasts,  and fibroblasts.",Non-OADS,/arxiv_data1/oa_pdf/99/78/ijn-11-2655.PMC4907714.pdf
"The pore size must be tailored according to specific cell morphologies, they must have  sufficient mechanical integrity to be handled easily during surgery, and finally they  must degrade at a controllable rate so that the targeted tissue becomes fully formed  via ECM deposition as the scaffold is fully resorbed.correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, Boston,   Ma 0211, Usa email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Bhardwaj and Webster Running head recto: XanoMatrix surfaces for mesenchymal stem cell culture and growth DOI: http://dx.doi.org/10.2147/IJN.S101838",Non-OADS,/arxiv_data1/oa_pdf/99/78/ijn-11-2655.PMC4907714.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/99/78/ijn-11-2655.PMC4907714.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/78/ijn-11-2655.PMC4907714.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/fd/opth-10-1039.PMC4907715.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1039–1046Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1039Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S10132 5 A stepwise approach for the management of  capsular contraction syndrome in hinge-based  accommodative intraocular lenses Timothy P Page1 Jeffrey whitman2 1Department of Ophthalmology,   Oakland University william Beaumont  School of Medicine, Royal Oak, M i,   2Key-whitman eye Center, Dallas,   TX, USAPurpose:  The aims of this study are to define the various stages of capsular contraction syndrome  (CCS) and its effect on refractive error with hinge-based accommodating intraocular lenses (IOLs)  and to describe a systematic approach for the management of the different stages of CCS.",Non-OADS,/arxiv_data1/oa_pdf/04/fd/opth-10-1039.PMC4907715.pdf
"These IOLs appeal to patients who do not wish to risk side effects Correspondence: Timothy P Page Oakland Ophthalmic Surgery, 800 South  Adams Road, Suite 201, Birmingham, Mi  48009, USA email tpagemd@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Page and Whitman Running head recto: CCS in hinge-based accommodative intraocular lenses DOI: http://dx.doi.org/10.2147/OPTH.S101325",Non-OADS,/arxiv_data1/oa_pdf/04/fd/opth-10-1039.PMC4907715.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/04/fd/opth-10-1039.PMC4907715.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/fd/opth-10-1039.PMC4907715.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/04/fd/opth-10-1039.PMC4907715.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/opth-10-1053.PMC4907716.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1053–1057Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1053Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10989 4 Worsening anatomic outcomes following  aflibercept for neovascular age-related macular  degeneration in eyes previously well controlled  with ranibizumab eric nudleman1 Jeremy D Wolfe2,3 Maria a Woodward4 Y oshihiro Y onekawa2,3 george a Williams2,3 Tarek s hassan2,3 1Department of Ophthalmology,   shiley eye Center, University of  California, san Diego, la Jolla, C a,   2Beaumont eye institute, Oakland  University William Beaumont school  of Medicine, 3associated retinal  Consultants, royal Oak, 4Kellogg  eye Center, University of Michigan  Medical School, Ann Arbor, MI, USAPurpose:  Antivascular endothelial growth factor injection is the mainstay of treating neovascular  age-related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/opth-10-1053.PMC4907716.pdf
"Keywords:  anti-VEGF; intravitreal injection; macula; optical coherence tomography; retina Introduction Age-related macular degeneration (AMD) is the leading cause of legal blindness in  the US.1–3 Neovascular AMD may cause vision loss secondary to subretinal fluid,  hemorrhage, intraretinal edema, or scarring.3 It is well established that vision loss from  neovascular AMD is dramatically reduced in eyes treated with intravitreal injections  of antibodies that target vascular endothelial growth factor (VEGF).4–6 Several groups have reported on patients treated with intravitreal ranibizumab  or bevacizumab who have a good initial response with resolution of subretinal or  intraretinal fluid, but then later become resistant to continued treatment with these agents  and develop recurrent exudation with vision loss.7 The mechanism of this acquired  recalcitrance to treatment is not known, but tachyphylaxis has been suggested.7–9 It has  been reported that switching from one anti-VEGF medication to another may lead to  a favorable result with improvement in vision and resolution of fluid.10Correspondence: Tarek s hassan associated retinal Consultants,  3535 West 13 Mile road, suite 344,  royal Oak, Mi 48073, Usa email tsahassan@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Nudleman et al Running head recto: Worsening with aflibercept conversion in neovascular AMD DOI: http://dx.doi.org/10.2147/OPTH.S109894",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/opth-10-1053.PMC4907716.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/opth-10-1053.PMC4907716.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/a2/opth-10-1053.PMC4907716.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 907–916Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  907Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8629 9 Clinical usefulness of mepolizumab in severe  eosinophilic asthma Francesco Menzella Mirco Lusuardi Gloria Montanari Carla Galeone Nicola Facciolongo Luigi Zucchi Department of Cardio-Thoracic- vascular and intensive Care  Medicine, Pneumology Unit, iRCCS –  Arcispedale Santa Maria Nuova,   Reggio emilia, italyAbstract:  Asthma is a chronic inflammatory disorder of the airways with variable clinical  severity from very mild and occasional symptoms to recurrent critical exacerbations, at risk of  fatal or near-fatal outcome, in a small percentage of patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
"The prevalence of  eosinophilic inflammation identifies one phenotype of asthma sustained by the biological Correspondence: Francesco Menzella Department of Cardio-Thoracic-vascular  and intensive Care Medicine, Pneumology  Unit, iRCCS – Arcispedale Santa  Maria Nuova, viale Risorgimento 56,  42123 Reggio emilia, italy Tel +39 0522 296 073 Fax +39 0522 296 182 email menzella.francesco@asmn.re.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Menzella et al Running head recto: Mepolizumab in severe asthma DOI: http://dx.doi.org/10.2147/TCRM.S86299",Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
"Available from  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm471031.ht m. Accessed January 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
33. http://www.ema.europa.eu/ema.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Avail - able from: https://clinicaltrials.gov/ct2/show/NCT0210596 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT02377427?term =mepolizuma b&cond=%22Asthma%22&rank =14.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0255537 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Available from http://www.ukmi.nhs.uk/applications/ndo/record_view_ open.asp?newDrugID =4675.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
Available from http://www.icer-review.,Non-OADS,/arxiv_data1/oa_pdf/8b/0b/tcrm-12-907.PMC4907717.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/64/79/ijn-11-2633.PMC4907718.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2633–2639International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2633OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10866 1 Peptide-coated gold nanoparticles for modulation  of angiogenesis in vivo catarina roma-rodrigues1 amelie heuer-Jungemann2 alexandra r Fernandes1 antonios g Kanaras2 Pedro V Baptista1 1UcIBIO, Departamento de ciências  da Vida, Faculdade de ciências e  Tecnologia, Universidade NOV a  de lisboa, caparica, Portugal;   2Institute for life sciences, Physics  and astronomy, Faculty of Physical  sciences and engineering, University  of southampton, southampton, UKAbstract:  In this work, peptides designed to selectively interact with cellular receptors  involved in the regulation of angiogenesis were anchored to oligo-ethylene glycol-capped gold  nanoparticles (AuNPs) and used to evaluate the modulation of vascular development using an  ex ovo chick chorioallantoic membrane assay.",Non-OADS,/arxiv_data1/oa_pdf/64/79/ijn-11-2633.PMC4907718.pdf
"The tumor environment presents an enhanced permeability and retention  effect, which results from the angiogenic nature of the tumor tissue and its ability  to sequester chemotherapeutic agents from healthy tissues.2,3 Ideal drug delivery  nanosystems may exploit this enhanced permeability and retention effect, accu - mulate in the tumor tissue, and release the desired cargo where needed at a high  concentration, thus reducing the undesirable deleterious effects to healthy tissue.4,5 correspondence: Pedro V Baptista UcIBIO, Departamento de ciências da  Vida, Faculdade de ciências e Tecnologia,  Universidade NOVa de lisboa, campus  de caparica, 2829-516, caparica, Portugal Tel +351 212 948 530 Fax +351 212 948 530 email pmvb@fct.unl.p t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Roma-Rodrigues et al Running head recto: Peptide gold nanoparticles for angiogenesis DOI: http://dx.doi.org/10.2147/IJN.S108661",Non-OADS,/arxiv_data1/oa_pdf/64/79/ijn-11-2633.PMC4907718.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/64/79/ijn-11-2633.PMC4907718.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/79/ijn-11-2633.PMC4907718.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/c2/ijn-11-2685.PMC4907719.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2685–2694International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2685OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10629 7 elimination of the biphasic pharmacodynamics  of 15d-PgJ2 by controlling its release from  a nanoemulsion saed abbasi* Kazuaki Kajimoto* hideyoshi harashima Faculty of Pharmaceutical sciences,   hokkaido University, sapporo,   hokkaido, Japan *These authors contributed equally  to this workAbstract:  15-Deoxy- Δ12,14-prostaglandin J2 (15d-PGJ2) has a dual action of stimulat - ing anti-inflammation and anti-proliferation when exogenously administered at high doses.",Non-OADS,/arxiv_data1/oa_pdf/88/c2/ijn-11-2685.PMC4907719.pdf
"Consequently, this naturally occurring correspondence: Kazuaki Kajimoto health research Institute, National  Institute of advanced Industrial science  and Technology, 2217-14 hayashi-cho,  Takamatsu 761-0395, Kagawa, Japan Tel +81 878 69 4208 Fax +81 878 69 3551 email k-kajimoto@aist.go.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Abbasi et al Running head recto: NE for controlling the biphasic pharmacodynamics of 15d-PGJ2 DOI: http://dx.doi.org/10.2147/IJN.S106297",Non-OADS,/arxiv_data1/oa_pdf/88/c2/ijn-11-2685.PMC4907719.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/88/c2/ijn-11-2685.PMC4907719.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/c2/ijn-11-2685.PMC4907719.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/93/60/1875.PMC4907721.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6f/b3/1885.PMC4907722.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e4/e1/1898.PMC4907723.pdf
"The following Drosophila  stocks  were obtained from the Bloomington Drosophila Stock Center,  Bloomington, IN (unless otherwise indicated), and are described in  FlyBase (http://flybase.org): hsp70 -GAL4 ( hs-GAL4), sqhAX3 FRT 19A,  Rok2 FRT 19A, FRT 19A, c306 -GAL4, slbo-GAL4, tub-GAL80ts  (“tsGAL80”), matalpha4-GAL-VP16 -GAL4 (“nurse cell GAL4”), UAS- mCD8:GFP , UAS-Rho1.V14 (“RhoAV14”), UAS-Venus:RokK116A (“Rok  KD”; from J. Zallen, Memorial Sloan Kettering Cancer Center, New  York, NY), UASp-T7.RhoGEF2, UAS- sqh RNAi (line 7916; Vienna  Drosophila  Resource Center [VDRC]; Vienna, Austria), UAS- Mbs  RNAi (line 105762; VDRC), UAS- Rok RNAi (line 9774R-2; National  Institute of Genetics Fly Stock Center [NIG-Fly]; Kyoto, Japan), UAS- Drak RNAi (line 107263, VDRC), UAS-GFP dsRNA (“GFP RNAi”),  sqh-sqhE20E21:FLAG (“Sqh-EE”) and sqhAX3; sqh-Sqh:GFP  (III) (“Sqh:GFP”; from R. Karess, Paris Diderot University, Paris, France),  sqh-sqhA20A21:FLAG (“Sqh-AA”; from L. Luo, Stanford University, Palo  Alto, CA), and ubi-Rok:GFP (from V. Mirouse, Clermont Université,  Clermont-Ferrand, France).",Non-OADS,/arxiv_data1/oa_pdf/e4/e1/1898.PMC4907723.pdf
Image brightness  and/or contrast of images were adjusted in the ImageJ distribution  Fiji (http://fiji.sc; Schindelin et al.,OADS,/arxiv_data1/oa_pdf/e4/e1/1898.PMC4907723.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/67/4c/1911.PMC4907724.pdf
"Density maps were created using the ks  library in R (http://cran.r-project.org), a free software package for  statistical computing.",OADS,/arxiv_data1/oa_pdf/67/4c/1911.PMC4907724.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/93/ff/1921.PMC4907725.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/42/7e/1928.PMC4907726.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/34/08/1938.PMC4907727.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/31/41/1948.PMC4907728.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/00/0d/1958.PMC4907729.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/5a/ijn-11-2619.PMC4907731.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2619–2631International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2619OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10869 2 Magnetic micro/nanoparticle flocculation-based  signal amplification for biosensing Omary Mzava1 Zehra Taş1 Kutay I.çöz1,2 1BioMIND s (Bio Micro/Nano Devices  and Sensors) Laboratory, Department  of electrical and electronics  engineering, 2Bioengineering  Department, Abdullah Gül University,   Kayseri, T urkeyAbstract:  We report a time and cost efficient signal amplification method for biosensors  employing magnetic particles.",Non-OADS,/arxiv_data1/oa_pdf/73/5a/ijn-11-2619.PMC4907731.pdf
"Kocasinan, Kayseri, 38080, Turkey email kutay.icoz@agu.edu.t r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Mzava et al Running head recto: Signal amplification for biosensing DOI: http://dx.doi.org/10.2147/IJN.S108692",Non-OADS,/arxiv_data1/oa_pdf/73/5a/ijn-11-2619.PMC4907731.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/73/5a/ijn-11-2619.PMC4907731.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/5a/ijn-11-2619.PMC4907731.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 931–940Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  931Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8633 0Clinical efficacy of dalbavancin for the treatment  of acute bacterial skin and skin structure  infections (ABSSSi) Kimberly D Leuthner1 Kristin A Buechler1 David Kogan1 Agafe Saguros1 H Stephen Lee2 1Department of Pharmaceutical  Services, University Medical Center  of Southern Nevada, Las Vegas, NV,   USA; 2Roseman University of Health  Sciences College of Pharmacy,   Henderson, N v, USAAbstract:  Acute bacterial skin and skin structure infections (ABSSSI) are a common disease  causing patients to seek treatment through the health care system.",Non-OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
"This trend was clearly established by Pallin et al3 who demonstrated almost three times Correspondence: Kimberly D Leuthner University Medical Center of Southern  Nevada, 1800 w Charleston Blvd.,  Las Vegas, NV 89102, USA Tel +1 702 383 1878 Fax +1 702 383 2052 email kimberly.leuthner@u mcsn.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Leuthner et al Running head recto: Clinical efficacy of dalbavancin for the treatment of ABSSSI DOI: http://dx.doi.org/10.2147/TCRM.S86330",Non-OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
"Available from: http://www.fda.gov/downloads/Dru gs/ Guidances /ucm071185.pd f. Accessed April 6, 2016.",OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
"Available from: http://www.fda.gov/do wnloads/ AdvisoryCommittees /CommitteesMeetingM aterials/Drugs/Anti-  InfectiveDrug sAdvisoryCommittee /UCM390792.pd f. Accessed  April 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/80/61/tcrm-12-931.PMC4907732.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/14/ott-9-3415.PMC4907733.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3415–3422OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3415Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10497 2gPr30 decreases with vascular aging and  promotes vascular smooth muscle cells  maintaining differentiated phenotype and  suppressing migration via activation of erK1/2 Fang huang1,2 Jianguo Yin2 Keyu li1 Ying li1 heng Qi1 li Fang1 cong Yuan1 Weiwei liu1 Min Wang2 Xiangping li2 1Department of cardiology, The First  hospital of changsha, 2Department  of cardiology, The second XiangYa  hospital of central south University,   changsha, hunan Province, People’s  republic of chinaAbstract:  Estrogen receptors, including classic nuclear receptors ER α, ERβ, and membrane  receptor GPR30, are expressed in vascular tissues and exert protective actions in vascular dis - eases.",Non-OADS,/arxiv_data1/oa_pdf/92/14/ott-9-3415.PMC4907733.pdf
"Estrogen can inhibit the endogenous aging of skin and reverse vascular calcifica - tion induced in vitro.5,6 The protective effects of estrogen on endothelium and vas - cular smooth muscle are dependent on its binding to the estrogen receptor.7 The loss correspondence: Xiangping li Department of cardiology, The second  XiangYa hospital of central south  University, 139 renmin road, changsha  410011, hunan Province, People’s  republic of china Tel +86 731 139 748 7901 email lixp@medmail.com.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Huang et al Running head recto: Estrogen receptors involve modulation of phenotype and functions of VSMCs DOI: http://dx.doi.org/10.2147/OTT.S104972",Non-OADS,/arxiv_data1/oa_pdf/92/14/ott-9-3415.PMC4907733.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/92/14/ott-9-3415.PMC4907733.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/14/ott-9-3415.PMC4907733.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/bd/ott-9-3433.PMC4907734.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3433–3441OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3433Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7942 7administration of polysaccharide from Panax  notoginseng  prolonged the survival of h22  tumor-bearing mice huaiyu li,1,* longlong gu,1,2,*   Yuanyuan Zhong,1 Yajuan  chen,1  lei Zhang,1 annie r  Zhang,3 robert W sobol,4,5  T ong chen,1,6 Jianfeng li4,5 1Yunnan Key laboratory of  Pharmacology for natural Products,   school of Pharmaceutical sciences,   2haiyuan college, Kunming Medical  University, Kunming, Yunnan, People’s  republic of china; 3graduate  school of applied and Professional  Psychology, rutgers, The state  University of new Jersey, Piscataway,   nJ, 4Department of Oncologic  sciences, 5Mitchell cancer institute,   University of south alabama, Mobile,   al, Usa; 6Yunnan Panax notoginseng  (Burk) F .h.",Non-OADS,/arxiv_data1/oa_pdf/6b/bd/ott-9-3433.PMC4907734.pdf
"Polysaccharides  extracted from various sources including higher plants demonstrated profound effects  on the immune system and are relatively nontoxic.5 For example, Lentinan, a polysac - charide from Lentinus edodes , has been successfully used in the treatment of various  types of cancer.6 Thus, the discovery of polysaccharides with antitumor activity from  new sources will broaden the drug choices for HCC immunotherapy.correspondence: Tong chen school of Pharmaceutical sciences and  Yunnan Key laboratory of Pharmacology  for natural Products, Kunming Medical  University, 1168 West chunrong road,  Yuhua avenue, chenggong District,  Kunming 650500, Yunnan, People’s  republic of china Tel +86 138 8861 0422 email chentongdoc@163.co m  Jianfeng li Mitchell cancer institute, University of  south alabama, 1660 springhill avenue,  Mobile, al 36604, Usa Tel +1 412 973 4647 email jianfengli@health.southalabama.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Administration of PPN prolonged the survival of H22 tumor-bearing mice DOI: http://dx.doi.org/10.2147/OTT.S79427",Non-OADS,/arxiv_data1/oa_pdf/6b/bd/ott-9-3433.PMC4907734.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/bd/ott-9-3433.PMC4907734.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/bd/ott-9-3433.PMC4907734.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/ef/ijn-11-2663.PMC4907735.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2663–2673International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2663OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10459 3 Fabrication of novel vesicles of triptolide for  antirheumatoid activity with reduced toxicity  in vitro and in vivo li Zhang1,2 T engteng Wang1,2 Qiang li1,2 Jing huang3 hao Xu1,2 Jinlong li1,2 Y ongjun Wang1,2 Qianqian liang1,2 1Department of Orthopaedics,   longhua hospital, 2Institute of spine,   shanghai University of Traditional  chinese Medicine, 3Biochemistry  and Molecular Biology, school of  life science, east china Normal  University, shanghai, People’s  republic of chinaAbstract:  Triptolide (TP) displays a strong immunosuppression function in immune-mediated  diseases, especially in the treatment of rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/75/ef/ijn-11-2663.PMC4907735.pdf
"TP can interact correspondence: Qianqian liang Institute of spine, shanghai University  of Traditional chinese Medicine,  725 Wan-Ping south road, shanghai  200032, People’s republic of china Fax +86 216 443 4704 email liangqianqiantcm@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Fabrication of TP nano-medicine for rheumatoid treatment DOI: http://dx.doi.org/10.2147/IJN.S104593",Non-OADS,/arxiv_data1/oa_pdf/75/ef/ijn-11-2663.PMC4907735.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/75/ef/ijn-11-2663.PMC4907735.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/ef/ijn-11-2663.PMC4907735.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/1a/opth-10-1047.PMC4907736.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1047–1051Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1047ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S10105 0 Ranibizumab in neovascular age-related macular  degeneration: a 5-year follow-up Nadezhda P Cvetkova Kristina Hölldobler Philipp Prahs Viola Radeck Horst Helbig David Märker Department of Ophthalmology,   University of Regensburg,   Regensburg, GermanyPurpose:  Our aim was to evaluate an optical coherence tomography (OCT) and visual acuity  (VA)-guided, variable-dosing regimen with intravitreal ranibizumab injection for treating  patients with neovascular age-related macular degeneration (AMD) from 2007 to 2012.",Non-OADS,/arxiv_data1/oa_pdf/7a/1a/opth-10-1047.PMC4907736.pdf
"Even earlier than that, bevacizumab (Avastin; Genentech, Inc.)  was described as an off-label ocular therapy.2 In Germany, three VEGF inhibitors  were approved for the treatment of neovascular AMD: pegaptanib (Macugen; Pfizer, Correspondence: Nadezhda P Cvetkova Department of Ophthalmology,  University of Regensburg, Franz-Josef- Strauß-Allee 11, 93053 Regensburg,  Germany Tel +49 941 944 9201 Fax +49 941 944 9202 Email nadezhda.cvetkova@ukr.d e Journal name: Clinical Ophthalmology Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 10 Running head verso: Cvetkova et al Running head recto: Ranibizumab in neovascular AMD: a 5-year follow-up DOI: http://dx.doi.org/10.2147/OPTH.S101050",Non-OADS,/arxiv_data1/oa_pdf/7a/1a/opth-10-1047.PMC4907736.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7a/1a/opth-10-1047.PMC4907736.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/1a/opth-10-1047.PMC4907736.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/71/ott-9-3423.PMC4907737.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3423–3432OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3423Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10070 6Comparative efficacy and safety of axitinib versus  sorafenib in metastatic renal cell carcinoma:  a systematic review and meta-analysis Hai wang Libo Man Guizhong Li Guanglin Huang Jianwei wang Department of Urology, Beijing  Jishuitan Hospital, Beijing, People’s  Republic of ChinaObjective:  This study was performed to evaluate the comparative efficacy and safety of axitinib  and sorafenib in the therapy of metastatic renal cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/f3/71/ott-9-3423.PMC4907737.pdf
"Targeted agents as a new class of drugs have better potential efficacy and fewer  adverse events (AEs) than immunotherapy.6,7 Recently, several novel targeted agents,  including sorafenib, bevacizumab (plus IFN- α), temsirolimus, sunitinib, pazopanib,  everolimus, and axitinib, have been assessed in large randomized controlled trials  (RCTs) in both the first- and second-line settings.8 The results of these clinical trials Correspondence: Hai wang Department of Urology, Beijing Jishuitan  Hospital, No 31, east Xinjiekou Street,  Xicheng District, 100035, Beijing,  People’s Republic of China Tel +86 10 583 98240 Fax +86 10 583 98240 email wanghai73@sina.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Axitinib vs sorafenib in metastatic renal cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S100706",Non-OADS,/arxiv_data1/oa_pdf/f3/71/ott-9-3423.PMC4907737.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f3/71/ott-9-3423.PMC4907737.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/71/ott-9-3423.PMC4907737.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/61/ijn-11-2695.PMC4907738.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2695–2709International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2695RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S9902 8From micro- to nanostructured implantable  device for local anesthetic delivery Laura Zorzetto1 Paola Brambilla1 elena Marcello1 Nora Bloise2 Manuela De Gregori3 Lorenzo Cobianchi4,5 Andrea Peloso4,5 Massimo Allegri6 Livia visai2,7 Paola Petrini1 1Department of Chemistry,   Materials and Chemical engineering  ‘G.",Non-OADS,/arxiv_data1/oa_pdf/cd/61/ijn-11-2695.PMC4907738.pdf
"Keywords:  pain management, microparticle, microencapsulation, nanoparticle production,  nanogels, liposomes Local anesthetics: clinical relevance for their use  in implantable delivery systems Local anesthetics (LAs) temporarily and reversibly prevent nociceptive nervous fibers  from sending stimuli to the brain.1 These drugs act by blocking sodium and other ion  channels present in the nerve cell membrane, thereby stopping the electrical signal  before it can cause feelings of pain.1,2 LAs have been used for acute or chronic pain management, and their principal use  is after surgery (eg, thoracotomy, laparotomy, cesarean section, breast cancer surgery,  cosmetic breast surgery, limb amputation, and others).2,3 A recent study has highlighted  the importance of LA administration after major operations to ward off chronic pain  onset after thoracotomies and cesarian sections.3Correspondence: Livia visai Department of Molecular Medicine,  Biochemistry Unit, University of Pavia,  viale Taramelli 3/b, 27100 Pavia, Italy Tel +39 382 98 7725 Fax +39 382 42 3108 email livia.visai@unipv.i t Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Zorzetto et al Running head recto: Device for local anesthetic delivery DOI: http://dx.doi.org/10.2147/IJN.S99028",Non-OADS,/arxiv_data1/oa_pdf/cd/61/ijn-11-2695.PMC4907738.pdf
"Available  from: http://www.frca.co.uk/documents/la.pd f. Accessed April 8,  2016.",Non-OADS,/arxiv_data1/oa_pdf/cd/61/ijn-11-2695.PMC4907738.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cd/61/ijn-11-2695.PMC4907738.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/61/ijn-11-2695.PMC4907738.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/cc/tcrm-12-927.PMC4907739.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 927–929Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  927Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10735 0 a case of gait disturbance caused by low-dose  gabapentin Megumi Kanao-Kanda Hirotsugu Kanda osamu Takahata Takayuki Kunisawa Department of anesthesiology and  Critical Care Medicine, asahikawa  Medical University, asahikawa,   Hokkaido, JapanAbstract:  Gabapentin, an anticonvulsant agent, is now often used for the treatment of  neuropathic pain all over the world.",Non-OADS,/arxiv_data1/oa_pdf/9d/cc/tcrm-12-927.PMC4907739.pdf
"The serum concentration of sodium valproate Correspondence: Hirotsugu Kanda Department of anesthesiology and  Critical Care Medicine, asahikawa  Medical University, Midorigaoka- higashi 2-1-1-1, asahikawa, Hokkaido  078-8510, Japan Tel +81 166 68 2583 Fax +81 166 68 2589 email h.kanda0629@nifty.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Kanao-Kanda et al Running head recto: A case of gait disturbance caused by gabapentin DOI: http://dx.doi.org/10.2147/TCRM.S107350",Non-OADS,/arxiv_data1/oa_pdf/9d/cc/tcrm-12-927.PMC4907739.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/9d/cc/tcrm-12-927.PMC4907739.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/cc/tcrm-12-927.PMC4907739.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2a/c5/ijn-11-2505.PMC4907740.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2505–2513International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2505OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10291 9acute hematologic, hepatologic, and nephrologic  changes after intraperitoneal injections of 18 nm  gold nanoparticles in hamsters hazem Mohamed saleh1 Omar a soliman2 Mohamed Osama elshazly3 alaa raafat2 adel K gohar2 Taher a salaheldin4 1Otolaryngology Unit, Department  of Medical applications, The National  Institute of laser enhanced sciences,   cairo University, 2Department of  clinical Pathology, 3Department  of Pathology, Faculty of Veterinary  Medicine, cairo University,   4Nanotechnology & advanced  Materials central laboratory,   agricultural research center,   guiza, egyptAbstract:  In vivo responses to gold nanoparticles (GNPs) vary not only according to the size,  shape, surface charge, and capping agent of GNPs but also according to the animal model, the  route of administration, and the exposure frequency and duration.",Non-OADS,/arxiv_data1/oa_pdf/2a/c5/ijn-11-2505.PMC4907740.pdf
"Intravenous route was  shown to be the safest12,25 followed by subcutaneous application.24 On the other hand,  intraperitoneal (I/P) administration of GNPs showed a moderate toxicity,12,16 while  the oral route was the most toxic.12,26 Eighteen-nanometer GNPs were found to have a high retention rate in living organ - isms after intraesophageal administration with a high accumulation rate in solid organs, correspondence: hazem Mohamed saleh Otolaryngology Unit, Department of  Medical applications, The National  Institute of laser enhanced sciences,  cairo University, 10 el Messaha square,  apartment 1401, 12311 guiza, egypt Tel +20 2 3748 2838 email hazemsalehniles@yahoo.com  Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Saleh et al Running head recto: Acute hematologic, hepatologic, and nephrologic changes in hamsters DOI: http://dx.doi.org/10.2147/IJN.S102919",Non-OADS,/arxiv_data1/oa_pdf/2a/c5/ijn-11-2505.PMC4907740.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2a/c5/ijn-11-2505.PMC4907740.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/c5/ijn-11-2505.PMC4907740.pdf
"Available from: http://www.toxpath.org/ssndc.as p. Accessed  September 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2a/c5/ijn-11-2505.PMC4907740.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/7e/ijn-11-2587.PMC4907741.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2587–2599International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2587OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10318 3Intratracheal instillation of ethyl pyruvate  nanoparticles prevents the development of  shunt-flow-induced pulmonary arterial hypertension  in a rat model Kai liu1 Xiquan Zhang1 guangqing cao1 Y ongjun liu2 chuanzhen liu1 hourong sun1 Xinyan Pang1 1cardiovascular surgery Department,   Qilu hospital of shandong University,   2Pharmacy college of shandong  University, Jinan, People’s republic  of chinaPurpose:  To investigate whether inhalation of ethyl pyruvate (EP) encapsulated with  poly(ethylene glycol)- block -lactide/glycolide copolymer nanoparticles (EP-NPs) can prevent  the development of shunt-flow-induced hyperkinetic pulmonary arterial hypertension (PAH)  in a rat model.",Non-OADS,/arxiv_data1/oa_pdf/52/7e/ijn-11-2587.PMC4907741.pdf
"Dysfunctional endothelial cells release the nuclear protein HMGB1 and acti - vate proinflammatory cytokines, such as IL-1, IL-6, and TNF α, which themselves correspondence: Xinyan Pang cardiovascular surgery Department,  Qilu hospital of shandong University,  107 Wenhua Xilu, Jinan, shandong  250012, People’s republic of china Tel +86 531 8216 6510 Fax +86 531 8216 6581 email 13793182001@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Nanotherapy for the prevention of PAH DOI: http://dx.doi.org/10.2147/IJN.S103183",Non-OADS,/arxiv_data1/oa_pdf/52/7e/ijn-11-2587.PMC4907741.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/52/7e/ijn-11-2587.PMC4907741.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/7e/ijn-11-2587.PMC4907741.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3405–3414OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3405Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10231 4 The prognostic roles of alDh1 isoenzymes in  gastric cancer Kai li1,2 Xiaoguang guo3 Ziwei Wang4 Xiaofeng li2 Y ouquan Bu5 Xuefeng Bai6 liansheng Zheng7 Ying huang2 1hepatobiliary Treatment center, The  First affiliated hospital of chongqing  Medical University, chongqing,   2Department of Medical Oncology,   3surgical Department, Baotou cancer  hospital, Baotou, inner Mongolia,   4Department of gastrointestinal  surgery, First affiliated hospital  of chongqing Medical University,   chongqing, 5Department of Biology,   chongqing Medical University,   chongqing, 6Department of Pathology,   7surgical Oncology, Baotou cancer  hospital, Baotou, inner Mongolia,   People’s republic of chinaAbstract:  Increased aldehyde dehydrogenase 1 (ALDH1) activity has been determined  to be present in the stem cells of several kinds of cancers including gastric cancer (GC).",Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
"correspondence: Ziwei Wang Department of gastrointestinal surgery,  First Affiliated Hospital of Chongqing  Medical University, no 1, Youyi road,  Yuanjiagang, Yuzhong District, chongqing  400016, People’s republic of china Tel +86 23 6881 1360 email ziweiwangmd@yahoo.co m  Kai li Department of Medical Oncology, Baotou  cancer hospital, 18 Tuanjie st, Qingshan,  Baotou, inner Mongolia 014030, People’s  republic of china email kailimd@yeah.ne tJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Prognostic roles of ALDH1 isoenzymes in GC DOI: http://dx.doi.org/10.2147/OTT.S102314",Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
Available from: http://www.ncbi.nlm.nih.gov/geo /.,OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
Available from: http://biospecimens.cancer.gov/ relatedinitiatives/overview/caBig.asp.,Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
Available from:  http://biospecimens.cancer.gov/relatedinitiatives/overview/caBig.asp/.,Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/3d/ott-9-3405.PMC4907742.pdf
"It is true that until the development of vaccine, rapid detect, respond and control measures of emerging in-fectious diseases like EHF and MERS should be Osong Public Health Res Perspect 2015 6, S1 eS2 http://dx.doi.org/10.1016/j.phrp.2015.12.008pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/ae/31/main.PMC4907785.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/31/main.PMC4907785.pdf
Avail-able from: http://www.whitehouse.gov/the-press-ofﬁce/ 2014/09/26/fact-sheet-golobal-health-security-agenda- getting-ahead-curve-epidemic-th [accessed on 30.11.2015].,Non-OADS,/arxiv_data1/oa_pdf/ae/31/main.PMC4907785.pdf
"E-mail: ghsa2015seoul@gmail.com Osong Public Health Res Perspect 2015 6, S25 eS27 http://dx.doi.org/10.1016/j.phrp.2015.12.006pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/fd/57/main.PMC4907786.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/57/main.PMC4907786.pdf
Available from: http://www.cdc.gov/globalhealth/security/pdf/ghs_ overarching_target.pdf [accessed on 30.11.15].,Non-OADS,/arxiv_data1/oa_pdf/fd/57/main.PMC4907786.pdf
"Osong Public Health Res Perspect 2015 6, S28 eS33 http://dx.doi.org/10.1016/j.phrp.2015.12.007pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/7a/8d/main.PMC4907787.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/main.PMC4907787.pdf
Available from: http://www.cdc.gov/ globalhealth/security.ghsagenda.htm [accessed on 30.11.2015].,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/main.PMC4907787.pdf
"E-mail: ghsa2015seoul@gmail.com Osong Public Health Res Perspect 2015 6, S6 eS24 http://dx.doi.org/10.1016/j.phrp.2015.12.005pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC4907788.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC4907788.pdf
"Available from: http://www.ghsa2015seoul.kr/en , [accessed on 30.11.15].2.",Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC4907788.pdf
"Avail- able from: http://www.ghsa2015seoul.kr/SeoulDeclaration.pdf , [accessed on 30.11.15].S24 GHSA Preparation Task Force Team",Non-OADS,/arxiv_data1/oa_pdf/46/51/main.PMC4907788.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Tuberous sclerosis EverolimusVigabatrinEarly treatmentEpilepsyNeurodevelopmental disorders 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/b2/main.PMC4907789.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.12.0012213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/b2/main.PMC4907789.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/b2/main.PMC4907789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LanguageTemporal lobe epilepsy fMRI NeurosurgeryReading 1.,Non-OADS,/arxiv_data1/oa_pdf/79/91/main.PMC4907790.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.10.003 2213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/91/main.PMC4907790.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/91/main.PMC4907790.pdf
"Stimuli & language tasks The stimuli were presented using a PC running EPrime software (Psychology Software Tools, Inc., http://www.pstnet.com ) through MRI compatible goggles (Cinemavision Inc., http://www.cinemavision.biz ).",OADS,/arxiv_data1/oa_pdf/79/91/main.PMC4907790.pdf
"These stimuli were matched on several of the characteristics available from the E-Lexicon Database ( http://elexicon.wustl.edu /,[19]).",OADS,/arxiv_data1/oa_pdf/79/91/main.PMC4907790.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Excessive supragastric belching Eructation SuggestionEpilepsy 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/6a/main.PMC4907791.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.12.002 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/6a/main.PMC4907791.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/6a/main.PMC4907791.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/cd/main.PMC4907893.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.03.003,OADS,/arxiv_data1/oa_pdf/05/cd/main.PMC4907893.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/57/main.PMC4907894.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.03.006,OADS,/arxiv_data1/oa_pdf/9b/57/main.PMC4907894.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Antiepileptic drugs PhenytoinDilantinAdverse drug reactionChronic coughNocturnal cough We report a 72-year-old man, with no personal or family history of seizures, who started having dyscognitive seizures –with occasional secondary generalization –at the age of 68 years.",Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4907895.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.03.002 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4907895.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/d7/main.PMC4907895.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/3b/main.PMC4907896.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.04.007,OADS,/arxiv_data1/oa_pdf/d2/3b/main.PMC4907896.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/4c/main.PMC4907897.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2016.04.005,Non-OADS,/arxiv_data1/oa_pdf/1a/4c/main.PMC4907897.pdf
"Biomed Res Int 2014 , 591703. http://dx.doi.org/10.1155/2014/591703 .",OADS,/arxiv_data1/oa_pdf/1a/4c/main.PMC4907897.pdf
http://dx.doi.org/10.1177/1557988315595693 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/1a/4c/main.PMC4907897.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.04.004,OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1200/JCO.2005.05.2308 .,OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.3748/wjg.v20.i7.1635 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1007/s10549-011-1471-9 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1093/annonc/mdl501 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1007/s00280-007-0476-x .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1200/JCO.2004.08.154 .,OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1016/S1470-2045(09)70259-1 .,OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1007/s10637-007-9088-x .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1016/S1470-2045(08)70035-4 .,OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
"Med Oncol 31(11), 287. http://dx.doi.org/10.1007/s12032-014-0287-y .260 Gastric Cancer Patients w/ Good Performance Status Wang et al.",OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1007/s00268-009-0302-1 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1007/s13277-013-1574-5 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1371/journal.pone.0111906 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
http://dx.doi.org/10.1007/s00280-011-1561-8 .,Non-OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
"World J Surg 30(1), 21–27.http://dx.doi.org/10.1007/s00268-005-0129-3 .",OADS,/arxiv_data1/oa_pdf/e7/ba/main.PMC4907898.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.03.008,OADS,/arxiv_data1/oa_pdf/d7/10/main.PMC4907899.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.12.004,OADS,/arxiv_data1/oa_pdf/3c/83/main.PMC4907970.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/8d/main.PMC4907971.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.04.001,OADS,/arxiv_data1/oa_pdf/ab/8d/main.PMC4907971.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/0b/main.PMC4907972.pdf
"http://dx.doi.org/10.1016/j.sjopt.2015.11.002 Introduction Worldwide, Glaucoma is the second most common cause of irreversible visual loss, with its prevalence in South Indiavarying between 1.62% and 2.6%.",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/main.PMC4907972.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/4f/main.PMC4907985.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.04.003,OADS,/arxiv_data1/oa_pdf/00/4f/main.PMC4907985.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.nicl.2015.08.003 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"Neurology 85 (1), 18 –28.http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1007/s10072017001211603615 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1001/archneur.63.9.130116966509 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"N e u r o l .6 4( 1 ) ,7 6 –80.http://dx.doi.org/10.1001/archneur.64.1.7617210812 .",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1136/ jnnp.25.4.31514016083 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1001/archneurol.2009.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1001/ archneur.64.10.141617923625 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"15 (1), 36 –41.http://dx.doi.org/10.1177/ 135245850809668618755823 .",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1097/WCO.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.10.00617112743 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.04.00921511042 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1017/ S0080456800027174 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/ ana.2143618661561 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1212/WNL.0b013e31820a0cc421209373 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1093/brain/awr18221840891 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1212/WNL.0b013e31828726cc23468546 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1006/nimg.2002.113212377157 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"5 (2), 143 – 156. http://dx.doi.org/10.1016/S1361- 8415(01)00036-611516708 .",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"Brain 122 (1), 17 –26.http://dx.doi.org/10.1093/brain/122.1.",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"Prion 7 (1), 66 –75.http://dx.doi.org/10.4161/pri.",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.mri.2013.12.01224512796 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1093/brain/awm03817438020 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"http://dx.doi.org/10.1093/brain/ awv01125681411 .Matsushita, T., Madireddy, L., Sprenger, T., Khankhanian, P., Magon, S., Naegelin, Y., Caverzasi, E., Lindberg, R.L.P., Kappos, L., Hauser, S.L., Oksenberg, J.R., Henry, R., Pelletier, D., Baranzini, S.E., 2015.",OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/ana.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.10.03216360321 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/ 10.1016/j.nicl.2012.11.00924179765 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/ 10.1016/j.nicl.2012.11.00924179765 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.5014/ajot.57.5.57014527120 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1212/01.wnl.0000250267.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1212/WNL.0b013e31821a44f121576686 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1136/jnnp-2012-30409423524331 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"198 (1), 49 –56.http://dx.doi.org/10.1016/j.jmr.2009.01.00119181549 .",OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1212/WNL.000000000000128125632085 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"282 (1 –2), 47 –54.http://dx.doi.org/10.1016/ j.jns.2008.12.034 .",OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.jns.2008.12.03419201003 .,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1177/ 135245851140491621586487 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1177/135245850910290719435749 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.03.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1371/journal.pone.006325023696802 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1093/brain/ awp33520123726 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1371/ journal.pone.006611724039694 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1212/ WNL.0b013e31824528a022218278 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1371/journal.pone.003704922615886 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1093/brain/awn03018375977 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.3174/ajnr.A095118272561 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"http://dx.doi.org/10.1177/ 135245850910661519556311 .van Munster, C.E., Jonkman, L.E., Weinstein, H.C., Uitdehaag, B.M., Geurts, J.J., 2015.",Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"Neuroscience 303, 446 – 461. http://dx.doi.org/10.1016/j.neuroscience.2015.07.00626164500 .",OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/jmri.2056416565955 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/mrm.24998 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.,OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1002/ mrm.2458523233445 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1148/ radiol.1111060122084205 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1148/radiol.1414052825208343 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
http://dx.doi.org/10.1093/brain/ awm29118056737 .,Non-OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
"2013, 231345. http://dx.doi.org/10.1155/2013/ 23134523365753 .175 J. Wen et al.",OADS,/arxiv_data1/oa_pdf/2a/04/main.PMC4907986.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/19/main.PMC4907987.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.04.006,OADS,/arxiv_data1/oa_pdf/0e/19/main.PMC4907987.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LeukodystrophyCYP27A1Bile acid synthesisKetosterolsNewborn screening LC-ESI-MS/MS 1.,Non-OADS,/arxiv_data1/oa_pdf/21/0c/main.PMC4908045.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.02.002 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/0c/main.PMC4908045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/0c/main.PMC4908045.pdf
Quaternary amonoxy (QAO) reagent ( O-(3-trimethylammoniumpropyl) hydroxyl- amine) bromide is commercially available as Amplifex ™Keto reagent from http://www.sciex.com .,Non-OADS,/arxiv_data1/oa_pdf/21/0c/main.PMC4908045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/85/main.PMC4908046.pdf
"http://dx.doi.org/10.1016/j.sjopt.2015.12.007 Introduction Diabetic macular edema (DME) is the most common cause of visual impairment in patients with diabetes mellitus.1 Posterior subtenon triamcinolone acetonide (PST) has beenused effectively in DME, as primary treatment option, 2as adjuvant to laser, and in refractory cases.",Non-OADS,/arxiv_data1/oa_pdf/ed/85/main.PMC4908046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/08/main.PMC4908048.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.01.003 Peer review under responsibility of Saudi Ophthalmological Society, King Saud University Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.com www.sciencedirect.comReceived 29 September 2015; received in revised form 24 December 2015; accepted 19 January 2016; available online 28 January 2016. aDhahran Eye Specialist Hospital, P.O.",Non-OADS,/arxiv_data1/oa_pdf/68/08/main.PMC4908048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/a4/main.PMC4908049.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.01.002 Introduction Optic nerve sheath meningiomas (ONSM) account for 2% of all orbital tumors.1They are the second most common optic nerve tumor after gliomas and represent 1–2% of all meningiomas.2,3Without treatment, continued growth of ONSM results in progressive loss of visual acuity, colorblindness and eventually complete loss of vision.",Non-OADS,/arxiv_data1/oa_pdf/23/a4/main.PMC4908049.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 441 –446 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.07.008 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/f1/43/main.PMC4908050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/43/main.PMC4908050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/43/main.PMC4908050.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 405 –412 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.04.008 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/22/23/main.PMC4908051.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/23/main.PMC4908051.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/23/main.PMC4908051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/58/main.PMC4908052.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.01.001 Introduction Descemet’s membrane detachment (DMD) may occur fol- lowing various intraocular procedures including deep ante-rior lamellar keratoplasty (DALK) which may result in the formation of a double chamber.,Non-OADS,/arxiv_data1/oa_pdf/d2/58/main.PMC4908052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/f8/main.PMC4908053.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 447 –451 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.07.010 1319-0164 ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/e9/f8/main.PMC4908053.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/f8/main.PMC4908053.pdf
http://dx.doi.org/ 10.1002/j.1875-9114.2012.01022.x .,Non-OADS,/arxiv_data1/oa_pdf/e9/f8/main.PMC4908053.pdf
<http://www.ahrq.gov/research/ﬁndings/ evidence-based-ports/ptsafetysum.pdf> .,OADS,/arxiv_data1/oa_pdf/e9/f8/main.PMC4908053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4b/main.PMC4908054.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 386 –404 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.04.007 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/39/4b/main.PMC4908054.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/4b/main.PMC4908054.pdf
"London, UK.Available at: < http://www.ema.europa.eu/docs/en_GB/docu- ment_library/Presentation/2010/09/WC500096193.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/39/4b/main.PMC4908054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/88/main.PMC4908055.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.02.003 Introduction Diabetic retinopathy is the most common retinal vascu- lopathy.,Non-OADS,/arxiv_data1/oa_pdf/69/88/main.PMC4908055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/97/main.PMC4908056.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.02.001 Systemic lupus erythematosus (SLE) is a chronic multisys- tem autoimmune disease.,Non-OADS,/arxiv_data1/oa_pdf/cb/97/main.PMC4908056.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/73/main.PMC4908057.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 379 –385 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.04.004 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/4e/73/main.PMC4908057.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/73/main.PMC4908057.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/7a/main.PMC4908059.pdf
"http://dx.doi.org/10.1016/j.sjopt.2015.12.006 Introduction Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, at times asymmetrical, seasonally exacerbated, allergic inflam- mation of the ocular surface, involving tarsal and/or bulbar conjunctiva.1The skin of the lid remains uninvolved.",Non-OADS,/arxiv_data1/oa_pdf/1c/7a/main.PMC4908059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/1d/main.PMC4908060.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 473 –484 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.013 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/18/1d/main.PMC4908060.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/1d/main.PMC4908060.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Congenital adrenal hyperplasia Newborn screening 17α-Hydroxyprogesterone 21-Hydroxylase de ﬁciency 1.,Non-OADS,/arxiv_data1/oa_pdf/89/d4/main.PMC4908061.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.02.005 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/d4/main.PMC4908061.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/d4/main.PMC4908061.pdf
"(2016), http://dx.doi.org/10.1159/ 000442975 .",Non-OADS,/arxiv_data1/oa_pdf/89/d4/main.PMC4908061.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mitochondrial diseaseMEGDELSERAC1Kidney 1.,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/main.PMC4908062.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.03.001 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/main.PMC4908062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/main.PMC4908062.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 413 –428 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.06.004 1319-0164 ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"Company Product name Technology Formulation Development phase Product References Apollo Life Science Oraldel /C228 Nanoparticles Tablet Clinical phase I b Insulin, TNF-blocker http:// apollolifesciences.com Emisphere Eligen Penetration enhancers- Salcaprozate sodiumTablet Phase II Calcitonin, insulin, PTH, heparin, calcitonin, enzymes (lipases, esterases, proteases)http://emisphere.com Nobex/Biocon HIM2 Pegylation + PE Liquid Abandoned Insulin, enkephalin, calcitonin, PTH Wajberg et al., 2004 Oramed ORMD-0801 ORMD-0901Salts of EDTA (enteric coated + PE)Capsule Phase I Insulin/Exenatide Kidron et al., 2004 Diasome pharmaceuticals Hepatic-directed vesicles-insulin(HDV-1)Liposomal insulin Tablet Phase II/III Insulin Schwartz et al., 2008 Diabetology Capsulin PE Capsule Phase II Insulin Whitelaw et al., 2005 Coremed Intesulin Nanoparticle encapsulationCapsule Preclinical Insulin Carino et al., 2000 Merrion pharma (Ireland) with Novo-Nordisk (Denmark)Vetsulin PE (sodium caprate {C10})Matrix tablet Phase I Insulin and GLP-1 analogues Walsh et al., 2011 Chiasma (Israel) Octreolin PE (sodium caprylate{C8})Suspension Phase I (phase I completed, phase III enrollingOctreotide http:// chiasmapharma.com Unigene/Tarsa (USA) Peptelligence TMPE (Citric acid + acyl carnitine)pH-dependent coated dosage form2011, Phase III completed Salmon calcitonin http:// tarsatherapeutics.com Altus CLEC/C210Protein crystallization Tablet Trial and error approach Calcitonin and other polypeptides Margolin (1996) Generex Oral–Lyn/C228PE Spray devices and aerosol particlesPhase IV Insulin, Macrotonin http:// www.generex.com Endorex OrasomeTMPolymerized liposome – Phase II Insulin, growth hormones, vaccines Okada et al., 1998 Provalis PLC MacrulinTMLipid basedmicroemulsionEmulsion Phase II Insulin, Salmon calcitonin Cilek et al., 2006 Eli–lily AI-401 Enzyme inhibitor Oral formulation Phase II Insulin http:// autoimmuneinc.com Abbreviations: EDTA, Ethylene diaminetetraacetic acid; PE, Penetration enhancers; PTH, Parathyroid hormone; TNF, Tumor necrosis factor.422 A. Muheem et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"gov, 2003; http://www.auto mmuneinc.com ).",Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
http://www.merrionphar- ma.com/archive/FandS-MP-051108.pdf (Accessed on 8 January 2013.,Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"Source AutoImmune Inc., additional information related data available on http://www.autoimmuneinc.com .",OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"Source Apollo life sciences, Apollo life science press release (2010) on additional clinical data from http://www.apollolifesciences.com .",OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
Available from URL: http://www.emisphere.com .,Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
Available from URL:http://www.accessdata.fda.gov/scripts/cderfob/docsltempai.cfm .,OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"Source Generex biotechnology corporation, Press release (2009) on additional clinical data from http://www.generex.com .",OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
"Source Tarsa Therapeutics, http://www.tarsatherapeutics.com/News/ 091811.Html (Accessed November 10th, 2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/0c/main.PMC4908063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/d7/main.PMC4908067.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 452 –457 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.08.002 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/d7/d7/main.PMC4908067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/d7/main.PMC4908067.pdf
< http://www.derm- web.com/therapy >.Microemulgel: an overwhelming approach 457,Non-OADS,/arxiv_data1/oa_pdf/d7/d7/main.PMC4908067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/c8/main.PMC4908068.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.02.006 Introduction Retinopathy of prematurity (ROP) is an abnormal growth of retinal blood vessels that affect premature infants bornat or before 32 weeks and weighing 1500 g or less at birth.ROP is usually bilateral and can lead to lifelong vision impair- ment or blindness.,Non-OADS,/arxiv_data1/oa_pdf/a7/c8/main.PMC4908068.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 429 –440 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.06.009 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/ 10.1177/0148607104028003176 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
"37 (2), 212– 222.http://dx.doi.org/10.1177/0148607112464781 .",Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/10.1542/peds.2005-1368 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
"Pediatrics 104 (2), 280–289.http://dx.doi.org/10.1542/peds.104.2.280 .",Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
"Pediatrics 107 (2), 270–273.http://dx.doi.org/10.1542/peds.107.2.270 .",Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
"32 (2), 140–144.http://dx.doi.org/10.1177/0148607108314373 .",Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/ 10.1345/aph.1G590 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/ 10.1345/aph.1K164 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/ 10.1177/0884533609339068 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/10.1177/ 0148607113488800 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/10.1177/0148607104028004251 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
http://dx.doi.org/10.2146/ajhp100711 .,Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
"23 (2), 189–194.http://dx.doi.org/10.1177/0884533608316164 .",Non-OADS,/arxiv_data1/oa_pdf/8c/03/main.PMC4908069.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/ca/main.PMC4908070.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.02.007 Introduction Pterygium (PT) is a common conjunctival lesion of unknown etiology that can cause ocular irritation, visualdisturbances, and most often cosmetic issues.",Non-OADS,/arxiv_data1/oa_pdf/cc/ca/main.PMC4908070.pdf
Modified from: [ http://www.who.int/uv/intersunprogramme/activities/uv_index/en/ index3.html ].,OADS,/arxiv_data1/oa_pdf/cc/ca/main.PMC4908070.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/bd/main.PMC4908095.pdf
"http://dx.doi.org/10.1016/j.sjopt.2015.11.009 Introduction Bilateral acute iris transillumination (BAIT) is a new clinical entity characterized by severe transillumination of the iris, acute onset of pigment dispersion in the anterior chamber, and a mydriatic pupil that is unresponsive or poorly respon-sive to light due to variable sphincter paralysis.",Non-OADS,/arxiv_data1/oa_pdf/b4/bd/main.PMC4908095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/c2/main.PMC4908096.pdf
http://dx.doi.org/10.1016/j.sjopt.2015.12.005 Introduction Glaucoma drainage implants (GDIs) are often used for controlling intraocular pressure (IOP) in patients with refrac-tory glaucoma.,Non-OADS,/arxiv_data1/oa_pdf/86/c2/main.PMC4908096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/6e/main.PMC4908097.pdf
"http://dx.doi.org/10.1016/j.sjopt.2015.11.005 Introduction Exophthalmometry is simple, routine clinical examination technique for the quantitative measurement of the globeposition in the orbit.",Non-OADS,/arxiv_data1/oa_pdf/72/6e/main.PMC4908097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/7a/main.PMC4908098.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 494 –505 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.009 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3c/7a/main.PMC4908098.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/7a/main.PMC4908098.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/main.PMC4908099.pdf
http://dx.doi.org/10.1016/j.sjopt.2015.11.004 Introduction Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries.Drusen is the earliest visible abnormality in AMD.,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/main.PMC4908099.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 485 –493 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.010 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
Available at <http://www.who-umc.org/defs.html > (accessed on 24.02.13).,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
"Value Health 16 (6 Suppl), S16–S19, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
Available from: < http://www.cdsco.nic.in/GSR%2053(E)%20 dated%2030.01.2013.pdf > (Last accessed on 2013 Feb 1).,OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
http://dx.doi.org/10.1371/journal.pone.0004439 .,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
"J. Healthcare Leadership 2, 43–48, http://dx.doi.org/ 10.2147/JHL.S8022 .",Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
http://dx.doi.org/10.1371/journal.pone.0028096 .,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
http://dx.doi.org/ 10.1371/journal.pone.0050127 .,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
http://dx.doi.org/10.1016/j.drudis.2008.,OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
"http://dx.doi.org/10.1007/s40264-013-0083-1 , Pub Med PMID: 23828659.",OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
< http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/4d/3d/main.PMC4908100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/48/main.PMC4908145.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.02.005 Introduction Kyrieleis plaques are a rarely encountered clinical entity in which whitish segmented deposits are seen scattered alongretinal arterial branches in a beaded pattern.,Non-OADS,/arxiv_data1/oa_pdf/69/48/main.PMC4908145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/11/main.PMC4908146.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 458 –472 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.10.001 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/11/main.PMC4908146.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/11/main.PMC4908146.pdf
"Kirby Neurobiology Center, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA;6Department of Communication Sciences and Disorders, College of Liberal Arts and Sciences, Uni- versity of Iowa, Iowa City, IA 52242, USA;7Iowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA 8These authors contributed equally to this work *Correspondence: richard-smith@uiowa.edu http://dx.doi.org/10.1016/j.ajhg.2016.03.028 .",Non-OADS,/arxiv_data1/oa_pdf/00/58/main.PMC4908151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/58/main.PMC4908151.pdf
"Because substantial chal- lenges remain in using gene therapy to restore the func-tional integrity of this unique and complex organ, webelieve that efforts to prevent autosomal-dominant non-syndromic hearing loss warrant a concerted effort by theresearch community as an example of ‘‘low-hanging fruit.’’ Supplemental Data Supplemental Data include seven ﬁgures, one table, and one movie and can be found with this article online at http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/00/58/main.PMC4908151.pdf
"Received: February 3, 2016 Accepted: March 30, 2016Published: May 26, 2016 Web Resources OMIM, http://omim.org/ RefSeq, http://www.ncbi.nlm.nih.gov/refseq/ World Health Organization, http://www.who.int/pbd/deafness/ estimates/en/ References 1.Smith, R.J., Bale, J.F., Jr., and White, K.R.",Non-OADS,/arxiv_data1/oa_pdf/00/58/main.PMC4908151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/55/main.PMC4908153.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.02.004 Introduction Morning glory syndrome (MGS) is an uncommon and uni- lateral congenital anomaly which was coined by Kindler in 1970.1The appearance of the anomaly was so similar to the tropical morning glory flower; therefore, this name waschosen.",OADS,/arxiv_data1/oa_pdf/eb/55/main.PMC4908153.pdf
http://dx.doi.org/ 10.1111/aos.12687 .,Non-OADS,/arxiv_data1/oa_pdf/eb/55/main.PMC4908153.pdf
http://dx.doi.org/10.1016/j.ajhg.2016.04.006 .,OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4908180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4908180.pdf
"Received: January 22, 2016 Accepted: April 13, 2016Published: June 2, 2016 Web Resources ClinVar, http://www.ncbi.nlm.nih.gov/clinvar/ ExAC Browser, http://exac.broadinstitute.org/ ExPasy ProtParam, http://web.expasy.org/protparam/ Integrative Genomics Viewer, https://www.broadinstitute.org/igv/ MutationTaster, http://www.mutationtaster.org/ OMIM, http://www.omim.org/ RefSeq, http://www.ncbi.nlm.nih.gov/refseq/ Skyline, https://skyline.gs.washington.edu/labkey/wiki/home/ software/Skyline/ UCSC Genome Browser, http://www.genome.ucsc.edu/ UniProt, http://www.uniprot.org/ References 1.Barile, M., Giancaspero, T.A., Brizio, C., Panebianco, C., Indi- veri, C., Galluccio, M., Vergani, L., Eberini, I., and Gianazza,E.",OADS,/arxiv_data1/oa_pdf/a5/7b/main.PMC4908180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"This article captures a two-day programme of multidisciplinary presentations, panel discussions and interactive dialogue on planningContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.02.004 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"27 (3) (2015) 165 –176, Available from 〈http://www.sciencedirect.com/science/article/pii/S030573720090210X 〉.",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
2(1) (2013) 22 –29 〈http://www.sciencedirect.com/science/article/pii/ S2212137413000031 〉.,Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"Breast Cancer 13 (2) (2015) 88 –94, Available from 〈http://www.sciencedirect.com/science/article/pii/ S152682091200256X 〉.",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"2 (4) (2015) 137 –144, Available from 〈http://www.sciencedirect.com/science/article/pii/ S2212137413000560 〉.",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"Brown, L. Karsh, Denosumab versus zoledronic acid for treatment of bone metastases in men with castra-tion-resistant prostate cancer: a randomised, double-blind study, Lancet 377 (9768) (2011) 813 –822, Available from: 〈http://www.sciencedirect.com/sci ence/article/pii/S0140673610623446 〉.",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"19 (5) (2012) e303 –e304, Available from: 〈http://www.pub medcentral.nih.gov/articlerender.fcgi?",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
"2 (2) (2013) 77–83, Available from: 〈http://www.sciencedirect.com/science/article/pii/ S2212137413000195 〉.",Non-OADS,/arxiv_data1/oa_pdf/a9/77/main.PMC4908181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"Recently, Hadji and colleagues demonstrated that persistence with intravenous and oral BIS is unexpectedly low and ought to beContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.02.006 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"153 (2015) 391 –395, http://dx.doi.org/10.1007/s10549-015-3530-0 , PMID: 26264467.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"Roumen, A.C. Voogd, Clinical management of women with metastatic breast cancer: a descriptive study according to age group, BMC Cancer 6 (2006) 179, http://dx.doi.org/10.1186/ 1471-2407-6-179 , PMID: 16824210.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"28 (2010) 3271 –3277, http://dx.doi.org/ 10.1200/JCO.2009.25.9820 , PMID: 20498394.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"Metastasis (2015) , http://dx.doi.org/10.1007/ s10585-015-9743-0 .",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"Metastasis 32 (2015) 125 –133, http://dx.doi.org/10.1007/ s10585-015-9697-2 , PMID: 25630269.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"[6] F. Saad, A. Lipton, R. Cook, Y.-M. Chen, M. Smith, R. Coleman, Pathologic fractures correlate with reduced survival in patients with malignant bonedisease, Cancer 110 (2007) 1860 –1867, http://dx.doi.org/10.1002/cncr.22991 , PMID: 17763372.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"Cancer Care 19 (2010) 755 –760, http://dx.doi.org/10.1111/ j.1365-2354.2009.01135.x , PMID: 19708928.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"38 (2012) 815 –824, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"(2014) , http://dx.doi.org/10.1200/JCO.2013.51.7367 , PMID: 24934786.",OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"139 (2013) 1149 –1155, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"(2015) , http://dx.doi.org/ 10.1007/s00432-015-2048-5 , PMID: 26377737.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"(2015) , http://dx.doi.org/10.1007/s00432-015-2091-2 , PMID: 26650199.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"[16] L. Jacob, K. Kostev, M. Kalder, Treatment of depression in cancer and non- cancer patients in German neuropsychiatric practices, Psychooncology (2016) , http://dx.doi.org/10.1002/pon.4066 , PMID: 26790839.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"134 (2012) 419 –428, http://dx.doi.org/10.1007/s10549-012-2066-9 , PMID: 22527111.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"21(2003) 602 –606, http://dx.doi.org/10.1200/JCO.2003.07.071 , PMID: 12586795.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"33 (2015) 2262 –2269, http://dx.doi.org/ 10.1200/JCO.2014.59.3673 , PMID: 26033800.",OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"26(2008) 3324 –3330, http://dx.doi.org/10.1200/JCO.2007.14.2471 , PMID: 18612148.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"28 (2006) 236 –242, http://dx.doi.org/ 10.1016/j.clinthera.2006.01.002 .",OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
"Res.23 (2008) 1569 –1575, http://dx.doi.org/10.1359/jbmr.080510 .L.",Non-OADS,/arxiv_data1/oa_pdf/78/65/main.PMC4908184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/a9/main.PMC4908186.pdf
"Therefore, lncRNAs may be utilized for osteo- sarcoma diagnosis and prognosis, and serve as potential ther- apeutic targets.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.05.003 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1e/a9/main.PMC4908186.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: lncRNA, long noncoding RNA; UCA1, Urothelial carcinoma asso- ciated 1; RT-PCR, reverse transcription-polymerase chain reaction; DMSO, dimethyl sulfoxide; MTT, 3-(4,5-dimethylthiazol-2-yl) /C02,5-diphenyltetrazolium bromide; DMEM, Dulbecco's modi ﬁed Eagle's medium; TNM, tumor-node-metastasis nCorrespondence to: Department of bone and joint trauma, Hanzhong Municipal Central Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/1e/a9/main.PMC4908186.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/a1/main.PMC4908187.pdf
"Our study suggested that miR-367 could be a bio- marker of the chemoresistance in OS treatment, and miR-367could be a potential target in clinical OS therapies.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.02.002 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/main.PMC4908187.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/a1/main.PMC4908187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/72/main.PMC4908188.pdf
"Here, we found an additional mechanism that involvesContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.03.001 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ff/72/main.PMC4908188.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: HIF-1 α, hypoxia-inducible factor 1-alpha; ROS, reactive oxygen species; OS, osteosarcoma; OC, osteochondroma; LC3, microtubule-associatedprotein-1 light chain 3; CQ, chloroquine; 3-MA, 3-methyladenine nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ff/72/main.PMC4908188.pdf
"The overall staining intensity (mixed nuclear and LC3 signals) was quanti ﬁed by the software Image J from multiple areas (http://imagej.nih.gov/ij/ ), and then averaged and normalized to the cell number.",OADS,/arxiv_data1/oa_pdf/ff/72/main.PMC4908188.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/e5/main.PMC4908189.pdf
PreviousContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.05.001 2212-1374/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/af/e5/main.PMC4908189.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/e5/main.PMC4908189.pdf
"A total of 72 animals were used in this study.Tables of Links TARGETS GPCRsa 5‐HT1Areceptors Transportersb SERT, SLC6A4LIGANDS 8‐OH DPAT, 8 ‐hydroxy ‐2‐(dipropylamino)tetralin Amphetamine L-DOPA Fluoxetine These Tables list key protein targets and ligands in this article which are h yperlinked to corresponding entries in http://www.guidetopharmacolog y. org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Pawson et al.",OADS,/arxiv_data1/oa_pdf/cb/d5/BPH-173-2135.PMC4908202.pdf
"First, capture was perfor med using a digital camera, and mean OD was visualized using image analysis NIH-produced software, ImageJ (http://rsb.info.nih.gov/nih.im-age/default.html).",OADS,/arxiv_data1/oa_pdf/cb/d5/BPH-173-2135.PMC4908202.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.04.002 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 141 e145,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
http://dx.doi.org/10.1164/rccm.200805-722OC .,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
http://dx.doi.org/10.1097/CCM.0b013e3181b42e13 .,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
"http://dx.doi.org/ 10.1001/jama.2012.5669 .9.Dubois AB, Britt AG, Fenn WO.",OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
http://dx.doi.org/ 10.1213/ANE.0b013e318247f6cc .,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
http://dx.doi.org/ 10.1186/cc9206 .,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
http://dx.doi.org/ 10.4187/respcare.02593 .,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
http://dx.doi.org/10.1016/j.jcrc.2013.,OADS,/arxiv_data1/oa_pdf/6d/7c/main.PMC4908214.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4908215.pdf
"From this perspective, the primary assessment of blast injury is essential to give ef ﬁcient acute care.DOI of original article: http://dx.doi.org/10.1016/j.cjtee.2015.06.004 .",Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4908215.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.09.010 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4908215.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 139 e140,Non-OADS,/arxiv_data1/oa_pdf/59/73/main.PMC4908215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/4f/main.PMC4908216.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.010 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/c1/4f/main.PMC4908216.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 156 e159,Non-OADS,/arxiv_data1/oa_pdf/c1/4f/main.PMC4908216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/fb/main.PMC4908217.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.013 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/d1/fb/main.PMC4908217.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 134 e135,Non-OADS,/arxiv_data1/oa_pdf/d1/fb/main.PMC4908217.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4908218.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.04.004 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4908218.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 164 e167,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4908218.pdf
http://dx.doi.org/10.3113/FAI.2011.0307 .,Non-OADS,/arxiv_data1/oa_pdf/03/70/main.PMC4908218.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/f0/main.PMC4908221.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.011 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/7b/f0/main.PMC4908221.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 182 e184,Non-OADS,/arxiv_data1/oa_pdf/7b/f0/main.PMC4908221.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/a3/main.PMC4908222.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.09.011 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/ec/a3/main.PMC4908222.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 168 e171,Non-OADS,/arxiv_data1/oa_pdf/ec/a3/main.PMC4908222.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4908223.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.03.001 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4908223.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 125 e128,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4908223.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/82/main.PMC4908224.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.05.005 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/f9/82/main.PMC4908224.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 129 e133,Non-OADS,/arxiv_data1/oa_pdf/f9/82/main.PMC4908224.pdf
http://dx.doi.org/10.1016/j.ajhg.2016.05.014 .,OADS,/arxiv_data1/oa_pdf/a1/86/main.PMC4908225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/86/main.PMC4908225.pdf
"Supplemental Data Supplemental Data include 5 ﬁgures, 12 tables, and a list of themembers of The European Alzheimer’s Disease Initiative Investiga- tors and can be found with this article online at http://dx.doi.org/ 10.1016/j.ajhg.2016.05.014 .Table 2.",OADS,/arxiv_data1/oa_pdf/a1/86/main.PMC4908225.pdf
"Received: February 19, 2016 Accepted: May 9, 2016Published: May 23, 2016 Web Resources A Package for Survival Analysis in S, http://www.mayo.edu/ research/documents/tr53pdf/doc-10027379 Burrows-Wheeler Aligner, http://bio-bwa.sourceforge.net/ Control FREEC, http://bioinfo-out.curie.fr/projects/freec/ dbVar, http://www.ncbi.nlm.nih.gov/dbvar/ GATK, https://www.broadinstitute.org/gatk/ IGAP Summary Statistics, http://web.pasteur-lille.fr/en/recherche/ u744/igap/igap_download.php ILLUMINA Tech Note, www.illumina.com/content/dam/illumina- marketing/documents/products/appnotes/appnote_cnv_loh.pdf OMIM, http://www.omim.org/ Picard, http://broadinstitute.github.io/picard/ PIVUS, http://www.medsci.uu.se/pivus/ ULSAM, http://www2.pubcare.uu.se/ULSAM/index.htm References 1.Bettens, K., Sleegers, K., and Van Broeckhoven, C. (2013).",Non-OADS,/arxiv_data1/oa_pdf/a1/86/main.PMC4908225.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/00/main.PMC4908226.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.04.007 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/main.PMC4908226.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 176 e178,Non-OADS,/arxiv_data1/oa_pdf/a5/00/main.PMC4908226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/a4/main.PMC4908227.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.015 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/97/a4/main.PMC4908227.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 146 e150,Non-OADS,/arxiv_data1/oa_pdf/97/a4/main.PMC4908227.pdf
Available from: http://www.mps.,Non-OADS,/arxiv_data1/oa_pdf/97/a4/main.PMC4908227.pdf
1991. http://dx.doi.org/10.4271/912901 .,Non-OADS,/arxiv_data1/oa_pdf/97/a4/main.PMC4908227.pdf
http://dx.doi.org/10.12659/ MSM.893622 .,Non-OADS,/arxiv_data1/oa_pdf/97/a4/main.PMC4908227.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/48/main.PMC4908228.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.06.004 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/8f/48/main.PMC4908228.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 136 e138,Non-OADS,/arxiv_data1/oa_pdf/8f/48/main.PMC4908228.pdf
Available at: http://www.scribd.com/doc/73658385/ EE7-200-%CE%95%CE%BB%CE%B1%CF%86%CF%81%CE%AC%CE%8C%CF%80%CE% BB%CE%B1%CE%A0%CE%B5%CE%B6%CE%B9%CE%BA%CE%BF%CF%8D#scribd .,Non-OADS,/arxiv_data1/oa_pdf/8f/48/main.PMC4908228.pdf
Available at: http://ptisidiastima.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/8f/48/main.PMC4908228.pdf
Available at: http://www.cdc.gov/masstrauma/ preparedness/primer.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8f/48/main.PMC4908228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/97/main.PMC4908229.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.011 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/ee/97/main.PMC4908229.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 172 e175,Non-OADS,/arxiv_data1/oa_pdf/ee/97/main.PMC4908229.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/d5/main.PMC4908231.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.04.001 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/96/d5/main.PMC4908231.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 160 e163,Non-OADS,/arxiv_data1/oa_pdf/96/d5/main.PMC4908231.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/4d/main.PMC4908232.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.03.003 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/6f/4d/main.PMC4908232.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 151 e155,Non-OADS,/arxiv_data1/oa_pdf/6f/4d/main.PMC4908232.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/9e/main.PMC4908233.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.04.003 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/60/9e/main.PMC4908233.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 179 e181,Non-OADS,/arxiv_data1/oa_pdf/60/9e/main.PMC4908233.pdf
http://dx.doi.org/10.1007/s00402-009-0898-5 .,Non-OADS,/arxiv_data1/oa_pdf/60/9e/main.PMC4908233.pdf
http://dx.doi.org/10.1007/s11999-009-1053-x .,Non-OADS,/arxiv_data1/oa_pdf/60/9e/main.PMC4908233.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DYNC1H1Intellectual disabilityCortical malformationCataract 1.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1016/j.mgene.2016.05.004 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
"Moreover, selected variants were cross compared with the Ensembl database ( www.ensembl.org ) as well as the Exome variant server (http://gvs.gs.washington.edu/gvs/ ).",OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
"Prediction analysis of the conse- quence of the identi ﬁed variants was carried out using Mutation Taster (http://www.mutationtaster.org /), PolyPhen2 ( http://genetics.bwh.",OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
harvard.edu/pph2/ ) and SIFT/Provean ( http://sift.jcvi.org /).,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/ 10.1002/0471142905.hg0720s76 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1002/9780470059180.ch13 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1016/j.pharmthera.2011.03.004 .,OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
"Group 8, 1 –10.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
1 –7http://dx.doi.org/10.1007/s12031 –015–0592-8 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1371/journal.pgen.0020001 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
"201, 201 – 215. http://dx.doi.org/10.1083/jcb.",Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1038/gim.2015.30 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1093/nar/gks539 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1002/ana.24251 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
2124 –2134 http://dx.doi.org/10.1007/s00415-015-7727-2 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1007/s10048-012-0337-6 .,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/3f/main.PMC4908276.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/67/main.PMC4908279.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.05.005 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/67/main.PMC4908279.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 1 e4,Non-OADS,/arxiv_data1/oa_pdf/8f/67/main.PMC4908279.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Apolipoprotein C3Coronary heart diseaseMeta-analysis Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4908280.pdf
http://dx.doi.org/10.1016/j.mgene.2016.04.004 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4908280.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4908280.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .,Non-OADS,/arxiv_data1/oa_pdf/f7/33/main.PMC4908280.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Multiple sclerosisNeuromyelitis optica Optical coherence tomography Magnetic resonance imagingMyelin water imagingOptic neuritis 1.,Non-OADS,/arxiv_data1/oa_pdf/92/1a/main.PMC4908282.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.014 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/1a/main.PMC4908282.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/1a/main.PMC4908282.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Multiple sclerosis Meta-analysis CD58 rs2300747EVI5 rs11808092CIITA rs3087456Polymorphisms 1.,Non-OADS,/arxiv_data1/oa_pdf/83/ef/main.PMC4908284.pdf
http://dx.doi.org/10.1016/j.mgene.2016.04.005 2214-5400/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/83/ef/main.PMC4908284.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/ef/main.PMC4908284.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Metastatic colorectal cancerFirst-line treatment Ras mutation Monoclonal antibodiesMeta-analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/b1/main.PMC4908286.pdf
http://dx.doi.org/10.1016/j.mgene.2016.05.001 2214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/b1/main.PMC4908286.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/b1/main.PMC4908286.pdf
http://dx.doi.org/ 10.1056/NEJMoa1305275 .,OADS,/arxiv_data1/oa_pdf/c7/b1/main.PMC4908286.pdf
http://dx.doi.org/10.1177/1947601911411084 .,Non-OADS,/arxiv_data1/oa_pdf/c7/b1/main.PMC4908286.pdf
"62 (1), 10–29.http://dx.doi.org/10.3322/caac.20138 .",Non-OADS,/arxiv_data1/oa_pdf/c7/b1/main.PMC4908286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Progressive Supranuclear PalsyParkinson's diseaseMRIMorphometry DTI 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/89/main.PMC4908307.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.0162213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/dc/89/main.PMC4908307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/89/main.PMC4908307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Brief praxis test Inﬂammation MyoinositolSevere impairment batteryTrisomy 21 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/28/main.PMC4908308.pdf
http://dx.doi.org/10.1016/j.nicl.2016.06.0012213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/6c/28/main.PMC4908308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/28/main.PMC4908308.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/36/main.PMC4908309.pdf
"After  positioning  the  prolapsed  stent  in  the duodenum,  intraoperative  endoscopy  was  performed  to  place  a total  of  three  Niti-S  gastroduodenal  stents  (2.2  ×  12  cm,  2.2  ×  8  cm, http://dx.doi.org/10.1016/j.ijscr.2016.05.061 2210-2612/© 2016  The  Authors.",OADS,/arxiv_data1/oa_pdf/f0/36/main.PMC4908309.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC4908310.pdf
No  lym- http://dx.doi.org/10.1016/j.ijscr.2016.05.055 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC4908310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cerebral palsyMagnetic resonance imagingBrain lesion 1.,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.018 2213-1582/© 2016 Commonwealth Scienti ﬁc and Industrial Research Organisation.,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1001/ jama.296.13.1602 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1097/01.chi.,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.neulet.2007.08.049 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/B978-0-444-53884-0.00022-1 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1093/brain/awp118 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.nicl.2015.04.005 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.2466/pms.1961.12.3.383 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
"17, 1 –18.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1076/chin.8.4.249.13513 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.pneurobio.2008.09.,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
"78, 69 –74.http://dx.doi.org/10.1016/j.brainresbull.",OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1093/brain/ awq347 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1093/brain/ awm216 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.earlhumdev.2010.08.013 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/S0165- 0173(99)00040-5 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.cmpb.,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1109/34.56205 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1111/dmcn.12331 .,Non-OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.media.2015.04.014 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.11.032 .,OADS,/arxiv_data1/oa_pdf/27/d2/main.PMC4908311.pdf
Availability and implementation: The software is freely available for download at: http://cbcb.umd.,Non-OADS,/arxiv_data1/oa_pdf/69/c8/btw073.PMC4908319.pdf
"1873 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/c8/btw073.PMC4908319.pdf
"For example, studies currently funded by the NIH are required to re-lease non-human genomic sequences including human microbiomedata (http://gds.nih.gov/PDF/NIH_GDS_Policy.pdf).",Non-OADS,/arxiv_data1/oa_pdf/69/c8/btw073.PMC4908319.pdf
publicly (http://www.europarl.europa.eu/sides/getDoc.do?pubRef ¼ -//EP//TEXT þTAþP7-TA-2014-0212 þ0þDOC þXML þV0//EN).,Non-OADS,/arxiv_data1/oa_pdf/69/c8/btw073.PMC4908319.pdf
Our initial work on v 2-test was based on a v2-test implementation using SNP data (https://github.com/wangxiao1254/idash_competition).,OADS,/arxiv_data1/oa_pdf/69/c8/btw073.PMC4908319.pdf
"We retrieved the MSD data from the project website (ftp://ftp.cbcb.umd.edu/pub/data/GEMS/MSD1000.biom) as well as the PGP and HMP datasets are from the American-Gut project site (https://github.com/biocore/American-Gut/tree/master/data) ( Blaser et al., 2013 ).",OADS,/arxiv_data1/oa_pdf/69/c8/btw073.PMC4908319.pdf
Availability and implementation : Ribomap is available as open source at http://www.cs.cmu.edu/ /C24ckingsf/software/ribomap.,OADS,/arxiv_data1/oa_pdf/a0/11/btw085.PMC4908323.pdf
"1880 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/11/btw085.PMC4908323.pdf
"i8 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/93/btw243.PMC4908327.pdf
Availability: http://datamining-iip.fudan.edu.cn/service/DrugE-Rank Contact: zhusf@fudan.edu.cn Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/6c/4e/btw244.PMC4908328.pdf
"i18 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/4e/btw244.PMC4908328.pdf
"Drug and target feature vectors DFV TFV Name General descriptor CTD Dimension 36 147 Calculation RDKit PROFEATDescription PEOE_VSA1 - PEOE_VSA14, SMR_VSA1 - SMR_VSA10, SlogP_VSA1 - SlogP_VSA12Composition, transition and distribution 1 http://www.rdkit.org/.DrugE-Rank i21",Non-OADS,/arxiv_data1/oa_pdf/6c/4e/btw244.PMC4908328.pdf
"(c) F-measure values for predicting drugs/targets, obtained by the union of prediction results 2 http://sourceforge.net/p/lemur/wiki/RankLib/.DrugE-Rank i23",OADS,/arxiv_data1/oa_pdf/6c/4e/btw244.PMC4908328.pdf
Availability and implementation: http://www.cs.purdue.edu/homes/mohammas/projects/ActPro.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/btw245.PMC4908329.pdf
"i243 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/b9/btw245.PMC4908329.pdf
"i28 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/dd/btw246.PMC4908330.pdf
"We ﬁnd that the utility of different semantics depends on disease categories and that, overall, Medusa recovers disease modules more accurately when combining different semantics.Availability and implementation: Source code is at http://github.com/marinkaz/medusa Contact: marinka@cs.stanford.edu, blaz.zupan@fri.uni-lj.si 1 Introduction In recent years, there is increasing evidence that gene–disease associ- ation prediction and disease module detection can benefit from inte-grative data analysis ( Moreau and Tranchevent, 2012 ;Ritchie et al., 2015 ).",OADS,/arxiv_data1/oa_pdf/a1/1b/btw247.PMC4908331.pdf
"i90 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/1b/btw247.PMC4908331.pdf
"GO ( Ashburner et al., 2000 ) annotations were downloaded from http://geneontology.org in December 2015 containing 481 685human gene product annotations.",OADS,/arxiv_data1/oa_pdf/a1/1b/btw247.PMC4908331.pdf
Improved rose plots of differentially expressed pathways in each cell highlight the utility of CCS for therapeutic decision-making.Availability and implementation: http://www.lussierlab.org/publications/CCS/ Contact: yves@email.arizona.edu or piegorsch@math.arizona.edu Supplementary information: Supplementary data are available at Bioinformatics online.,Non-OADS,/arxiv_data1/oa_pdf/0b/00/btw248.PMC4908332.pdf
"i80 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/00/btw248.PMC4908332.pdf
"Availability and implementation: The programs we used are either public or directly from the referred authors, such as MALSAR (http://www.public.asu.edu/~jye02/Software/MALSAR/)package.",Non-OADS,/arxiv_data1/oa_pdf/df/27/btw249.PMC4908333.pdf
"i37 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/27/btw249.PMC4908333.pdf
"We observed that the results of the simulations performed using our framework were entirely consistent with the simulation results reported by the researchers who developed the original models in a proprietary language.Availability and Implementation: The framework, implemented in Java, is open source and its source code, documentation and tutorial are available at http://www.ibi.vu.nl/programs/BioASF.",OADS,/arxiv_data1/oa_pdf/8c/3c/btw250.PMC4908334.pdf
Contact: j.heringa@vu.nl 1 Introduction The National Human Genome Research Institute (NHGRI) has defined a biological pathway as ‘a series of actions among moleculesin a cell that leads to a certain product or a change in a cell’ (http://www.genome.gov/27530687).,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/btw250.PMC4908334.pdf
According to Pathguide (http://www.pathguide.org) ( Bader et al.,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/btw250.PMC4908334.pdf
"i60 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/3c/btw250.PMC4908334.pdf
A snapshot from the Prote ´g e´ OWL editor (http://protege.stanford.edu/ overview/protege-owl.html) showing the core concepts of the BioPAX lan-guage and their hierarchical relationshipsFig.,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/btw250.PMC4908334.pdf
We use simulated and biological data to demonstrate the ability of PHOCOS to recover multi-attribute crosstalk networks from cellular perturbation assays.Availability and implementation: PHOCOS is available in open source at https://github.com/ AltschulerWu-Lab/PHOCOS Contact: steven.altschuler@ucsf.edu or lani.wu@ucsf.edu 1 Introduction A fundamental challenge in molecular biology is to understand how information flows through complex signal transduction networks (Collins et al.,OADS,/arxiv_data1/oa_pdf/d1/29/btw251.PMC4908335.pdf
"i44 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/29/btw251.PMC4908335.pdf
"i52 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/9c/btw252.PMC4908336.pdf
"The proposed novel method has a wide range of applications, including inferring isoform-speciﬁc ribosome footprints, designing transcripts with fast translation speeds and dis- covering unknown modulation during translation.Availability and implementation: A software package called riboShape is freely available at https://sourceforge.net/projects/riboshape Contact: yss@berkeley.edu 1 Introduction Gene expression is a fundamental biological process consisting of two parts: transcription of mRNAs from DNAs and translation of proteins from mRNAs.",Non-OADS,/arxiv_data1/oa_pdf/25/c0/btw253.PMC4908337.pdf
"i183 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/c0/btw253.PMC4908337.pdf
"We experimentally validated several of TimePaths’ predictions highlighting the usefulness of temporal models.Availability and Implementation: Data, Supplementary text and the TimePath software are avail- able from http://sb.cs.cmu.edu/timepath Contact: zivbj@cs.cmu.edu Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/da/3d/btw254.PMC4908338.pdf
"i253 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/3d/btw254.PMC4908338.pdf
"(2015) http://www.ingenuity.com/products/ipa.Kulkarni,S.",Non-OADS,/arxiv_data1/oa_pdf/da/3d/btw254.PMC4908338.pdf
"We explore how to establish thesufﬁciency of training data for these learning tasks, and we have created a ﬂexible cloud-based framework that permits the rapid exploration of alternative neural network architectures for prob- lems in computational biology.Availability and Implementation: All the models analyzed are available at http://cnn.csail.mit.edu.",OADS,/arxiv_data1/oa_pdf/77/c7/btw255.PMC4908339.pdf
"i121 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/c7/btw255.PMC4908339.pdf
"We used Amazon EC2 GPU- enabled machine instances to train and test our networks efficiently,and we are making our scalable Amazon EC2 implementation available with this paper for others to use and extend (http://cnn.csail.mit.edu).",OADS,/arxiv_data1/oa_pdf/77/c7/btw255.PMC4908339.pdf
"(2015) and Zhou and Troyanskaya (2015) , we obtained 690 ChIP-seq experiments from ENCODE (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeAwgTfbsUniform/) We constructed separate datasets for motif discovery and motif occupancy.",OADS,/arxiv_data1/oa_pdf/77/c7/btw255.PMC4908339.pdf
We performed hyper-parameter search using Mri (https://github.com/Mri-monitoring/Mri-docs/blob/master/mriapp.rst).,OADS,/arxiv_data1/oa_pdf/77/c7/btw255.PMC4908339.pdf
Detailed instruction ofhow to run the model on Amazon EC2 can be found on our paper’ssupporting website (http://cnn.csail.mit.edu).4.3 Comparison with gkm-SVM and DeepBind We used the default training parameters for the gkm-SVM R pack- age (https://cran.r-project.org/web/packages/gkmSVM) for all of ourexperiments.,Non-OADS,/arxiv_data1/oa_pdf/77/c7/btw255.PMC4908339.pdf
Availability and implementation: The source code of BNMF and tutorials on how to use the software to extract local clusters from contact maps are available at http://yiplab.cse.cuhk.edu.hk/bnmf/.,OADS,/arxiv_data1/oa_pdf/69/26/btw256.PMC4908340.pdf
"i111 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/26/btw256.PMC4908340.pdf
", 2010 ) and we downloaded the data from http://www.replicationdo main.org.",OADS,/arxiv_data1/oa_pdf/69/26/btw256.PMC4908340.pdf
Availability and implementation: http://bioinfo.ifm.liu.se/ProQDock Contact: bjornw@ifm.liu.se Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/bc/07/btw257.PMC4908341.pdf
"i262 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/07/btw257.PMC4908341.pdf
"The combined data set contained73 792 docking models from 131 targets and is available at http://bioinfo.ifm.liu.se/ProQDock/.2.2 Independent test set, BM5 Although, training of the machine learning algorithm was per- formed using a cross-validation procedure, the efficacy of ProQDock was independently tested on a dataset based on 55 newdocking targets added to the Benchmark 4.0 in its updated version, Benchmark 5.0 ( Vreven et al.",OADS,/arxiv_data1/oa_pdf/bc/07/btw257.PMC4908341.pdf
"i209 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/3b/btw258.PMC4908342.pdf
We have produced a freely available implementation of phRAIDER distributed from https://github.com/karroje/phRAIDER under the GNU General Public License (version 3).,OADS,/arxiv_data1/oa_pdf/9d/3b/btw258.PMC4908342.pdf
http://osc.edu/ark:/19495/ f5s1ph73.,Non-OADS,/arxiv_data1/oa_pdf/9d/3b/btw258.PMC4908342.pdf
Availability and Implementation: Software and models are freely available at http://rck.csail.mit.,OADS,/arxiv_data1/oa_pdf/86/6d/btw259.PMC4908343.pdf
"i351 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/6d/btw259.PMC4908343.pdf
R package version 1.14.0. http://bioconductor.org/packages/release/bioc/html/motifStack.html.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/btw259.PMC4908343.pdf
"i278 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/04/btw260.PMC4908344.pdf
Hydrogen atoms were implicitly represented in the attached atoms (see http://www.genome.jp/kegg/reaction/KCF.,OADS,/arxiv_data1/oa_pdf/25/04/btw260.PMC4908344.pdf
"Simulation results show that the CompactCH algorithm enables efﬁcient and accurate inference of population trees with much more haplotypes than a previous approach.Availability: The CompactCH algorithm is implemented in the STELLS software package, which is available for download at http://www.engr.uconn.edu/ywu/STELLS.html.",OADS,/arxiv_data1/oa_pdf/21/79/btw261.PMC4908345.pdf
"i225 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/79/btw261.PMC4908345.pdf
5 Results We have implemented our new CompactCH algorithm as part of the STELLS program (http://www.engr.uconn.edu/ywu/STELLS.html).,Non-OADS,/arxiv_data1/oa_pdf/21/79/btw261.PMC4908345.pdf
FlexScore agrees with experts’ intuitive assessment of computational models and provides information of practical usefulness of models.Availability and implementation: https://bitbucket.org/mjamroz/ﬂexscore Contact: dkihara@purdue.edu Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/5f/6b/btw262.PMC4908346.pdf
"i314 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/6b/btw262.PMC4908346.pdf
"i271 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/44/btw263.PMC4908347.pdf
"i306 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/89/btw264.PMC4908348.pdf
"http://www.chemaxon.comMathelier,A.",Non-OADS,/arxiv_data1/oa_pdf/34/89/btw264.PMC4908348.pdf
"Availability: RNAiFold2T is publicly available as part of the new release RNAiFold3.0 at https:// github.com/clotelab/RNAiFold and http://bioinformatics.bc.edu/clotelab/RNAiFold, which latter has a web server as well.",OADS,/arxiv_data1/oa_pdf/a7/f4/btw265.PMC4908349.pdf
"i360 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/f4/btw265.PMC4908349.pdf
"Moreover, since it is written in C þþ using the OR-Tools engine https://github.com/google/or-tools, together with plug-ins to ViennaRNA Package ( Lorenz et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/f4/btw265.PMC4908349.pdf
"Availability and implementation : deBWT is implemented in C language, the source code is avail- able at https://github.com/hitbc/deBWT or https://github.com/DixianZhu/deBWTContact: ydwang@hit.edu.cn Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/d5/d6/btw266.PMC4908350.pdf
"i174 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/d6/btw266.PMC4908350.pdf
", 2009b ; https://github.com/ lh3/wgsim).",Non-OADS,/arxiv_data1/oa_pdf/d5/d6/btw266.PMC4908350.pdf
"(iii) A dataset consists of eight primate genomes includ-ing gibbon, gorilla, orangutan, rhesus, baboon, chimp, bonobo and human (downloaded from: http://hgdownload.soe.ucsc.edu/down loads.html).",OADS,/arxiv_data1/oa_pdf/d5/d6/btw266.PMC4908350.pdf
This enables a 4- to 20-fold reduction in sequencing requirements and a 5-fold increase in assembly contiguity on both genomic and metagenomic datasets relative to state-of-the-art assembly strat- egies aimed directly at fully subassembled long reads.Availability and Implementation: Our source code is freely available at https://github.com/kule shov/architect.,Non-OADS,/arxiv_data1/oa_pdf/05/8e/btw267.PMC4908351.pdf
"i216 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/8e/btw267.PMC4908351.pdf
Availability and Implementation: lem is available as a R package at http://www.mimuw.edu.pl/ /C24szczurek/lem.,OADS,/arxiv_data1/oa_pdf/93/7d/btw268.PMC4908352.pdf
"i297 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/7d/btw268.PMC4908352.pdf
"i322 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/30/btw269.PMC4908353.pdf
Availability and implementation : Software is available at http://www.sailing.cs.cmu.edu/.,OADS,/arxiv_data1/oa_pdf/06/08/btw270.PMC4908354.pdf
"i164 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/08/btw270.PMC4908354.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/06/08/btw270.PMC4908354.pdf
"i332 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/d4/btw271.PMC4908355.pdf
"i156 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/f4/btw272.PMC4908356.pdf
"i369 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/b3/btw273.PMC4908357.pdf
"i288 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/73/btw274.PMC4908358.pdf
"i128 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/a7/btw275.PMC4908359.pdf
"Relevance to PI3K was eval- uated using a state of the art context-aware literature search tool,BEST (http://best.korea.ac.kr/).",OADS,/arxiv_data1/oa_pdf/c1/a7/btw275.PMC4908359.pdf
Availability and Implementation: https://bitbucket.org/whatshap/whatshap Contact: t.marschall@mpi-inf.mpg.de 1 Introduction Humans are diploid and determining the sequences of both homolo- gous copies of each chromosome is desirable for many reasons.,Non-OADS,/arxiv_data1/oa_pdf/3a/bc/btw276.PMC4908360.pdf
"i234 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/bc/btw276.PMC4908360.pdf
"The program was given the 1000 Genomes reference panel (https://mathgen.stats.ox.ac.uk/impute/1000GP_Phase3.tgz), the corres-ponding genetic map (http://www.shapeit.fr/files/genetic_map_b37.tar.gz), and the unphased genotypes as input.",OADS,/arxiv_data1/oa_pdf/3a/bc/btw276.PMC4908360.pdf
"For each individual, we downloaded aligned Pacific Biosciences (PacBio) reads (ftp://ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/AshkenazimTrio/(HG002_NA24385_son jHG003_NA 24149_father jHG004_NA24143_mother)/PacBio_MtSinai_NIST/ MtSinai_blasr_bam_GRCh37/), which had an average coverage of42.3/C2in mother, 46.8 /C2in father and 60.2 /C2in child, respectively.",OADS,/arxiv_data1/oa_pdf/3a/bc/btw276.PMC4908360.pdf
We downloaded the corresponding files (ftp://ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/AshkenazimTrio/(HG002_NA24385_sonjHG003_NA24149_father jHG004_NA24143_mother)/10XGe nomics) for comparison purposes.,OADS,/arxiv_data1/oa_pdf/3a/bc/btw276.PMC4908360.pdf
"The algorithms to solvewMEC and PedMEC-G described in Section 3 have been imple-mented in the WhatsHap software package (https://bitbucket.org/whatshap/whatshap), distributed as Open Source software under theterms of the MIT license.",OADS,/arxiv_data1/oa_pdf/3a/bc/btw276.PMC4908360.pdf
"Availability and implementation: RapMap is implemented in C þþ11 and is available as open- source software, under GPL v3, at https://github.com/COMBINE- lab/RapMap.Contact: rob.patro@cs.stonybrook.edu Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/88/dc/btw277.PMC4908361.pdf
"i192 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/dc/btw277.PMC4908361.pdf
Availability and Implementation: The R package containing the implementation of the proposed method in C þþis available at: https://github.com/JavonSun/mvbc.git and also at the R platform https://www.r-project.org/.,OADS,/arxiv_data1/oa_pdf/5b/1f/btw278.PMC4908362.pdf
"i137 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/1f/btw278.PMC4908362.pdf
"Availability and Implementation : Source code of BCALM 2 is freely available at: https://github.com/ GATB/bcalm Contact: rayan.chikhi@univ-lille1.fr 1 Introduction Modern sequencing technology can generate billions of reads from a sample, whether it is RNA, genomic DNA, or a metagenome.",Non-OADS,/arxiv_data1/oa_pdf/25/f7/btw279.PMC4908363.pdf
"i201 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/f7/btw279.PMC4908363.pdf
Availability and implementation: http://biomine.ece.ualberta.ca/DFLpred/.,OADS,/arxiv_data1/oa_pdf/ad/ad/btw280.PMC4908364.pdf
"i341 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/btw280.PMC4908364.pdf
"The training and test datasets have 144 sequences and 60 sequences, respectively,and they are available at http://biomine.ece.ualberta.ca/DFLpred/.",OADS,/arxiv_data1/oa_pdf/ad/ad/btw280.PMC4908364.pdf
3.6 Webserver DFLpred is freely available as a webserver at http://biomine.ece.ual berta.ca/DFLpred.,OADS,/arxiv_data1/oa_pdf/ad/ad/btw280.PMC4908364.pdf
"Prediction results on publicly available MeRIP-seq datasets are also validated and shown to be able to recapitulate the known patterns of m 6A, further validating the im- proved performance of MeTPeak.Availability and implementation: The package ‘MeTPeak’ is implemented in R and C þþ, and add- itional details are available at https://github.com/compgenomics/MeTPeak Contact: yufei.huang@utsa.edu or xdchoi@gmail.com Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/ec/e1/btw281.PMC4908365.pdf
"i378 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/e1/btw281.PMC4908365.pdf
"i101 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/27/btw282.PMC4908366.pdf
"[https://msdw.mountsinai.org/] Namjou,B.",Non-OADS,/arxiv_data1/oa_pdf/48/27/btw282.PMC4908366.pdf
The results suggest classes of genes with different modes of alternative splicing regulation during the experiment.Availability and Implementation: R and Matlab codes implementing the method are available at https://github.com/PROBIC/diffsplicing.,OADS,/arxiv_data1/oa_pdf/60/f7/btw283.PMC4908367.pdf
An interactive browser for viewing all model ﬁts is available at http://users.ics.aalto.ﬁ/hande/splicingGP/Contact: hande.topa@helsinki.ﬁ or antti.honkela@helsinki.ﬁ Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/60/f7/btw283.PMC4908367.pdf
"i147 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/f7/btw283.PMC4908367.pdf
which we downloaded from ftp://ftp.sanger.ac.uk/pub/gencode/ Gencode_human/release_19/.,OADS,/arxiv_data1/oa_pdf/60/f7/btw283.PMC4908367.pdf
"1 Introduction Medical Subject Headings (MeSH) is a comprehensive controlled vo- cabulary, which has been developed and maintained by NationalLibrary of Medicine (NLM), resulting in already 27 455 MeSH mainheadings (MHs) (http://www.nlm.nih.gov/pubs/factsheets/mesh.html)by 2015.",Non-OADS,/arxiv_data1/oa_pdf/2a/14/btw294.PMC4908368.pdf
"Currently, human curators in NLM assign most relevant MeSH headings to documents, resulting in that 806 326 MEDLINE cit-ations were indexed in 2015 (http://www.nlm.nih.gov/bsd/bsd_key.html).",OADS,/arxiv_data1/oa_pdf/2a/14/btw294.PMC4908368.pdf
"i70 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/14/btw294.PMC4908368.pdf
"MeSHLabeler is a state-of-the-art automatic MeSH indexing algorithm, which won the first place in the large-scale MeSH indexing task of bothBioASQ2 and BioASQ3 competition (http://bioasq.org) ( Liuet al.",OADS,/arxiv_data1/oa_pdf/2a/14/btw294.PMC4908368.pdf
"4.2 Implementation and parameter setting Several open source tools were used in the implementation ofDeepMeSH: RankLib (http://sourceforge.net/p/lemur/wiki/RankLib/)to implement our LTR model, LambdaMart ( Burges, 2010 )a n d LibSVM to implement support vector regression (SVR) ( Chang and Lin, 2011 ).",OADS,/arxiv_data1/oa_pdf/2a/14/btw294.PMC4908368.pdf
"Seman ., http://www.aueb.gr/users/ion/docs/ jbms_dense_vectors.pdf Le,Q.",OADS,/arxiv_data1/oa_pdf/2a/14/btw294.PMC4908368.pdf
"i3 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/46/btw296.PMC4908369.pdf
"i386 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/85/btw297.PMC4908370.pdf
"Editorial ISMB 2016 Proceedings This special issue of Bioinformatics serves as the proceedings of the 24th annual conference Intelligent Systems for Molecular Biology(ISMB), which took place in Orlando, Florida, July 8–12, 2016(http://www.iscb.org/ismb2016).",Non-OADS,/arxiv_data1/oa_pdf/bb/31/btw326.PMC4908371.pdf
"ISMB 2016, the official conferenceof the International Society for Computational Biology (ISCB,http://www.iscb.org/), was accompanied by 11 Special InterestGroup meetings of 1 or 2 days each, and two satellite meetings.Since its inception, ISMB has been the largest international confer-ence in computational biology and bioinformatics.",Non-OADS,/arxiv_data1/oa_pdf/bb/31/btw326.PMC4908371.pdf
"i1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/31/btw326.PMC4908371.pdf
Target analysis Bioinformatic analysis was performed by using the speci ﬁc program TargetScan (http://www.targetscan.org/).,OADS,/arxiv_data1/oa_pdf/d3/36/onc2015357a.PMC4908437.pdf
The in silico analysis was performed by Transfact software (http://www.gene-regulation.com).,OADS,/arxiv_data1/oa_pdf/d3/36/onc2015357a.PMC4908437.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc).AP2αcontrols the balance between miR-126&126* and miR-221&222 N Felli et al 3026 Oncogene (2016) 3016 –3026 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d3/36/onc2015357a.PMC4908437.pdf
"In support, analysis of the publicallyavailable Matsuyama microarray gene expression data setindicated that the INPP4B mRNA expression was higher in lasercapture micro-dissected CRC cells compared with homogenizedcolon cancer tissues that were a mixture of CRC cells and adjacentnoncancerous cells (Figure 1d; http://r2.amc.nl).",OADS,/arxiv_data1/oa_pdf/32/24/onc2015361a.PMC4908438.pdf
( d) Comparison of INPP4B mRNA levels in LCM colon cancer cells (LCM) (n=77) and homogenized colon cancer tissues (HC) ( n=17) from the Matsuyama microarray gene expression data set (http://r2.amc.nl).,OADS,/arxiv_data1/oa_pdf/32/24/onc2015361a.PMC4908438.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)INPP4B in colon cancer ST Guo et al 3061 © 2016 Macmillan Publishers Limited Oncogene (2016) 3049 –3061",Non-OADS,/arxiv_data1/oa_pdf/32/24/onc2015361a.PMC4908438.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ovarian cancer Cytoreductive surgeryDiaphragm resectionCardiophrenic lymph nodesPost-operative morbidity 1.,Non-OADS,/arxiv_data1/oa_pdf/db/6e/main.PMC4908458.pdf
http://dx.doi.org/10.1016/j.gore.2016.05.006 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/6e/main.PMC4908458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/6e/main.PMC4908458.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/56/main.PMC4908459.pdf
"After  10  days  of  medical  treatment,  a  deterioration  of  the patient’s  clinical  status  was  observed  with  persistent  fever,  persis- tence  of  biological  inﬂammatory  syndrome  ((C-  reactive  proteine 440  mg/mL,  leukocytosis  20  ×  109/L,  Procalcitonin  29  /H9262g/L),  occur- rence  of  bleeding  disorders  with  a  49%  PT  time,  cholestasis  (PAL http://dx.doi.org/10.1016/j.ijscr.2016.05.020 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/d3/56/main.PMC4908459.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/99/main.PMC4908606.pdf
In  the  radiographic  examination  performed  upon  pain  on http://dx.doi.org/10.1016/j.ijscr.2016.04.023 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/99/main.PMC4908606.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/02/main.PMC4908607.pdf
Due  to  haemodinamic  impairment http://dx.doi.org/10.1016/j.ijscr.2016.05.045 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/02/main.PMC4908607.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/bf/main.PMC4908608.pdf
All  three  of  these http://dx.doi.org/10.1016/j.ijscr.2016.05.006 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/bf/main.PMC4908608.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/a6/main.PMC4908609.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.04.011 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/a6/main.PMC4908609.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 18 (2016) 93 e95,Non-OADS,/arxiv_data1/oa_pdf/f1/a6/main.PMC4908609.pdf
"Health 9 (2010) 17, http://dx.doi.org/10.1186/1476-069X-9- 17.",Non-OADS,/arxiv_data1/oa_pdf/f1/a6/main.PMC4908609.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/83/main.PMC4908610.pdf
The  jejunal  volvulus  was  reduced http://dx.doi.org/10.1016/j.ijscr.2016.05.025 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/83/main.PMC4908610.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/6e/main.PMC4908611.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.026 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/6e/main.PMC4908611.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/86/hepatmon-16-05-35532.PMC4908612.pdf
Available from: http://www.cdc.gov/hepatitis/hcv/guidelinesc.,Non-OADS,/arxiv_data1/oa_pdf/2c/86/hepatmon-16-05-35532.PMC4908612.pdf
Available from: https://www.idf.org/webdata/ docs/WHO_IDF_deﬁnition_diagnosis_of_diabetes.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/86/hepatmon-16-05-35532.PMC4908612.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/b9/hepatmon-16-05-30385.PMC4908613.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/db/hepatmon-16-05-35597.PMC4908614.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/82/hepatmon-16-05-35162.PMC4908672.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Task force Culturally sensitive multipronged toolTHRIVESSub-Saharan AfricaStroke prevention 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
http://dx.doi.org/10.1016/j.ensci.2016.04.003 2405-6502/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
Contents lists available at ScienceDirect eNeurologicalSci journal homepage: http://ees.elsevier.com/ensci/,Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
"[2] P. Lloyd-Sherlock, Stroke in Developing Countries: Epidemiology, Impact and Policy Implications, School of International Development, University of East Anglia, 2009 Available at https://www.uea.ac.uk/polopoly_fs/1.133457!Stroke%20in%20develop- ing%20countries.pdf .",Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
"[10] The Results Group, Start Your Task Force on High Performance Track, 2009. http://www.theresultsgroup.com/articles3.php [11] M.O.",Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
"8 (9) (2008), http://dx.doi.org/10.1186/1471-2415-8-9 .",Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
"Kuhns, A. Johnson, et al., Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive,daily text message reminders, J Med Internet Res 14 (2) (2012), e51, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
"Akinyemi, M. Gebregziabher, et al., Randomized controlled trial of a multipronged intervention to improve blood pressure control among strokesurvivors in Nigeria, Int J Stroke 18 (2014), http://dx.doi.org/10.1111/ijs.12331 .14 O.S.",Non-OADS,/arxiv_data1/oa_pdf/a4/be/main.PMC4908828.pdf
Available from: http://www.ada.,Non-OADS,/arxiv_data1/oa_pdf/17/33/PR-8-169.PMC4908843.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs330/en/.,Non-OADS,/arxiv_data1/oa_pdf/ce/9f/PR-8-202.PMC4908850.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011042).,Non-OADS,/arxiv_data1/oa_pdf/a3/75/bmjopen-2016-011042.PMC4908862.pdf
2010. http://www.regioner.dk/~/media/Filer/Sundhed/Retningslinjer%20for%20visitation%20og%20henvisning%20af%20degenerative%20lidelser%20i%20columna_PDF.ashx (accessed 9 Aug 2014).,OADS,/arxiv_data1/oa_pdf/a3/75/bmjopen-2016-011042.PMC4908862.pdf
2012. http://www.kronikerenheden.dk/NR/rdonlyres/793069EE-2361-40D0-8DA3-71E5685F5521/0/Patientforløbiprimærsektorenforpatientermedlænderygsmerterendeligversionjanuar2012.pdf (accessed 9 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/a3/75/bmjopen-2016-011042.PMC4908862.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012292).,Non-OADS,/arxiv_data1/oa_pdf/3e/c3/bmjopen-2016-012292.PMC4908863.pdf
The trial is regis-tered at ClinicalTrials.Gov (http://www.clinicalstrials.gov identi ﬁer NCT02587351).,Non-OADS,/arxiv_data1/oa_pdf/3e/c3/bmjopen-2016-012292.PMC4908863.pdf
http://apps.who.int/iris/ bitstream/10665/63109/1/PCS_96.29.pdf (accessed Dec 2015).,OADS,/arxiv_data1/oa_pdf/81/1e/bmjopen-2015-011003.PMC4908864.pdf
2015. http://www.kela.fi/documents/ 10180/1630858/Kelan_tyoterveyshuoltotilasto_2013.pdf/c9ae7415-4fa7-4a59-99bd-1df77d1eb375 (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/81/1e/bmjopen-2015-011003.PMC4908864.pdf
"Copenhagen: WHO Regional Office for Europe, 2009. http://www.euro.who.int/__data/assets/pdf_file/0017/43325/E92645.pdf(accessed Dec 2015).",OADS,/arxiv_data1/oa_pdf/81/1e/bmjopen-2015-011003.PMC4908864.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008680).,Non-OADS,/arxiv_data1/oa_pdf/78/69/bmjopen-2015-008680.PMC4908865.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011396).,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/bmjopen-2016-011396.PMC4908871.pdf
2015. http://www.pewinternet.org/files/2015/04/PI_TeensandTech_ Update2015_0409151.pd (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/bmjopen-2016-011396.PMC4908871.pdf
"American Community Survey Reports, ACS-28.Washington DC, 2014. https://www.census.gov/content/dam/Census/library/publications/2014/acs/acs-28.pdf (accessed Dec2015).",OADS,/arxiv_data1/oa_pdf/1c/d1/bmjopen-2016-011396.PMC4908871.pdf
http://www.datstat.com (accessed Jan 2016).41.,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/bmjopen-2016-011396.PMC4908871.pdf
http://www.iedea.org/ (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/1c/d1/bmjopen-2016-011396.PMC4908871.pdf
http://www.eurocoord.net/(Accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/bmjopen-2016-011396.PMC4908871.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011248).,Non-OADS,/arxiv_data1/oa_pdf/e3/63/bmjopen-2016-011248.PMC4908875.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2008. http://www.hscic.gov.uk/ catalogue/PUB02580/nati-diab-audi-07-08-exec-summ.pdf(accessed Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2014. http://www.hscic.gov.uk/catalogue/PUB13648/Obes-phys-acti-diet-eng-2014-rep.pdf (accessed July 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2012. http://www.nwph.net/dentalhealth/Oral%20Health%205yr%20old%20children%202012%20final%20report%20gateway%20approved.pdf (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2013. https://www.noo.,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2014. http://www.nwph.net/dentalhealth/reports/DPHEP%20for%20England%20OH%20Survey%203yr%202013%20Report.pdf (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2014. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/338934/Adult_obesity_and_type_2_diabetes_.pdf (accessed 2 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/339771/ Draft_SACN_Carbohydrates_and_Health_report_consultation.pdf (accessed 1 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2015. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/446010/Why_5__-_The_Science_Behind_SACN.pdf (accessed July 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2014. https://www.gov.uk/government/publications/national- diet-and-nutrition-survey-results-from-years-1-to-4-combined-of-the- rolling-programme-for-2008-and-2009-to-2011-and-2012 (accessed2 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2011. http://transparency.dh.gov.uk/2012/06/21/sodium-levels-among-adults/(accessed 2 Dec 2015).,OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2010. http://guidance.nice.org.uk/PH25 (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2007. http://www.food.gov.uk/multimedia/pdfs/lidnssummary.pdf (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
2015. http://www.beveragedaily.com/Markets/Coca-Cola-Sprite-Euromonitor-sugar-calories-Pepsi (accessed 2 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7a/b2/bmjopen-2016-011052.PMC4908876.pdf
"The approximate F testing was obtained using the R package lmerTest(A Kuznetsova, P Brockhoff, R Christenses, lmerTest: T ests in Liner Mixed Effects Models, R package version 2.0–25, 2015. http://CRAN.R-project.org/package= lmerTest).",OADS,/arxiv_data1/oa_pdf/d4/52/openhrt-2016-000430.PMC4908877.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010764).,Non-OADS,/arxiv_data1/oa_pdf/38/3c/bmjopen-2015-010764.PMC4908878.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011347).,Non-OADS,/arxiv_data1/oa_pdf/6d/f7/bmjopen-2016-011347.PMC4908879.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/f7/bmjopen-2016-011347.PMC4908879.pdf
PROSPERO 2015;CRD42015024879.http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015024879.,Non-OADS,/arxiv_data1/oa_pdf/0b/8d/bmjopen-2015-010142.PMC4908880.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e010200corr1.,Non-OADS,/arxiv_data1/oa_pdf/40/09/bmjopen-2015-010200corr1.PMC4908881.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010903).,Non-OADS,/arxiv_data1/oa_pdf/7e/0b/bmjopen-2015-010903.PMC4908882.pdf
The quality of included studies was assessed using the NationalInstitutes of Health Quality Assessment tool for Observational Cohort and Cross Sectional Studies (http://www.nhlbi.nih.gov/h ealth-pro/guidelines/in- develop/cardiovascular-risk -reduction/tools/cohort).,OADS,/arxiv_data1/oa_pdf/7e/0b/bmjopen-2015-010903.PMC4908882.pdf
"World Health Organisation, 2003. http://www.who.int/nut/ ida.htm (updated 9 Apr 2003; cited 25 July 2003).",OADS,/arxiv_data1/oa_pdf/7e/0b/bmjopen-2015-010903.PMC4908882.pdf
http://www.cardia.dopm.uab.edu/ exam-materials2/manual-of-operations/year-20 (accessed 10 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/08/3f/bmjdrc-2016-000213.PMC4908883.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011041).,Non-OADS,/arxiv_data1/oa_pdf/81/44/bmjopen-2016-011041.PMC4908885.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/bmjopen-2016-012677.PMC4908887.pdf
Application of the Q-Genie tool The Q-Genie tool is available from the Population Genomics Program website http://fhs.mcmaster.ca/ pgp/links.html.,OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
An updated Q-Genie tool will be made available from the Population Genomics Program website <http://fhs.mcmaster.ca/pgp/links.html>.,Non-OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
http://dx.doi.org/10.1093/ije/dym018 8.,OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/10789670 (accessed 19 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/11570228 (accessed 10 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
"Toronto: Oxford University Press, 2008. http://www.amazon.ca/Health-Measurement-Scales-practical-development/dp/0199231885 (accessed 23 Apr 2014).",Non-OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
http://www.ncbi.nlm.nih.gov/pubmed/7746979 (accessed8 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/2f/0f/bmjopen-2015-010403.PMC4908888.pdf
2001. https://nts122.chcr.brown.edu/dying/ 2001DATA.HTM 4.,Non-OADS,/arxiv_data1/oa_pdf/07/91/bmjopen-2015-010628.PMC4908890.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012213).,Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"[serial online] , 2012. http://www.bbc.co.uk/news/uk-england-suffolk- 17550982 (accessed 31 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"Right-to-die man Tony Nicklinson dead after refusing food, 2012. http://www.bbc.co.uk/news/uk-england-19341722 (accessed 31 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"Hope remains despite Supreme Court rejection of right to die campaign , 2014. http://www.itv.com/news/calendar/2014-06-25/ hope-remains-despite-supreme-court-rejection-of-right-to-die-campaign/ (accessed 31 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"Coronation Street shows controversial right to die scene , 2014. http://www.itv.com/news/2014-01-20/coronation-street-controversial-assisted-suicide-scene-hayley-cropper/ (accessed 31May 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
http://news.gc.ca/web/article-en.do?nid=1051809&tp=1 (accessed 29 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"The Commission on Assisted Dying, 2011. http://www.demos.co.uk/ files/476_CoAD_FinalReport_158×240_I_web_single-NEW_.pdf?1328113363 (accessed 31 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"University of York Health Sciences Research Governance Committee, 2015. http://www.york.ac.uk/healthsciences/research-information/rsg/ (accessed 31 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
"Putting patients, carers and clinicians at the heart of palliative and end of lifecare research , 2015. http://www.palliativecarepsp.org.uk/wp-content/ uploads/2015/01/PeolcPSP_Final_Report.pdf (accessed 31st May2016).",Non-OADS,/arxiv_data1/oa_pdf/ce/32/bmjopen-2016-012213.PMC4908896.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011045).,Non-OADS,/arxiv_data1/oa_pdf/5d/4f/bmjopen-2016-011045.PMC4908897.pdf
"18Further details of the questionnaire, variables, sampling and recruitment processes are docu- mented online at http://otru.org/research-evaluation/ontario-tobacco-survey/ots -technical-documentation/.",OADS,/arxiv_data1/oa_pdf/5d/4f/bmjopen-2016-011045.PMC4908897.pdf
Data sharing statement Research teams may apply for access to OTS data through one of the following university-based data libraries: Propel Centre for Population Health Impact —Population Health Data Repository at the University of Waterloo (http://www.propel.uwaterloo.ca/index.cfm?,Non-OADS,/arxiv_data1/oa_pdf/5d/4f/bmjopen-2016-011045.PMC4908897.pdf
"Gallup News Services, 2006. http://www.gallup.com/poll/23791/smoking-habits-stable-most-would-like-quit.aspx (accessed 21 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/5d/4f/bmjopen-2016-011045.PMC4908897.pdf
"Retrieved May 20, 2011 from http://www.otru.org/pdf/ots/OTS_Technical_Report.pdf 19.",Non-OADS,/arxiv_data1/oa_pdf/5d/4f/bmjopen-2016-011045.PMC4908897.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. Cooper A, Calvert N, Skinner J, et al.Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort ofsuspected cardiac origin .",Non-OADS,/arxiv_data1/oa_pdf/ac/b8/openhrt-2016-000406.PMC4908898.pdf
"London: National Clinical Guideline Centre for Acute and Chronic Conditions, 2010. http://www.nice.org.uk/guidance/cg95/evidence/full-guideline-245282221 (accessed 9 Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/ac/b8/openhrt-2016-000406.PMC4908898.pdf
http://www.nice.org.uk/guidance/cg126/evidence/full-guideline-183176605 (accessed 9 Dec2015).3.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/openhrt-2016-000406.PMC4908898.pdf
http://www.nice.org.uk/guidance/cg181/evidence/lipid-modification-update-full-guideline-243786637 (accessed 9 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/openhrt-2016-000406.PMC4908898.pdf
http://www.nice.org.uk/guidance/cg127/evidence/full-guideline-248588317 (accessed 9 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/openhrt-2016-000406.PMC4908898.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 011018).,Non-OADS,/arxiv_data1/oa_pdf/47/d4/bmjopen-2015-011018.PMC4908900.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010761).,Non-OADS,/arxiv_data1/oa_pdf/ae/37/bmjopen-2015-010761.PMC4908902.pdf
Koushede V. Project Newborn –Preparation for Birth and Parenthood 2014. http://www.interventionsforskning.dk/userfiles/files/nyfdt/projektprotokol-version-23_2.pdf (accessed 7 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/37/bmjopen-2015-010761.PMC4908902.pdf
"Copenhagen, 2009. http://sundhedsstyrelsen.dk/publ/ Publ2009/CFF/gravide/Svangreomsorgen.pdf (accessed 9 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/ae/37/bmjopen-2015-010761.PMC4908902.pdf
https://clinicaltrials.gov/ct2/results?term=NCT01672437 Last update: December 2015 (accessed 3 Dec2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/37/bmjopen-2015-010761.PMC4908902.pdf
Population highest completed education 2014. http://www.statistikbanken.dk/statbank5a/default.asp?w=1422(accessed 16 Mar 2015).,OADS,/arxiv_data1/oa_pdf/ae/37/bmjopen-2015-010761.PMC4908902.pdf
2012. http://www.websm.org/uploadi/editor/1367569624Internet_use_in_households_and_by_individual_2012_Eurostat.PDF (accessed 1Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/75/f8/bmjopen-2015-010806.PMC4908903.pdf
"Tuomilehto J, Gabriel R. ePREDICE Early Prevention of Diabetes Complications in Europe 2011. http://www.epredice.eu 35.",Non-OADS,/arxiv_data1/oa_pdf/75/f8/bmjopen-2015-010806.PMC4908903.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011053).,Non-OADS,/arxiv_data1/oa_pdf/8c/3f/bmjopen-2016-011053.PMC4908906.pdf
"2015. https://www.ftc.gov/system/files/documents/reports/federal-trade-commission-cigarette-report-2012/150327-2012cigaretterpt.pdf Brame LS, et al.BMJ Open 2016; 6:e011053.",OADS,/arxiv_data1/oa_pdf/8c/3f/bmjopen-2016-011053.PMC4908906.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010860).,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
http://www.ons.gov.uk/ons/ dcp171778_414574.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737420455 7.,OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
"Canberra: Commonwealth of Australia, 2007 (cited 31 October 2015).http://www.drugfree.org.au/fileadmin/Media/Reference/DFA_ DrugRelatedStats.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
https://www.ontario.ca/page/get-medical-advice-telehealth-ontario 17.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
"Oslo: Norwegian Institute of Public Health, 2014 (cited 31 October 2015).http://www.whocc.no/filearchive/publications/2015_guidelines.pdf 20.",Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/1379.0.55.001Explanatory%20Notes12002-2006?OpenDocument.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
http://www.nhs.uk/conditions/Medicinesinfo/Pages/Introduction.aspx 30.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
"London: Government of the United Kingdom, 2014 (cited 31 October 2015)https://www.gov.uk/government/publications/ best-practice-in-the-labelling-and-packaging-of-medicines.",Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
"http://www.medicines.org.uk/emc/about-the-emc Lau SM, et al.BMJ Open 2016; 6:e010860.",Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
http://www.sanofi.com.au/products/aus_cmi_panamax.pdf 33.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
http://www.telegraph.co.uk/news/uknews/9134065/Paracetamol-should-be-prescription-only.html 40.,Non-OADS,/arxiv_data1/oa_pdf/37/92/bmjopen-2015-010860.PMC4908911.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011322).,Non-OADS,/arxiv_data1/oa_pdf/80/af/bmjopen-2016-011322.PMC4908913.pdf
"Theconversation, 2015. https://theconversation.com/if-we-dont-talk-about-value-cancer-drugs-will-become-terminal-for-health-systems-44072 24.",Non-OADS,/arxiv_data1/oa_pdf/80/af/bmjopen-2016-011322.PMC4908913.pdf
2013. http://www.nhi.gov.tw/webdata/webdata.aspx?menu=21&menu_id=713&webdata_id=2919 42.,OADS,/arxiv_data1/oa_pdf/80/af/bmjopen-2016-011322.PMC4908913.pdf
October 2004. http://www.nhi.gov.tw/Resource/ webdata/Attach_8661_1_s92.pdf (accessed 8 Jun 2011).,OADS,/arxiv_data1/oa_pdf/80/af/bmjopen-2016-011322.PMC4908913.pdf
http://www.stata.com/).,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
"Reference: https://www.healthiernorthwestlondon.nhs.uk/UCC, urgent care centre.",Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
2015. http://www.hscic.gov.uk/ catalogue/PUB16728/acci-emer-atte-eng-2013-14-rep.pdf (accessed6 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
http://www.gov-news.org/gov/uk/news/up_to_30m_to_develop_20_nhs_fast_access_walk/37123.html 12.,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
2015. http://www.patients-association.org.uk/wp-content/uploads/2015/06/rcem-pa-report-time-to-act.pdf (accessed 6Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
2012. http://data.london.gov.uk/datastorefiles/documents/2011-census-first-results.pdf 18.,OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
2006. http://www.lbhf.gov.uk/Images/3.%20FINAL%20proof%20-%20Population_tcm21-56259.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
http://www.nres.nhs.uk/applications/is-your-project-research/ 20.,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
http://www.advancedcomputersoftware.com/ahc/products/adastra-patient-management-system.php 21.,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
http://systems.hscic.,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
http://www.hscic.gov.uk/catalogue/PUB01077 23.,Non-OADS,/arxiv_data1/oa_pdf/85/79/bmjopen-2015-010672.PMC4908914.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010973).,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/bmjopen-2015-010973.PMC4908915.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011817).,Non-OADS,/arxiv_data1/oa_pdf/10/db/bmjopen-2016-011817.PMC4908916.pdf
Telegraph 2012 2012-08-01. http://www.telegraph.co.uk/news/health/news/9441885/Thousands-of-juniors-start-jobs-in-NHS-killing-season.html (accessed 5 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/10/db/bmjopen-2016-011817.PMC4908916.pdf
http://www.bma.org.uk/ support-at-work/contracts/juniors-contracts/assistantships-shadowing-and-induction (accessed 12 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/10/db/bmjopen-2016-011817.PMC4908916.pdf
"Oxford: UK Medical Careers Research Group, 2009. http://www.walesdeanery.org/images/stories/Files/Documents/careers/Welsh_Graduates_Report_Draft_250809.pdf (accessed 15Oct 2015).",Non-OADS,/arxiv_data1/oa_pdf/10/db/bmjopen-2016-011817.PMC4908916.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010269).,Non-OADS,/arxiv_data1/oa_pdf/f8/dc/bmjopen-2015-010269.PMC4908919.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011485).,Non-OADS,/arxiv_data1/oa_pdf/ee/29/bmjopen-2016-011485.PMC4908920.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/bmjopen-2016-011485.PMC4908920.pdf
https://www.cancer.ie/sites/default/files/content-attachments/coping_with_fatigue.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/bmjopen-2016-011485.PMC4908920.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Anti-nerve growth factor in pain management:  current evidence David S Chang1 Eugene Hsu2 Daniel G Hottinger1 Steven P Cohen1,3–5 1Department of Anesthesiology and  Critical Care Medicine, Johns Hopkins  University School of Medicine,   Baltimore, MD, 2Clinical Excellence  Research Center, Stanford University  School of Medicine, Stanford, CA,   3Department of Anesthesiology,   4Department of Physical Medicine  and Rehabilitation, Uniformed  Services University of the Health  Sciences, Bethesda 5Department of  Physical Medicine and Rehabilitation,   Johns Hopkins University School of  Medicine, Baltimore, MD, USA Correspondence: Steven P Cohen   Department of Anesthesiology and  Critical Care Medicine, Johns Hopkins  University School of Medicine,   550 North Broadway, Suite 301,  Baltimore, MD 21205 USA   T el +1 410 955 1822   Fax +1 410 614 7592   Email scohen40@jhmi.ed uAbstract:  There continues to be an unmet need for safe and effective pain medications.",Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
"Available from: http://www.fda.gov/downloads/Advisory- Committees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisory - Committee/UCM295204.pd f. Accessed November 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
"Available from: http://www.fda.gov/downloads/Advisory Committees/ CommitteesMeetingMaterials/Drugs/ArthritisDrugsAdvisory- Committee/UCM301302.pd f. Accessed November 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Avail - able from: https://clinicaltrials.gov/ct2/show/NCT0252818 8.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0228971 6.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0233669 8.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0233668 5.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0230123 4.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0251661 8.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/36/jpr-9-373.PMC4908933.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/cc/ijwh-8-191.PMC4908934.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 191–202International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  191RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10548 3 Women’s autonomy in health care decision- making in developing countries: a synthesis  of the literature Pauline e Osamor Christine Grady Department of Bioethics, Clinical  Center, National Institutes of Health,   Bethesda, MD, USAAbstract:  Autonomy is considered essential for decision-making in a range of health care  situations, from health care seeking and utilization to choosing among treatment options.",Non-OADS,/arxiv_data1/oa_pdf/4f/cc/ijwh-8-191.PMC4908934.pdf
"In the literature on maternal health,  women’s decision-making ability regarding use of health services is often discussed  using the concept of autonomy.1 Despite significant philosophical literature devoted Correspondence: Pauline e Osamor Department of Bioethics, Clinical Center,  Building 10/1C118, National Institutes of  Health, Bethesda, MD 20892-1156, USA Tel +1 301 451 6750 Fax +1 301 496 2429 email pauline.osamor@nih.go v Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Osamor and Grady Running head recto: Women’s health care decision-making autonomy DOI: http://dx.doi.org/10.2147/IJWH.S105483",Non-OADS,/arxiv_data1/oa_pdf/4f/cc/ijwh-8-191.PMC4908934.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4f/cc/ijwh-8-191.PMC4908934.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/cc/ijwh-8-191.PMC4908934.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/8f/clep-8-201.PMC4908935.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinical epidemiology 2016:8 201–209submit your manuscript | www.dovepress.co m Dove press  201 http: //dx.doi.org/10.2147/CLEP .S9730 3implementation of interval walking training  in patients with type 2 diabetes in Denmark:  rationale, design, and baseline characteristics Mathias ried-larsen1–3 reimar W Thomsen2,4 Klara Berencsi4 cecilie F Brinkløv1,5 charlotte Brøns1,5 laura s Valentiner1,6 Kristian Karstoft1,3 henning langberg1,6 allan a Vaag1,2,5 Bente K Pedersen1,3 Jens s nielsen7 1Department of infectious Diseases,   centre for Physical activity  research, rigshospitalet, University  of copenhagen, copenhagen,   2The Danish Diabetes academy,   Odense University hospital,   Odense, 3Department of infectious  Diseases, centre of inflammation  and Metabolism, rigshospitalet,   University of copenhagen,   copenhagen, 4Department of clinical  epidemiology, aarhus University  hospital, aarhus nord, 5Department  of endocrinology (Diabetes and  Metabolism), rigshospitalet, University  of copenhagen, 6copenrehab,   Department of Public health, section  of social Medicine, University  of copenhagen, copenhagen,   7Department of endocrinology,   Odense University hospital, Odense,   Denmark correspondence: Mathias ried-larsen   Department of infectious Diseases,  centre for Physical activity research,  rigshospitalet, University of copenhagen,  Blegdamsvej 9, 2100 copenhagen,  Denmark   T el +45 3545 0699   email Mathias.ried-larsen@regionh.d kAbstract:  Promoting physical activity is a first-line choice of treatment for patients with type 2  diabetes (T2D).",Non-OADS,/arxiv_data1/oa_pdf/1a/8f/clep-8-201.PMC4908935.pdf
Available from: https://www.dst.dk/ da/Statistik/emner/forbrug/elektronik-i-hjemmet?tab=nog #.,OADS,/arxiv_data1/oa_pdf/1a/8f/clep-8-201.PMC4908935.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/1a/8f/clep-8-201.PMC4908935.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/62/ndt-12-1333.PMC4908936.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1333–1339Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1333OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10591 8 investigating analgesic and psychological factors  associated with risk of postpartum depression  development: a case–control study Thangavelautham  suhitharan1 Thi Phuong T u Pham2 helen chen2,3 Pryseley Nkouibert assam4 rehena sultana2 Nian-lin reena han5 ene-choo Tan6,7 Ban leong sng1,2 1Department of Women’s anaesthesia,   KK Women’s and children’s hospital,   2Duke-NUs Medical school, 3Women’s  service, Department of Psychological  Medicine, KK Women’s and children’s  hospital, 4singapore clinical research  institute, 5Division of clinical support  services, 6research laboratory, KK  Women’s and children’s hospital,   7singhealth Paediatrics academic  clinical Programme, Duke-NUs   Medical school, singaporeAim:  The aim of this study was to investigate the role of peripartum analgesic and psychological  factors that may be related to postpartum depression (PPD).",Non-OADS,/arxiv_data1/oa_pdf/87/62/ndt-12-1333.PMC4908936.pdf
"PPD occurs in ~10%–20% of females  in the US5 and ~8% of females in Singapore.6 A recent study assessing depressive  symptoms using Edinburgh Postnatal Depression Scale (EPDS) in parturients at correspondence: Ban leong sng Department of Women’s anaesthesia,  KK Women’s and children’s hospital,  100 Bukit Timah road, singapore 229899,  singapore Tel +65 6394 1081 Fax +65 6291 2661 email sng.ban.leong@singhealth.com.s g Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Suhitharan et al Running head recto: Mode of analgesia and risk of postpartum depression DOI: http://dx.doi.org/10.2147/NDT.S105918",Non-OADS,/arxiv_data1/oa_pdf/87/62/ndt-12-1333.PMC4908936.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/87/62/ndt-12-1333.PMC4908936.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/62/ndt-12-1333.PMC4908936.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/e2/ppa-10-1043.PMC4908937.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1043–1050Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1043OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9969 0Magnetic resonance enterography or video  capsule endoscopy – what do crohn’s disease  patients prefer?",Non-OADS,/arxiv_data1/oa_pdf/42/e2/ppa-10-1043.PMC4908937.pdf
"The use of bowel imaging serves to confirm the correspondence: Adi lahat Department of gastroenterology, chaim  sheba Medical center, Tel hashomer,  ramat gan 52651, israel Tel +972 3 530 2660 Fax +972 3 530 3160 email zokadi@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lahat et al Running head recto: Tolerability of Crohn’s disease patients to MRE versus capsule endoscopy DOI: http://dx.doi.org/10.2147/PPA.S99690",Non-OADS,/arxiv_data1/oa_pdf/42/e2/ppa-10-1043.PMC4908937.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/42/e2/ppa-10-1043.PMC4908937.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7c/2d/idr-9-119.PMC4908938.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/7c/2d/idr-9-119.PMC4908938.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Focus on JNJ-Q2, a novel fluoroquinolone, for  the management of community-acquired bacterial  pneumonia and acute bacterial skin and skin  structure infections  Travis M Jones1,2 Steven W Johnson1,3 V Paul DiMondi1,4 Dustin T Wilson1,2 1Department of Pharmacy Practice,   College of Pharmacy and Health  Sciences, Campbell University, Buies  Creek, 2Department of Pharmacy,   Duke University Hospital, Durham,   3Department of Pharmacy, Forsyth  Medical Center, Novant Health,   Winston-Salem, 4Department of  Pharmacy, Durham VA Medical Center,   Durham, NC, USA Correspondence: Travis M Jones   Department of Pharmacy,  Duke University Hospital, PO Box 3089,  Durham, NC 27710, USA   T el +1 919 668 1956   Fax +1 919 681 2741   Email tjones@campbell.ed uAbstract:  JNJ-Q2 is a novel, fifth-generation fluoroquinolone that has excellent in vitro and in  vivo activity against a variety of Gram-positive and Gram-negative organisms.",Non-OADS,/arxiv_data1/oa_pdf/7c/2d/idr-9-119.PMC4908938.pdf
Available from: http://www.cdc.gov/drugresistance/ threat-report-2013 /.,OADS,/arxiv_data1/oa_pdf/7c/2d/idr-9-119.PMC4908938.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/7c/2d/idr-9-119.PMC4908938.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/2d/idr-9-119.PMC4908938.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/1a/ppa-10-1021.PMC4908939.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1021–1024Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1021OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10877 1 impact of strabismus on the quality of life  of chinese han teenagers changsen T u liang Ye longfei Jiang Yuwen Wang Yingzi li The eye hospital of Wenzhou Medical  University, school of Ophthalmology  and Optometry, Wenzhou Medical  University, Wenzhou, People’s  republic of chinaBackground:  Although much research has been conducted on the impact of strabismus on the  quality of life (QoL) of adults, the effect of this condition on teenagers has not been extensively  studied.",Non-OADS,/arxiv_data1/oa_pdf/3b/1a/ppa-10-1021.PMC4908939.pdf
"Strabismus has an incidence of ~10% in the general population.6 Its presence can  have a profound impact on teenagers due to visual dysfunction, lack of confidence,  and social and emotional barriers, all of which can decrease HRQoL.6,7 In addi - tion, the appearance of misaligned eyes in strabismus patients can result in social  discrimination.8,9 Several studies have assessed the impact of strabismus on the QoL  of adult patients.7,10 However, there is little literature on the impact of this condition on correspondence: Yingzi li The eye hospital of Wenzhou Medical  University, school of Ophthalmology  and Optometry, Wenzhou Medical  University, 270 West college road,  325000 Wenzhou, People’s republic  of china Tel +86 577 8806 8888 email liyingzi_0@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tu et al Running head recto: Effect of strabismus on QoL of Chinese teenagers DOI: http://dx.doi.org/10.2147/PPA.S108771",Non-OADS,/arxiv_data1/oa_pdf/3b/1a/ppa-10-1021.PMC4908939.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/3b/1a/ppa-10-1021.PMC4908939.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/43/ppa-10-1025.PMC4908940.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1025–1035Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1025OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10276 0cost-effectiveness analysis of universal noninvasive  testing for post-treatment confirmation of  Helicobacter  pylori eradication and the impact  of patient adherence susan h Boklage1 Allen W Mangel2 Varun ramamohan2 Deirdre Mladsi2 Tao Wang1 1Otsuka America Pharmaceutical, inc,   Princeton, nJ, 2rTi health solutions,   research Triangle Park, nc, UsABackground:  The treatment failure rate for Helicobacter pylori  eradication therapy is ~20%  due to poor patient compliance and increased antibiotic resistance.",Non-OADS,/arxiv_data1/oa_pdf/0b/43/ppa-10-1025.PMC4908940.pdf
"Keywords:  health-economic, decision-analytic modeling, infectious disease Introduction Helicobacter pylori  infection is a common chronic infection that is associated with  upper gastrointestinal diseases, including chronic gastritis, peptic ulcers, and gastric  cancer.1 Individuals infected with H. pylori  have a 15% lifetime risk of developing  peptic ulcer disease and are ten times more likely to develop gastric adenocarcinoma  than those who are not infected.2,3 The recommended first-line treatment for H. pylori   infection according to the American College of Gastroenterology (ACG) practice  guidelines is clarithromycin-based triple therapy, consisting of a proton pump inhibitor,  clarithromycin, and either amoxicillin or metronidazole, or alternatively, bismuth qua - druple therapy, consisting of bismuth, a proton pump inhibitor or histamine-2-receptor correspondence: Tao Wang Department of Medical Affairs,  Otsuka America Pharmaceutical, inc,  2440 research Boulevard, rockville,  MD 20850, UsA Tel +1 240 683 3213 Fax +1 301 721 7213 email tao.wang@otsuka-us.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Boklage et al Running head recto: Cost-effectiveness of confirmation testing after H. pylori  eradication DOI: http://dx.doi.org/10.2147/PPA.S102760",Non-OADS,/arxiv_data1/oa_pdf/0b/43/ppa-10-1025.PMC4908940.pdf
"The abstract was published in The American  Journal of Gastroenterology , Vol 109, Supplement 2, Page  s662, October 2014 ( http://www.nature.com/ajg/journal/ v109/n2s/pdf/ajg2014280a.pd f).",Non-OADS,/arxiv_data1/oa_pdf/0b/43/ppa-10-1025.PMC4908940.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/0b/43/ppa-10-1025.PMC4908940.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0b/43/ppa-10-1025.PMC4908940.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/dhps-8-059.PMC4908941.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/5f/dhps-8-059.PMC4908941.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2016:8 59–63Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 59 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S105962 T opiramate-induced maculopathy in IgG4-related  disease Joanna DaCosta1,2 Saad Y ounis1 1Ophthalmology Department, Imperial  College Healthcare NHS Trust,   Western Eye Hospital,  2Barts Health  NHS Trust, Whipps Cross University Hospital, London, UKAbstract: This report describes a case of reversible topiramate-induced maculopathy in a  32-year-old female patient with IgG4-related disease.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/dhps-8-059.PMC4908941.pdf
"Her past medical history included epilepsy, chronic migrainous headache,  Correspondence: Joanna DaCosta Barts Health NHS Trust, Whipps Cross University Hospital, Leytonstone, London E11 1NR, UKTel +44 20 8539 5522Fax +44 20 8558 8115Email Joanna.DaCosta@bartshealth.nhs.ukJournal name: Drug, Healthcare and Patient Safety Article Designation: CASE REPORTY ear: 2016V olume: 8Running head verso: DaCosta and Y ounisRunning head recto: Topiramate-induced maculopathy in IgG4-related diseaseDOI: http://dx.doi.org/10.2147/DHPS.S105962",Non-OADS,/arxiv_data1/oa_pdf/05/5f/dhps-8-059.PMC4908941.pdf
"Drug, Healthcare and Patient Safety 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/dhps-8-059.PMC4908941.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 63 T opiramate-induced maculopathy in IgG4-related disease  7.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/dhps-8-059.PMC4908941.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/63/ppa-10-983.PMC4908942.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 983–992Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  983OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10387 4 A validated measure of adherence to antibiotic  prophylaxis in children with sickle cell disease natalie A Duncan1 William g Kronenberger2 Kisha c hampton1 ellen M Bloom1 Angeli g rampersad1 christopher P roberson1 Amy D shapiro1 1Department of hematology, indiana  hemophilia and Thrombosis center,   2Department of Psychiatry, indiana  University school of Medicine riley  and child Adolescent Psychiatry  clinic, indianapolis, in, UsABackground:  Antibiotic prophylaxis is a mainstay in sickle cell disease management.",Non-OADS,/arxiv_data1/oa_pdf/32/63/ppa-10-983.PMC4908942.pdf
"These include  medical record reviews,20 urinalysis,13,14,17,20 self-/parent-report by questionnaires, inter - views, or visual analog scales,14,18,20,25 parent/proxy Morisky scores,25 medical provider  reports,25 clinic visit attendance,25 medication event monitoring system (MEMS) pill correspondence: natalie A Duncan indiana hemophilia and Thrombosis  center, 8326 naab rd, indianapolis,  in 46260, UsA Tel +1 317 871 0011 ext 273 Fax +1 317 871 0010 email nduncan@ihtc.or g Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Duncan et al Running head recto: Sickle cell antibiotic adherence scale validation DOI: http://dx.doi.org/10.2147/PPA.S103874",Non-OADS,/arxiv_data1/oa_pdf/32/63/ppa-10-983.PMC4908942.pdf
Available from: http://www.nhlbi.nih.gov/health-pro/guidelines/sickle- cell-disease-guideline s  40.,Non-OADS,/arxiv_data1/oa_pdf/32/63/ppa-10-983.PMC4908942.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/32/63/ppa-10-983.PMC4908942.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/b9/cia-11-761.PMC4908943.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 761–765Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  761Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S10882 2 Underestimated factors may also precipitate  delirium and can lead to the misinterpretation  of frailty in these patients Correspondence: Birkan I ˙lhan Division of Geriatrics, Department of  Internal Medicine, Istanbul Faculty of  Medicine, Istanbul University, turgut  Ozal street, PB 34093, Sehremini, Fatih,  Istanbul, turkey email birkanilhan@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: I ˙lhan et al Running head recto: Underestimated factors precipitating delirium leading to misinterpretation DOI: http://dx.doi.org/10.2147/CIA.S108822 Birkan I˙lhan Fatih tufan Gülistan Bahat Mehmet Akif Karan Division of Geriatrics, Department  of Internal Medicine, Istanbul Faculty  of Medicine, Istanbul University,   Istanbul, turkeyDear editor We have read the article entitled “Association between frailty and delirium in older  adult patients discharged from hospital” by Verloo et al1 with great interest.",Non-OADS,/arxiv_data1/oa_pdf/6c/b9/cia-11-761.PMC4908943.pdf
Available from: http://guidelines.gov/ content.aspx?f =rss&id =3241 7.,OADS,/arxiv_data1/oa_pdf/6c/b9/cia-11-761.PMC4908943.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6c/b9/cia-11-761.PMC4908943.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6c/b9/cia-11-761.PMC4908943.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/56/4e/ijgm-9-191.PMC4908944.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/56/4e/ijgm-9-191.PMC4908944.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of General Medicine 2016:9 191–198International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  191OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S10063 7Atrial fibrillation among the black population in a  Ugandan tertiary hospital Charles Lugero1,2 Davis Kibirige3 James Kayima1,2 Charles Kizza Mondo2 Jurgen Freers2 1Division of Adult Cardiology,   Uganda Heart Institute, 2Department  of Medicine, Makerere University  College of Health Sciences, Kampala,   3Department of Medicine, Our Lady  of Consolata Hospital, Kisubi, Uganda Correspondence: Charles Lugero   Department of Medicine, Makerere  University College of Health Sciences,  PO Box 7062, Kampala, Uganda   T el +256 414 541188   email charleslug@yahoo.co mBackground:  Atrial fibrillation (AF) is the most common type of sustained cardiac arrhythmia  in adults, accounting for one-third of hospitalizations due to arrhythmia and related compli - cations worldwide.",Non-OADS,/arxiv_data1/oa_pdf/56/4e/ijgm-9-191.PMC4908944.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/56/4e/ijgm-9-191.PMC4908944.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/4e/ijgm-9-191.PMC4908944.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e1/b2/imcrj-9-139.PMC4908945.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e1/b2/imcrj-9-139.PMC4908945.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal 2016:9 139–143International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  139Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S10039 5Case of early-disseminated Rhizopus microsporus  var.",Non-OADS,/arxiv_data1/oa_pdf/e1/b2/imcrj-9-139.PMC4908945.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/e1/b2/imcrj-9-139.PMC4908945.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/b2/imcrj-9-139.PMC4908945.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d5/84/ppa-10-1037.PMC4908946.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1037–1042Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1037OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10526 0Psychosocial impact of dental aesthetics and  desire for orthodontic treatment among chinese  undergraduate students song Yi1 chuqin Zhang2 chulei ni1 Ying Qian3 Jun Zhang4 1Department of Orthodontics,   school and hospital of  stomatology, 2Ophthalmology and  Otorhinolaryngology Department, The  second Affiliated hospital & Yuying  children’s hospital, 3Department of  Orthodontics, school of stomatology,   Wenzhou Medical University,   Wenzhou, Zhejiang, 4Department of  Orthodontics, school of stomatology,   shandong University, Jinan, shandong  Province, People’s republic of chinaObjective:  The objective of this study is to evaluate the psychosocial impact of dental aesthetics  in undergraduate students in the People’s Republic of China and to investigate the association  between normal orthodontic treatment needs, psychosocial impact of dental aesthetics, and  desire for orthodontic treatment.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/ppa-10-1037.PMC4908946.pdf
"However, recent studies  have proved that orthodontic treatment can improve an individual’s appearance, oral  function, psychosocial well-being, and quality of life.2,5,6 Dominant motives for orth - odontic treatment have evolved into improving dental–facial appearance and other  psychosocial factors.6–8 Some indices have been developed and widely used to assess objective orthodontic  treatment needs and outcomes.9–11 The Index of Orthodontic Treatment Need (IOTN) was correspondence: Jun Zhang Department of Orthodontics, school  of stomatology, shandong University,  no 44-1, Wenhua West road,  Jinan, shandong Province 250012,  People’s republic of china Tel +86 531 8838 2070 Fax +86 531 8295 0194 email zhangj@sdu.edu.c n Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Yi et al Running head recto: Psychosocial impact of dental aesthetics DOI: http://dx.doi.org/10.2147/PPA.S105260",Non-OADS,/arxiv_data1/oa_pdf/d5/84/ppa-10-1037.PMC4908946.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/ppa-10-1037.PMC4908946.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/44/ndt-12-1319.PMC4908947.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1319–1331Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1319OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10477 7 cognitive behavioral therapy for depression in  Japanese Parkinson’s disease patients: a pilot study issei shinmei1,2 Kei Kobayashi3 Yuki Oe1 Yuriko Takagishi1,4 ayako Kanie1 Masaya ito1 Y oshitake Takebayashi1,5 Miho Murata3 Masaru horikoshi1 roseanne D Dobkin6 1National center for cognitive  Behavioral Therapy and research,   National center of Neurology and  Psychiatry, T okyo, Japan; 2Department  of Neuropsychiatry, interdisciplinary  graduate school of Medicine and  engineering, University of Yamanashi,   Yamanashi, Japan; 3Department of  Neurology, National center of  Neurology and Psychiatry, T okyo,   Japan; 4Department of Psychology,   surugadai University, saitama, Japan;   5risk analysis research center, The  institute of statistical Mathematics,   T okyo, Japan; 6Department of  Psychiatry, rutgers- robert Wood  Johnson Medical school, NJ, UsaObjectives:  This study evaluated the feasibility of cognitive behavioral therapy (CBT) for  Japanese Parkinson’s disease (PD) patients with depression.",Non-OADS,/arxiv_data1/oa_pdf/13/44/ndt-12-1319.PMC4908947.pdf
"Depression in individuals with PD is a common neuropsychiatric  syndrome, with a prevalence rate of ~50%.1 PD depression is highly comorbid with  anxiety, closely associated with worsening PD motor function, symptom fluctuations,  decreasing quality of life (QOL), and hastening PD progression.2,3 Unfortunately,  depressive symptoms in PD (dPD) often remain undetected by medical doctors,  caregivers, and the patients themselves.4,5 The suboptimal recognition of dPD may be  due to the overlapping of somatic features of depressive symptoms (eg, apathy and  fatigue) with the motor symptoms of PD,6 poor mental health literacy, and the stigma  of mental health concerns.7 In the treatment of PD depression, antidepressants (selective serotonin reuptake  inhibitors and tricyclic antidepressants) are commonly used.8 Recent meta-analyses correspondence: issei shinmei National center for cognitive Behavior  Therapy and research, National  center of Neurology and Psychiatry,  4-1-1 Ogawa-higashi, Kodaira,  Tokyo 187-8553, Japan Tel +81 3 4234 6271 email issei@ncnp.go.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Shinmei et al Running head recto: CBT for Parkinson’s disease DOI: http://dx.doi.org/10.2147/NDT.S104777",Non-OADS,/arxiv_data1/oa_pdf/13/44/ndt-12-1319.PMC4908947.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/13/44/ndt-12-1319.PMC4908947.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/44/ndt-12-1319.PMC4908947.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fb/66/ppa-10-1003.PMC4908948.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1003–1010Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1003OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10134 9Development of a new diabetes medication  self-efficacy scale and its association with both  reported problems in using diabetes medications  and self-reported adherence Betsy Sleath1,2 Delesha M carpenter1 susan J Blalock1 scott A Davis1 Ryan P Hickson1 charles lee3 stefanie P Ferreri4 Jennifer e scott5 lisa B rodebaugh6 Doyle M Cummings6,7 1Division of Pharmaceutical Outcomes  and Policy, UNC Eshelman School of  Pharmacy, The University of North  carolina at chapel hill, chapel hill,  2cecil g. sheps center for health  Services Research, The University of  north carolina at chapel hill, chapel  hill, 3Polyglot Systems, Inc., Morrisville,  4Division of Practice Advancement  and Clinical Education, UNC Eshelman  School of Pharmacy, 5consortium for  implementation science, Department of  Health Policy and Management, Gillings  school of global Public health, The  University of North Carolina at Chapel  hill, chapel hill, 6Department of Family  Medicine, Brody School of Medicine,  East Carolina University, Greenville,  7Department of Public Health, Brody  school of Medicine, east carolina  University, Greenville, NC, USABackground:  Although there are several different general diabetes self-efficacy scales, there  is a need to develop a self-efficacy scale that providers can use to assess patient’s self-efficacy  regarding medication use.",Non-OADS,/arxiv_data1/oa_pdf/fb/66/ppa-10-1003.PMC4908948.pdf
"Poor medication understanding and adherence are common among the diabetes  patients.4,5 Research has shown that the African-American patients worry more about side  effects and medication dependency and are less likely to adhere to their diabetes medications  than the White patients.6–8 Adherence to diabetes medications is important because  better medication adherence has been associated with improved diabetes control.9Correspondence: Betsy Sleath UNC Eshelman School of Pharmacy,  Division of Pharmaceutical Outcomes  and Policy, The University of North  carolina at chapel hill, cB 7573,  Chapel Hill, NC 27599-7573, USA Tel +1 919 966 8969 Fax +1 919 966 1634 email betsy_sleath@unc.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Sleath et al Running head recto: Diabetes medication self-efficacy and adherence DOI: http://dx.doi.org/10.2147/PPA.S101349",Non-OADS,/arxiv_data1/oa_pdf/fb/66/ppa-10-1003.PMC4908948.pdf
"Available from: http://www.cdc.gov/diabetes/data/ statistics/2014statisticsreport.htm l. Accessed March 3, 2016.",OADS,/arxiv_data1/oa_pdf/fb/66/ppa-10-1003.PMC4908948.pdf
Available from: http://minorityhealth.hhs.gov/omh/browse.,Non-OADS,/arxiv_data1/oa_pdf/fb/66/ppa-10-1003.PMC4908948.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/fb/66/ppa-10-1003.PMC4908948.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).risk Management and healthcare Policy 2016:9 113–127submit your manuscript | www.dovepress.co m Dove press  113 http: //dx.doi.org/10.2147/RMHP .S10112 4impact of disasters on child stunting in nepal surya gaire1 T efera Darge Delbiso1 srijana Pandey2 Debarati guha-sapir1 1centre for research on the  epidemiology of Disaster (creD),   institute of health and society (irss),   Université catholique de louvain  (Ucl), Brussels, Belgium; 2Department  of nursing, Tribhuvan University  Teaching hospital (TUT h), institute  of Medicine (iOM), Baluwatar,   Kathmandu, nepal correspondence: surya gaire   centre for research on the epidemiology  of Disasters (creD), Université  catholique de louvain (Ucl), clos  chapelle-aux-champs, Bte B1.30.15, 1200  Brussels, Belgium   T el +977 98 5122 7273   email sugaire@gmail.co mBackground:  Stunting is a major public health problem that results from inadequate nutritional  intake over a long period of time.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
Available from:  http://www-wds.worldbank.org/external/default/WDSContentServer/ WDSP/IB/2015/04/23/090224b082e00a32/1_0/Rendered/PDF/Philip - pines0000own0Option00CAT0DDO0.pd f.  5.,Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Available from: http://www.unescap.org/sites/default/files/ Technical%20paper-Overview%20of%20natural%20hazards%20 and%20their%20impacts_final.pd f. Accessed February 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
Available from http://www.dwidp.gov.,Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Available from http://dhsprogram.com/pubs/pdf/FR257/ FR257%5B13April2012%5D.pd f. Accessed February 4, 2016.",OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
Available from:   http://mics.unicef.org/files?job =W1siZiIsIjIwMTUvMDQvMDgvMD gvMjgvNTIvODQ2L01JQ1MzX0NoYXB0ZXJfMF9fX1RpdGxlX1B - hZ2VfYW5kX0NvbnRlbnRzLnBkZiJdXQ&sha =9434bf73f759e62 5.,Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Available from http://unicef.org.np/uploads/ files/44234273128039655-nmics-5-key-findings.pd f. Accessed  February 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
Available from: http://www.unicef.org/nutrition/training/2.5/4.,Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Available from  https://dhsprogram.com/pubs/pdf/FRIND3/FRIND3-V ol1AndV ol2.pd f.  Accessed February 4, 2016.",OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
Available from:  http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.175.2774 &rep=rep1&type =pdf.,OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Available from: http://www.who.int/nutrition/publications/guiding_  principles_compfeeding_breastfed.pd f. Accessed February 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Available  from: http://www.unicef.org/socialpolicy/files/Dalits_in_India_and_ Nepal_Policy_Options_for_Improving_Social_Inclusion(1).pd f.  Accessed February 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
"Avail - able from http://www.adb.org/sites/default/files/publication/156773/ adbi-dp21.pd f. Accessed February 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b3/47/rmhp-9-113.PMC4908949.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012074).,Non-OADS,/arxiv_data1/oa_pdf/45/6d/bmjopen-2016-012074.PMC4908951.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010516).,Non-OADS,/arxiv_data1/oa_pdf/fc/65/bmjopen-2015-010516.PMC4908961.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/65/bmjopen-2015-010516.PMC4908961.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/57/38/mtm201626.PMC4909093.pdf
69 The intensified interest from biotech and pharmaceutical com- panies will surely accelerate the development of improved manu- facturing platforms.7 An increasing number of tools are available  for clinical CAR-T cell manufacturing and consortiums such as the CCRM and NNMI are forming (http://ccrm.ca/cell-manufacturing;  http://www.manufacturing.gov/nist-nnmi-institutes.html).,Non-OADS,/arxiv_data1/oa_pdf/81/38/mto201615.PMC4909095.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/ea/sft064.PMC4909126.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/8a/main.PMC4909132.pdf
Past  surgical  his- tory  was  signiﬁcant  for  4  laparotomies  which  were  excision  of http://dx.doi.org/10.1016/j.ijscr.2016.05.043 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/8a/main.PMC4909132.pdf
"Deprez,  M.  Häfner,  D.  Hartmann,  C.  Hassan,  T.  Hucl, G.  Lesur,  L.  Aabakken,  A.  Meining,  Removal  of  foreign  bodies  in  the  upper gastrointestinal  tract  in  adults:  European  Society  of  Gastrointestinal Endoscopy  (ESGE)  clinical  guideline,  Endoscopy  (February  (10))  (2016), http://dx.doi.org/10.1055/s-0042-100456 .",Non-OADS,/arxiv_data1/oa_pdf/d4/8a/main.PMC4909132.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/52/cvw090.PMC4909162.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/9c/dsw007.PMC4909306.pdf
"It displaysa cryptic body colour, is covered by a mucous scaleless skin, followsa carnivorous narrow prey-spectrum diet, and undergoes a completemetamorphosis to adapt to benthic life (https://aquatrace.eu/lea ﬂets/ turbot).",Non-OADS,/arxiv_data1/oa_pdf/4a/9c/dsw007.PMC4909306.pdf
"2 The great commercial value of turbot has promoted its intensive farming during the last decade ( ∼75,000 t) (https://aquatrace.eu/ leaﬂets/turbot).",Non-OADS,/arxiv_data1/oa_pdf/4a/9c/dsw007.PMC4909306.pdf
"15Sequences of orthologous genes from anchored scaffolds were compared withthe updated versions from model ﬁsh genomes downloaded from ftp://ftp.ensembl.org: Tetraodon nigroviridis v. 8.61, Oryzias latipes v.1.61 and C. semilaevis , in order to identify syntenies.",OADS,/arxiv_data1/oa_pdf/4a/9c/dsw007.PMC4909306.pdf
RNA genes annotation Non-coding RNA (ncRNA) genes were annotated by running the pro-gram cmsearch v1.1 within Infernal (http://www.ncbi.nlm.nih.gov/pubmed/24008419) against the RFAM database of RNA families(v12.0) (http://www.ncbi.nlm.nih.gov/pubmed/23125362).,OADS,/arxiv_data1/oa_pdf/4a/9c/dsw007.PMC4909306.pdf
Paralogy relationships between turbotproteins were deduced using a reciprocal second best-match strategy.Pairs of paralogues were annotated using BlastKOALA (http://www.kegg.jp/blastkoala/) for KO codes.,OADS,/arxiv_data1/oa_pdf/4a/9c/dsw007.PMC4909306.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/1d/dsw009.PMC4909308.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
We also searched the predicted WRKY genes on other sources like chickpea transcriptome database (CTDB) (http://www.nipgr.res.in/ctdb.html)and http://bioinfo.bti.cornell.edu/cgi-bin/itak/index.cgi.,OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
The M. truncatula -annotated proteins were derived from http://jcvi.org/ medicago/.,OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
The exon –intron structure was generated using online tool Gene Structure Display Server (GSDS 2.0; http://gsds.cbi.pku.edu.cn).,OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
truncatula WRKY proteins was executed using PROMALS3D (http://prodata.swmed.edu/promals3d/promals3d.php) and MUS-CLE.,OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
Domain and motif identi ﬁcation The SMART (http://smart.embl-heidelberg.de/) and Pfam (http://pfam .sanger.ac.uk/search) were used to predict and verify the functionaldomains.,OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
MEME (Multiple Expectation Maximization for MotifElicitation) program 4.11.1 available at http://meme-suite.org/tools/meme was used to predict the potential motifs in WRKY proteins.The transmembrane (TM) helices were predicted by the use ofTMHMM Server v.2.0 (http://www.cbs.dtu.dk/services/TMHMM/).,OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
"At least 10 clones,for each position of CaWRKY16 ’sselected genomic region, were sequenced, and data were analysed online by Kismeth software (http://katahdin.mssm.edu/kismeth/revpage.pl).",OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
"These 82 genomic regions were further checked for the ex-pression by analysing the CTDB database (http://www.nipgr.res.in/ctdb.html), the 454 cDNA reads derived from A. rabiei inoculated aer- ial chickpea tissue (Kumar et al., unpublished) and chickpea RNA-seqdata from NCBI.",OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
8)a n da l s oi n Arachis duranensis (http://peanutbase.org).,Non-OADS,/arxiv_data1/oa_pdf/87/45/dsw010.PMC4909309.pdf
PTEMD and the genome-wide polymorphic TEs in M. oryzae and maize are publically available at http://www.kanglab.cn/blast/PTEMD_V1.02.htm.,OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"Genome sequence data TheMagnaporthe oryzae reference genome sequence (version 8) was downloaded from the Broad Institute (http://www.broadinstitute.org).To test the PTEMD program, we re-sequenced the genomes of M.oryzae strains HM-1 and HM-2, which were isolated from rice lesions by the single-spore method (data available from the PTEMD programhomepage http://www.kanglab.c n/blast/PTEMD_V1.02.htm).",OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"The re- sequence data sets of M. oryzae generations 0, 10, and 20 were down- loaded from a M. oryzae re-sequencing project (GenBank accession number: one isolate of generation 0: SRX220856; three isolates ofgeneration 10: SRX220857, SRX220858, and SRX220859; three iso-lates of generation 20: SRX220860, SRX220861, and SRX220862).The maize B73 reference genome sequence was downloaded from thePlant Genome Database (http://www.plantgdb.org/).",OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
The library used in this study is the Repbase library (version 19.06; http://www.girinst.org/repbase/).,Non-OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"The programs used in this study are RepeatMasker (version4.05; http://www.repeatmasker.org), Repeatscout version 1.0.5 14, Piler (http://drive5.com/piler), and RECON version 1.08 (http://www.repeatmasker.org/RECON-1.08.tar.gz).",OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"We then anno-tated the sequences by aligning them with NT/NR, Repbase, andmaize TE database (http://maizetedb.org/~maize/), and manually clas-siﬁed them based on their structure, terminal sequences, and target site duplications (TSDs).",OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"To determine the identity of those 81 sequences families, we compared them with four databases (Repbase, NT, NR, and themaize-speci ﬁc TE database: http://maizetedb.org/~maize/).",OADS,/arxiv_data1/oa_pdf/91/1f/dsw011.PMC4909310.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"Thus, genome ana-lyses in various non-model crops are underway, and the genomes of>50 non-model crops have already been sequenced (CoGepedia;https://genomevolution.org/).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"Here, we used NGS-based technology to sequence the buckwheat genome, and constructed the Buckwheat Genome DataBase (BGDB;http://buckwheat.kazusa.or.jp).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"The PE and MP reads were subjected to quality trimming byPRINSEQ 0.20.4, 17and further to adaptor trimming by the fas- tx_clipper program in the FASTX-toolkit 0.0.14 (http://hannonlab.cshl.edu/fastx_toolkit).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"After the assembly, gaps in scaffolds were closed using GapCloser 1.10 (http://soap.genomics.org.cn/soapdenovo.html)(P= 31).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"Sequences hom- ologous to bacteria, fungi, and human (hg19) genome sequences, vectorsequences from UniVec (http://www.ncbi.nlm.nih.gov/tools/vecscreen/univec/), chloroplast (accession number: NC_000932.1), and mito-chondrial (accession number: NC_001284.2) genome sequences fromA.",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"Finally, scaffolds longer than 300 bp were selected and designated FES_r1.0.Repetitive sequences in FES_r1.0 were detected using RepeatScout1.0.5 23and RepeatMasker 4.0.3 (http://www.repeatmasker.org) according to a previously described method.18 2.5.",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
The merged genes were subjected to similarity searches against NCBI ’s NR database (ftp://ftp.ncbi.nlm.nih.gov/blast/db/FASTA/nr.gz) and amino acid sequences of A. thaliana from TAIR10 (https://www.,OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"Gaps in the contigs were closed using GapCloser 1.10(http://soap.genomics.org.cn), and mate-pair reads were used forscaffolding in SSPACE2.0.",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
The BGDB is available from theKazusa DNA Research Institute (http://buckwheat.kazusa.or.jp).,OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"In thisstudy, we tried to identify the promoter sequences of genes in the ﬂavon- oid biosynthetic pathway and estimated the TFBSs using PLACE (http://www.dna.affrc.go.jp/PLACE/).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"To assign these seven putative SSs of buckwheat to previously proposed phylogenetic groups, 67we performed NJ analysis using the deduced amino acid sequences of SSs from various plant species.A keyword search using ‘starch synthase ’was also conducted in Phy- tozome 10.3 (http://phytozome.jgi.doe.gov/) analysing 36 angiospermspecies (Supplementary Table S10).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"The scaffold sequences are available under the acces-sion numbers BCYN01000001-BCYN01387594 (387,594 entries).The draft genome sequence FES_r1.0, CDS and protein sequences,and annotation ﬁle (gff ﬁle) are also available from the Buckwheat Genome DataBase (BGDB; http://buckwheat.kazusa.or.jp).",OADS,/arxiv_data1/oa_pdf/89/8d/dsw012.PMC4909311.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/d3/dsw014.PMC4909313.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/a7/dsw015.PMC4909314.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/ab/dsw016.PMC4909315.pdf
"Molecular markers During map construction in this study, 5,299 new primer pairs were applied, including 4,569 newly published SSRs (2,937 MON-preﬁxed, 664 NBRI-pre ﬁxed, 670 CCRI-pre ﬁxed, 200 HAU-pre ﬁxed, and 98 NAU-pre ﬁxed; http://www.cottongen.org/) and 730 other batches of primers (579 GhirPIP-pre ﬁxed, 13115 cg-pre ﬁxed,14and 36 cot-pre ﬁxed14).",OADS,/arxiv_data1/oa_pdf/a6/ab/dsw016.PMC4909315.pdf
"Next, the best hit for each marker was chosen, and all the best hits were illustrated intui-tively using online drawing tools (http://circos.ca/).",Non-OADS,/arxiv_data1/oa_pdf/a6/ab/dsw016.PMC4909315.pdf
"Cancer 12, 835 –848.EBioMedicine 7 (2016) 11 DOIs of original article: http://dx.doi.org/10.1016/j.ebiom.2016.03.018 ,http:// dx.doi.org/10.1016/j.ebiom.2016.03.031 .",OADS,/arxiv_data1/oa_pdf/f4/2e/main.PMC4909323.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.019 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/main.PMC4909323.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/main.PMC4909323.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Myotonic dystrophy 2Myalgia Quantitative sensory testing Pressure pain thresholdRNA SeqMAO B inhibitor 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.0172352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
functions were analysed using Quick GO gene ontology database (http://www.ebi.ac.uk/QuickGO/ ).,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1002/art.24037 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.pain.2013.05.047 .,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
"http://dx.doi.org/10.1016/S1097- 2765(02)00572-5 .Depetris, R.S., Hu, J., Gimpelevich, I., Holt, L.J., Daly, R.J., Hubbard, S.R., 2005.",OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.molcel.2005.09.001 .,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1111/ejn.12458 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1126/ scitranslmed.3007017 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1210/jc.2011-3037 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
Pain http://dx.doi.org/10.1097/AJP.0000000000000300 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1001/archneurol.2011.191 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
"Pain 2, 24. http://dx.doi.org/10.1186/1744-8069-2-24 .",Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1007/978-3-642-45106-5_10 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1126/science.1062125 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
"BMC Genomics 12, 98. http://dx.doi.org/10.1186/1471-2164-12-98 .",OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.berh.2007.03.003 .,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.bbadis.2014.05.019 .,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
"Pain 147, 72 –83.http://dx.doi.org/10.1016/j.pain.2009.08.010 .",OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1038/nn.3612 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1093/hmg/ddr515 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1016/j.pain.2006.01.041 .,OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1086/421528 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
"Muscle Nerve 45, 70–74.http://dx.doi.org/10.1002/mus.22249 .210 R. Moshourab et al.",Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
http://dx.doi.org/10.1093/hmg/ddr568 .,Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
"10, 95. http://dx.doi.org/10.1186/1479-5876-10-95 .",Non-OADS,/arxiv_data1/oa_pdf/f6/66/main.PMC4909324.pdf
